Web Catalog CRS

List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001414 Human Hepatitis B immunoglobulin BRP
Effective from 2013/11/12

Batch n Quantity Sale
per vial Unit
1
100 mg
1 55 IU/vial
Information
Monograph Leaflet
Storage
Extra
Price
charges
90
c
0722, 0338
Yes
-20C
0673
Yes
+5C
79
2439
Yes
+5C
79
Yes
+5C
79
+5C
79
Y0001484 Medroxyprogesterone acetate for peak identification
25 mg
Y0001523 Ursolic acid
25 mg
Y0001532 Norethisterone acetate for system suitability
2.585 mg
0850
Y0001562 Doxylamine hydrogen succinate
60 mg
1589
Y0001565 Recombinant Major Allergen rBet v 1
0.01025 mg 1
10.25 micrograms of rBet v 1
1063
Yes
-20C
90
Y0001566 Recombinant Major Allergen rPhl p 5a
0.00856 mg 1
8.56 micrograms of rPhl p 5a
1063
Yes
-20C
90
Y0001567 Docusate sodium
10 mg
Y0001570 Nitrofural impurity B
30 mg
Y0001571 Naloxone impurity D
25 mg
Y0001572 Atovaquone
270 mg
Y0001573 Atovaquone for system suitability
10 mg
New Y0001574 Mesalazine for system suitability
10 mg
Batch 1 is valid until 30 April 2014
Y0001575 Bupivacaine impurity F
70 mg
2,6-dimethylaniline
Y0001577 Isoprenaline impurity A
15 mg
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone
Y0001580 Rocuronium bromide
10 mg
Y0001585 Cellulose acetate butyrate
60 mg
Y0001591 Flutamide for system suitability
10 mg
Y0001592 Ivy leaf dry extract HRS
70 mg
Y0001594 Megestrol acetate impurity K
0.01 mg
150 mg
New Y0001595 Diacerein
94.0 % CHO
1418
94.8 % CHON; (5-nitrofuran-2-yl)methylene diacetate
99.3% CHClO
+5C
79
1135
Yes
+5C
79
0729
Yes
+5C
79
2192
Yes
+5C
79
2192
Yes
+5C
79
1699
Yes
+5C
79
0541
+5C
79
1332
+5C
79
1764
-20C
g(c)
79
+5C
79
1423
Yes
+5C
79
16% of CHO
2148
Yes
-20C
79
+5C
79
99.2% CHO
2409
Yes
+5C
79
94,4%
Y0001596 Diacerein impurity B
20 mg
2409
Yes
+5C
79
Y0001597 Diacerein impurity mixture
0.014 mg
2409
Yes
+5C
79
Y0001598 Dutasteride
150 mg
2641
Yes
+5C
79
Y0001599 Wedelolactone
15 mg
2564
Yes
-20C
79
Y0001603 Dutasteride for system suitability
10 mg
2641
Yes
+5C
79
Y0001604 Finasteride for peak identification
15 mg
Yes
+5C
79
Y0001605 Eucommia bark HRS
2100 mg
Yes
-20C
79
Y0001609 Norflurane - reference spectrum
1 mg
79
Y0001611 Esculetin
25 mg
99.9% CHO
2452
Yes
+5C
79
Y0001612 Esculin
25 mg
92,4% CHO
2452
Yes
+5C
79
Y0001615 Beta-sitosterol
72.5% CHO
2579
Yes
-20C
79
1592
Yes
+5C
79
+5C
79
2410
Yes
+5C
79
+5C
79
25 mg
New Y0001617 Ketotifen for peak identification
15 mg
New Y0001619 Ketotifen hydrogen fumarate
10 mg
New Y0001620 2,4-dichlorobenzyl alcohol
250 mg
New Y0001621 2,4-Dichlorobenzyl alcohol impurity A
25 mg
Council of Europe, all rights reserved 2013
2412
99,9% CHClO
2410
1
For extra charges, please see supply terms and conditions.

Order
Reference Standard
Code
New Y0001622 2,4-Dichlorobenzyl alcohol impurity C

per vial Unit
1
25 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
g
2410
+5C
0822
+5C
79
+5C
79
Y0001633 Ethylcellulose
100 mg
New Y0001642 Capecitabine
150 mg
New Y0001643 Capecitabine impurity A
5 mg
+5C
79
New Y0001644 Capecitabine impurity B
5 mg
2762
+5C
79
New Y0001645 Capecitabine impurity D
10 mg
2762
+5C
79
Y0001561 Abacavir sulfate
20 mg
2589
+5C
79
Y0001551 Abacavir for system suitability
10 mg
2589
Yes
+5C
79
Y0001552 Abacavir for peak identification
10 mg
2589
Yes
+5C
79
Y0000055 Acamprosate calcium - reference spectrum
n/a
79
Y0000116 Acamprosate impurity A
50 mg
3-aminopropane-1-sulphonic acid
1585
+5C
79
Y0000500 Acarbose
94.7 mg
94.7 mg CHNO
2089
+5C
79
Y0000354 Acarbose for identification
10 mg
2089
+5C
79
Y0000427 Acarbose for peak identification
20 mg
A0040000 Acebutolol hydrochloride
50 mg
Y0000359 Acebutolol impurity B
10 mg
-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)
Y0000127 Acebutolol impurity C
20 mg
Y0000128 Acebutolol impurity I
0.004 mg
Y0000056 Aceclofenac - reference spectrum
n/a
Y0001094 Aceclofenac for peak identification
10 mg
Y0000085 Aceclofenac impurity F
20 mg
benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate ; Batch 1 is
valid until 31 March 2014
1281
Y0000086 Aceclofenac impurity H
10 mg
[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid
Y0000810 Acemetacin
100 mg
Y0000811 Acemetacin impurity A
10 mg
Y0000842 Acemetacine impurity mixture
0.06 mg
A0070000 Acesulfame potassium
50 mg
A0070020 Acesulfame potassium impurity B
15 mg
A0100000 Acetazolamide
100 mg
Y0001084 Acetazolamide for system suitability
0.0068 mg
0454
Y0000002 Acetylcholine chloride
50 mg
1485,1971
A0150000 Acetylcysteine
50 mg
A0152000 Acetylcysteine impurity C
10 mg
88.5% CHNOS; N,N'-diacetyl-L-cystine
10 mg
N,-diacetyl-L-cysteine
2
A0153000 Acetylcysteine impurity D

1585
2089
+5C
79
0871
+5C
79
0871
+5C
79
N-(3-acetyl-4-hydroxyphenyl)butanamide
0871
+5C
79
N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide
0871
+5C
79
79
+5C
79
+5C
79
1281
+5C
79
1686
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Batch 1 is valid until 1 May 2013

propoxy]phenyl]
Yes
1281
1281
Yes
1686
4-chlorobenzoic acid
1686
Yes
1282
5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide ; Batch 3 is valid
until 31 August 2013
1282
Yes
0454
Yes
0967
0967
Yes
+5C
79
-20C
79
+5C
79
+5C
79
79
0967
+5C
a

Order
Reference Standard
Code
Y0000565 -Acetyldigoxin

per vial Unit
2
50 mg
1 98.6% CHO
Information
Monograph Leaflet
2168
Y0000642 -Acetyldigoxin for peak identification
10 mg
2168
A0200000 Acetylsalicylic acid
15 mg
0309
Y0001460 Acetylsalicylic acid for peak identification
10.26 mg
0309
A0208000 N-Acetyltryptophan
125 mg
1383
A0202000 N-Acetyltyrosine
200 mg
Y0001462 Acetylsulfadiazine
0.002 mg
Y0000693 Acholeplasma laidlawii BRP
1 ml
20607
A0220000 Aciclovir
75 mg
0968
Y0001271 Aciclovir for peak identification 1
0.303 mg
0968
Y0001269 Aciclovir for peak identification 2
0.004 mg
0968
Y0001264 Aciclovir for system suitability
10 mg
A0225000 Acitretin
100 mg
Y0001464 Actaea racemosa dry extract for system suitability HRS
1200 mg
Y0001543 Actaea racemosa for assay CRS
300 mg
Y0001463 Actaea racemosa HRS
1200 mg
Y0001121 Adapalene
100 mg
99.9% CHO
2445
Y0001120 Adapalene impurity C
6 mg
1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane
2445
Y0001119 Adapalene for peak identification
2.022 mg
2445
A0230000 Adenine
50 mg
A0230200 Adenosine
50 mg
Y0000110 Adipic acid
50 mg
Y0000882 Adrenaline
5 mg
A0300000 Adrenaline tartrate
Y0000740 Adrenaline impurity mixture

Y0000707 Adrenaline tartrate with impurity A
Y0000883 Adrenaline with impurity F
Y0000728 Agnus castus fruit standardised dry extract
Storage
+5C
Yes
Extra
Price
charges
79
f
+5C
79
+5C
79
+5C
79
+5C
79
1384
+5C
79
0294
+5C
79
-80C
120
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
Yes
+5C
79
1385
Yes
+5C
g(b)
79
2069
Yes
-20C
79
2069
Yes
+5C
79
2069
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0800,1486
+5C
79
1486
+5C
79
1586
+5C
79
2303
+5C
79
100 mg
0254, 0285,
0732
+5C
79
0.005 mg
0254,2303
Yes
+5C
79
15 mg
0254
Yes
+5C
79
10 mg
2303
Yes
+5C
79
200 mg
2147
Yes
-20C
79
A0325000 Alanine
60 mg
0614,0752
+5C
79
A0325100 Albendazole
50 mg
1386
+5C
79
A0325200 Alcuronium chloride
50 mg
A0325450 Alfacalcidol
5 mg
Y0001601 Alfacalcidol for system suitability
2.5 mg
A0325451 Alfacalcidol - reference spectrum
n/a
A1225000 Alfadex
150 mg
0968
99.7% CHO
74.7% CHNO; Monoammonium glycyrrhizate
0.13% CHO
Yes
1285
-20C
g(c)
79
1286
Yes
-20C
e(d)
300
1286
Yes
-20C
e(d)
79
1286
79
79
99.8% CHO ; Batch 7 is valid until 31 December 2012
89.7% [CH0]
3
1070,1487
+5C

Order
Reference Standard
Code
A0325500 Alfentanil hydrochloride - reference spectrum

per vial Unit
1
n/a
1
Information
Monograph Leaflet
1062
A0325800 Alfuzosin hydrochloride
10 mg
Y0001581 Alimemazine for system suitability
5 mg
Y0000832 Alfuzosin for system suitability
10 mg
1287
Y0001583 Alimemazine hemitartrate
15 mg
2650
A0349000 Allantoin
60 mg
A0350000 Allopurinol
100 mg
99.9% CHNO
0576
A0350010 Allopurinol impurity A
10 mg
5-amino-1H-pyrazole-4-carboxamide
A0350020 Allopurinol impurity B
10 mg
5-formylamino-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 31

December 2012
A0350030 Allopurinol impurity C
10 mg
A0350040 Allopurinol impurity D
15 mg
G0400000 Glycerol (85 per cent) - reference spectrum
n/a
A0350050 Allopurinol impurity E
20 mg
A0351000 Allylstrychnine bromide
10 mg
H0215000 Hepatitis C Virus RNA for NAT testing BRP
40 mg
HCV-RNA content 500 IU per vial; For plasma pool testing by NAT
Y0000235 Almagate
25 mg
13.4% carbonic acid
Y0000255 Almagate - reference spectrum
n/a
2010
A0357000 Alprazolam - * psy
100 mg
1065
A0360000 Alprenolol hydrochloride
100 mg
Y0000054 Alprostadil
50 mg
99.4% CHO ; Batch 1 is valid until 31 January 2013
Y0000606 Altizide
150 mg
99.9% CHClNOS
Y0000843 Altizide impurity B
15 mg
3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene
Y0000687 Alverine citrate
5 mg
0.125 mg
Batch 1 is valid until 31 December 2013
2156
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
New Y0000595 Alverine for peak identification
Storage
1287
Extra
Price
charges
79
l
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0576
+5C
79
0576
+5C
79
5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 1

May 2013
0576
+5C
79
ethyl 5-amino-1H-pyrazole-4-carboxylate
0576
+5C
79
79
+5C
79
1288
Yes
0496,0497
0576
ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate
1285
See leaflet,
20621
Yes
2010
-20C
g(c)
79
-20C
e(d)
242
+5C
79
79
79
+5C
0628,0876
+5C
79
1488
Yes
-20C
g(c)
79
0370,2185
Yes
+5C
79
+5C
79
2185
2156
Yes
+5C
79
-20C
79
Y0000607 Alverine impurity D
10 mg
2156
+5C
79
A0363000 Amantadine hydrochloride
100 mg
0463
+5C
79
A0363700 Ambroxol hydrochloride
125 mg
1489
+5C
79
A0900000 Amfetamine sulfate - reference spectrum
n/a
0368
79
A0365000 Amidotrizoic acid dihydrate
100 mg
0873
+5C
79
Y0001461 Amidotrizoic acid for system suitability
0.08 mg
0873
Yes
+5C
79
A0368000 Amikacin
200 mg
91.7 % CHNO ; Batch 2 is valid until 28 February 2013
1289,1290
Yes
+5C
79
Y0001467 Amikacin impurity I
20 mg
(2S)-4-amino-2-hydroxybutanoic acid
1290
+5C
79
A0365900 Amikacin sulfate
200 mg
The batch 3 is not suitable for use in the assay in monograph 1290:07/2012.
Amikacin CRS A0368000 is also needed. See leaflet.
1290
+5C
79
Yes

Order
Reference Standard
Code
Y0001117 Amikacin for system suitability

Information
per vial Unit
2
10 mg
1 amikacin for system suitability CRS 1 is suitable for 01/2010:1289 and
01/2010:1290 only. Batch 2 is suitable for 07/2012:1289 and 07/2012:1290.
Monograph Leaflet
1289,1290
Yes
A0370000 Amiloride hydrochloride
100 mg
Y0000020 Amiloride impurity A
20 mg
Y0000173 4-Aminobenzoic acid
60 mg
A0420000 Aminocaproic acid
50 mg
A0460000 7-Aminodesacetoxycephalosporanic acid
20 mg
A0496000 Aminoglutethimide
125 mg
A0496005 Aminoglutethimide impurity A
20 mg
A0496020 Aminoglutethimide impurity D
10 mg
A0575000 Amiodarone hydrochloride
100 mg
Y0000129 Amiodarone impurity D
20 mg
Y0000130 Amiodarone impurity E
20 mg
A0590000 Amisulpride
10 mg
1490
Y0001534 Amisulpride for system suitability
1.0015 mg
1490
Y0000563 Amitriptyline hydrochloride
10 mg
Y0000049 Amlodipine besilate
150 mg
99.7% CHClNOS
1491
Yes
Y0001067 Amlodipine for peak identification
15 mg
Batch 1 is valid until 31 August 2013
1491
Y0001068 Amlodipine impurity A
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate ;

Batch 1 is valid until 1 June 2013
1491
Y0001069 Amlodipine impurity B
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 30 November 2013
Y0001070 Amlodipine impurity G
15 mg
dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 1 June 2013
Y0000302 Ammonio methacrylate copolymer(type A) - reference

spectrum
n/a
Y0000303 Ammonio methacrylate copolymer(type B) - reference

spectrum
n/a
A0650000 Amobarbital - * psy
A0700000 Amobarbital sodium - * psy

A0800000 Amoxicillin trihydrate
Y0001521 Amoxicillin trihydrate for performance verification

Storage
+5C
Extra
Price
charges
79
a
0651
+5C
79
0651
+5C
79
1687
+5C
79
0874
+5C
79
0708,0813
+5C
79
1291
+5C
79
(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)
1291
+5C
79
3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)
1291
+5C
79
0803
+5C
g(b)
79
(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
0803
+5C
79
(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
0803
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
1491
+5C
79
1491
+5C
79
2081
79
2082
79
500 mg
0594
+5C
79
500 mg
0166
+5C
79
200 mg
86.2% CHNOS
0167,0168,0
260,
0577,0578,0
813,
1140,1653
+5C
79
5000 mg
Instructions
+5C
79
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate ; Batch 2 is valid until 31

August 2013
Cefadroxyl impurity B
Yes
0464
Yes
5

Order
Reference Standard
Code
Y0000005 Amphotericin B
Y0001014 Amphotericin B for peak identification

Information
per vial Unit
4
100 mg
1 Batch 4 is not suitable for microbiological assay (see leaflet).
2
10 mg
1 Batch 1 is valid until 1 June 2013
Monograph Leaflet
1292
Yes
-20C
1292
Yes
-20C
79
Yes
-20C
79
0167,0168,0
578,
1168,1169
Yes
+5C
79
+5C
79
+5C
79
100 mg
944 IU per mg
A1000000 Ampicillin (anhydrous)
220 mg
97.7% CHNOS ; Batch 4 is valid until 31 December 2013
A1100000 Ampicillin trihydrate
150 mg
Y0001522 Anastrozole
100 mg
100.0% CHN
2406
Y0001531 Anastrozole impurity E
10 mg
2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2406
Y0001386 Angelica dahuria root
160 mg
A1200000 Anhydrotetracycline hydrochloride
15 mg
93.3% CHNO
Y0001244 Amylmetacresol
285 mg
99.5% CHO
Y0001245 Amylmetacresol for peak identification
10 mg
Y0001466 Anhydrous Docetaxel
15 mg
A1210000 Antazoline hydrochloride
50 mg
A1220000 Alpha-apo-oxytetracycline
20 mg
Y0001465 Apomorphine hydrochloride hemihydrate
15 mg
Y0001471 Apomorphine impurity B (morphine sulfate) * - narc
40 mg
88.2% CHNOS,5HO; morphine sulfate
0136
Yes
A1230000 Beta-apo-oxytetracycline
20 mg
88,0% CHNO
0198
Yes
A1250000 Aprotinin solution BRP
0.5 ml
22.3 Ph. Eur. Units per ml
0579,0580
Y0001154 Aprotinin for system suitability
2.7 mg
0580
A1269000 L-Arabinitol
10 mg
Y0000806 Arbutin
100 mg
93.5% CHO
1054
Yes
A1270000 Arginine
50 mg
99.8% CHNO
0806,0930,1
654,
2114,2566
Yes
Y0000304 Arginine aspartate
20 mg
New A1271000 Arginine hydrochloride
60 mg
New Y0001649 Aripiprazole
170 mg
See leaflet
2617
New Y0001650 Aripiprazole impurity F
10 mg
7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]-3,4-dihydroquinolein-2
(1H)-one
2617
Y0001323 Aristolochia
140 mg
Y0001185 Aristolochic acid I
1 mg
Y0001175 Aristolocholic acid for system suitability
1 mg
0168,0260,0
577,
0578,0808,2
211, 2212
Yes
+5C
79
2556
Yes
+5C
79
0210,0211,1
654
Yes
+5C
79
2405
Yes
+5C
79
2405
Yes
+5C
79
2593
+5C
79
0972
+5C
79
+5C
79
+5C
79
+5C
90
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
2096
+5C
79
0805,0885,0
998
+5C
79
+5C
79
+5C
79
0198
Yes
0136
1381
1.00 mg CHNO
6
Extra
Price
charges
79
c
20702
Y0001361 Amphotericin B for microbiological assay
Storage
Yes
20821
Yes
+5C
79
20821
Yes
+5C
79
20821
Yes
+5C
79

Order
Reference Standard
Code
Y0000079 Articaine hydrochloride

per vial Unit
2
100 mg
1
Information
Monograph Leaflet
Storage
1688
+5C
Extra
Price
charges
79
a
Y0000080 Articaine impurity A
15 mg
methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate
1688
+5C
79
Y0000081 Articaine impurity E
10 mg
methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate
1688
+5C
79
A1300000 Ascorbic acid
100 mg
Vitamin C ; Batch 3 is valid until 31 December 2012
0253,0958,1
791
+5C
79
Y0001024 Ascorbic acid impurity C
20 mg
D-xylo-hex-2-ulosonic acid (D-sorbosonic acid)
0253,1791
+5C
79
Y0001170 Ascorbic acid impurity D
10 mg
methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate) ; Batch 1 is valid until

31 December 2012
0253,1791
+5C
79
Y0000800 Ascorbyl palmitate
10 mg
0807
+5C
79
Y0000305 Asparagine monohydrate
60 mg
2086
+5C
79
A1320000 Aspartame
40 mg
0973
+5C
79
A1321000 Aspartame impurity A
10 mg
0973
+5C
79
A1330000 Aspartic acid
50 mg
0750,0797
+5C
79
Y0001171 Astragaloside IV
40 mg
2435
-20C
79
A1340000 Atenolol
100 mg
0703
+5C
79
Y0001089 Atenolol for system suitability
5 mg
0703
Yes
+5C
79
Y0001587 Atomoxetine for impurity A identification
10 mg
N-methyl-3-phenoxy-3-phenylpropan-1-amine
2640
Yes
+5C
79
Y0001586 Atomoxetine hydrochloride
110 mg
99,9% CHClNO
2640
Yes
+5C
79
Y0001588 Atomoxetine impurity B
10 mg
(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1amine
2640
+5C
79
Y0001589 Atomoxetine impurity D
5 mg
(3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1amine
2640
+5C
79
Y0001327 Atorvastatin calcium trihydrate
150 mg
95.3% CHCaFNO ; Batch 1 is valid until 30 November 2013
2191
+5C
79
Y0001328 Atorvastatin impurity A
10 mg
desfluoroatorvastatin ; Batch 1 is valid until 31 January 2014
2191
+5C
79
Y0001329 Atorvastatin impurity B
10 mg
3-epi-atorvastatin ; Batch 1 is valid until 30 November 2013
2191
+5C
79
Y0001330 Atorvastatin impurity C
10 mg
fluoroatorvastatin
2191
+5C
79
Y0001331 Atorvastatin impurity D
10 mg
3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide ; Batch 1 is valid until 31 August 2013
2191
+5C
79
Y0001332 Atorvastatin impurity E
10 mg
ent-atorvastatin ; Batch 1 is valid until 28 February 2013
2191
+5C
79
Y0000424 Atracurium besilate
120 mg
98.5% CHNOS
1970
Yes
+5C
g(b)
79
Y0000105 Rutoside trihydrate
100 mg
87.6% CHO
1795,1874,2
184,
2427,2639
Yes
+5C
79
Y0000503 Atracurium for impurity F identification
5 mg
1970
Yes
+5C
g(b)
79
Y0000504 Atracurium for peak identification
5 mg
1970
Yes
+5C
g(b)
79
Y0000878 Atropine
30 mg
2056
+5C
79
Y0000845 Atropine for peak identification
0.25 mg
+5C
79
2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)

97.8% CHO
Batch 1 is valid until 31 January 2013

7
0068,2056
Yes
Yes

Order
Reference Standard
Code
Y0000816 Atropine impurity B

Information
per vial Unit
1
10 mg
1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)
A1400000 Atropine sulfate
Y0000029 Azaperone
A1500000 Azathioprine
Monograph Leaflet
Storage
Extra
Price
charges
79
g
0068,2056
+5C
0068
+5C
79
20 mg
50 mg
1708
+5C
79
100 mg
0369
+5C
79
Y0001240 Azathioprine impurity A
10 mg
1-methyl-4-nitro-1H-imidazol-5-amine
0369
+5C
79
Y0001246 Azathioprine impurity G
5 mg
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine)
0369
+5C
79
Y0000326 Azelastine hydrochloride
25 mg
1633
+5C
79
Y0000327 Azelastine impurity B
5 mg
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane
1633
+5C
79
Y0000328 Azelastine impurity D
5 mg
4-(4-chlorobenzyl)phthalazin-1(2H)-one
1633
+5C
79
Y0000329 Azelastine impurity E
5 mg
3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
1633
+5C
79
Y0000306 Azithromycin
200 mg
94.4% CHNO ; Batch 3 is valid until 31 December 2013
1649
Yes
+5C
79
Y0000637 Azithromycin for peak identification
15 mg
1649
Yes
+5C
79
Y0000641 Azithromycin for system suitability
0.05 mg
Batch 5 is valid until 31 October 2013
1649
Yes
+5C
79
Y0000307 Azithromycin impurity A
10 mg
6-demethylazithromycin
+5C
79
Y0000285 B19 virus DNA for NAT testing BRP
150 mg
B19 virus DNA content log 5.8 IU per ml for plasma pool testing by NAT
Yes
-20C
e(d)
242
B0070000 Bacampicillin hydrochloride
120 mg
92.9% CHClNOS
+5C
79
B0100000 Bacitracin zinc
150 mg
62.9 IU per mg
Yes
-20C
79
B0200000 Baclofen
50 mg
+5C
79
B0200050 Baclofen impurity A
50 mg
91.4% CHClNO; (4RS)-4-(4-chlorophenyl)pyrrolidin-2-one ; Batch 2 is

valid until 31 January 2013
0653
Yes
+5C
79
Y0001273 Baicalin
10 mg
88.5% CHO
2438
Yes
+5C
79
B0250000 Bambuterol hydrochloride
100 mg
1293
+5C
79
B0300000 Barbital - * psy
500 mg
0170
+5C
79
Y0001525 Basic butylated methacrylate copolymer
20 mg
1975
+5C
79
Y0000295 Basic butylated methacrylate copolymer -reference

spectrum
n/a
1975
79
B0305000 Beclometasone dipropionate anhydrous
150 mg
+5C
79
Y0000351 Beclometasone dipropionate monohydrate
10 mg
Y0000352 Beclometasone dipropionate for system suitability
15 mg
Y0000469 Beclometasone dipropionate for peak identification
10 mg
0.052 mg
110 mg
New Y0001073 Beclometasone dipropionate impurities F and N

Y0001607 Belamcanda chinensis rhizome HRS
1649
See leaflet,
0557,
1527,1646
0808,0852
0465,0466,2
0702
0653
Yes
99.2% CHClO ; Batch 3 is valid until 1 June 2013
0654,1449,
1709
Yes
+5C
79
Batch 2 is valid until 28 February 2013
0654,1709
Yes
+5C
79
0654,1709
Yes
+5C
79
0654,1709
Yes
+5C
79
2561
Yes
+5C
79
1709

Order
Reference Standard
Code
Y0001025 Benazepril hydrochloride

per vial Unit
1
160 mg
1 99.5 % CHClNO
Information
Monograph Leaflet
2388
Y0001038 Benazepril for system suitability
0.016 mg
Y0001026 Benazepril impurity A
10 mg
B0400000 Bendroflumethiazide
100 mg
Y0000564 Bendroflumethiazide impurity A
5 mg
B0470000 Benperidol
100 mg
B0477000 Benserazide hydrochloride
50 mg
B0477010 Benserazide impurity A
20 mg
Y0001071 Benserazide impurity C
10 mg
Y0001079 Benserazide for peak identification
10 mg
1173
Y0001064 Benzaldehyde
150 mg
Y0001060 Benzalkonium chloride for system suitability
20 mg
B0490000 Benzarone
10 mg
(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
1393
B0500000 Benzathine benzylpenicillin
200 mg
90.7% CHNOS
24.1% CHN (N,N'-dibenzylethylenediamine)
0373
Y0000775 Benzbromarone
10 mg
B0550000 Benzethonium chloride
100 mg
B0600000 Benzocaine
50 mg
Y0001470 Benzoic acid
Y0000647 Benzophenone
Y0000167 Benzyl alcohol
B0670000 Benzyl benzoate - reference spectrum

B0680000 S-Benzylmercaptoacetyltriglycin
+5C
+5C
79
+5C
79
0370
+5C
79
0370
+5C
79
1010,1172,1
254, 1708
+5C
79
1173
+5C
79
(2RS)-2-amino-3-hydroxypropanohydrazide
1173
+5C
79
(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
1173
+5C
79
Yes
+5C
79
0372,0371
Yes
+5C
79
0371,0372
Yes
+5C
79
+5C
79
+5C
79
1393
+5C
79
0974
+5C
79
0011,1088
+5C
79
30 mg
0934
+5C
79
40 mg
1784
+5C
79
50 mg
+5C
79
n/a
0705
79
10 mg
1372
+5C
79
B0700000 Benzylpenicillin potassium
100 mg
0113,0148,0
149
+5C
79
B0900000 Benzylpenicillin sodium
200 mg
99.4% CHNNaOS; Penicillin G sodium
Y0001149 Berberine chloride
20 mg
84.3% CHClNO
B0950000 Betadex
200 mg
88.4% [CHO]
Y0000391 Betahistine dihydrochloride
50 mg
B0990000 Betahistine mesilate
100 mg
B1000000 Betamethasone
75 mg
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide
0256,0371,0
372,1827
See leaflet
Yes
Extra
Price
charges
79
a
2388
2388
Storage
Yes
Yes
0113,0114,0
148, 0149
Yes
+5C
79
1831,2500
Yes
+5C
79
1070,1487,1
804
+5C
79
1665
+5C
79
1071
+5C
79
0312,0354,0
388,
0561,0811
+5C
79

Order
Reference Standard
Code
B1030000 Betamethasone acetate

per vial Unit
2
100 mg
1
B1040000 Betamethasone dipropionate
150 mg
Y0001416 Betamethasone dipropionate for peak identification
10 mg
Y0001418 Betamethasone dipropionate for system suitability
10 mg
B1045000 Betamethasone sodium phosphate
B1054000 Betamethasone 17-valerate
B1055000 Betamethasone 21-valerate

Y0001027 Betamethasone valerate for system suitability
Information
Monograph Leaflet
0548,0975
Storage
+5C
Extra
Price
charges
79
g
0809
Yes
+5C
79
0809
Yes
+5C
79
0809
Yes
+5C
79
100 mg
0549,0810
+5C
79
100 mg
0322,0811
+5C
79
15 mg
0811
+5C
79
25 mg
0811
+5C
79
Y0001065 Betamethasone valerate impurity mixture
0.018 mg
0811
+5C
79
B1103000 Betaxolol hydrochloride
60 mg
1072
+5C
79
B1103100 Betaxolol impurity A
10 mg
(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol
1072
+5C
79
Y0001354 Betaxolol impurity C
5 mg
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
1072
-20C
79
Y0001360 Betaxolol for peak identification
15 mg
1072
+5C
79
B1115000 Bezafibrate
100 mg
1394
+5C
79
Y0001444 Bicalutamide
100 mg
2196
Yes
+5C
79
Y0001448 Bicalutamide for system suitability
15 mg
2196
Yes
+5C
79
Y0001078 Bicisate labelling kit
24 mg
2123
+5C
79
B1110000 Bifonazole
100 mg
1395
+5C
79
Y0001421 Bifonazole for system suitability
10 mg
1395
Yes
+5C
79
Y0001059 Bilberry dry extract
250 mg
3.44% of cyanidin 3-O-glucoside chloride (CHClO)
2394
Yes
-20C
79
B1116000 Biotin
20 mg
Vitamin H
1073
+5C
79
B1120000 Biperiden hydrochloride
60 mg
1074
+5C
79
B1121000 Biperiden impurity A
20 mg
1074
+5C
79
B1140000 Bisacodyl
50 mg
0595
+5C
79
Y0000608 Bisacodyl for peak identification
10 mg
0595
+5C
79
Y0000694 Bisacodyl for system suitability
5 mg
0595
+5C
79
Y0000812 Bisoprolol fumarate
50 mg
1710
+5C
79
Y0000877 Bisoprolol for peak identification
1.007 mg
Bisoprolol for system suitability method A CRS has been renamed as

Bisoprolol for peak identification CRS.
1710
Yes
+5C
79
New Y0000813 Bisoprolol for system suitability
1.003 mg
Bisoprolol for system suitability method B CRS has been renamed as

Bisoprolol for system suitability CRS ; Batch 2 is valid until 30 April 2014
1710
Yes
+5C
79
New B1141000 Bleomycin sulfate
99.5% CHFO; Betamethasone dipropionate CRS 2 is suitable for

monograph 01/008:0809 only.
99.8% CHFNOS
(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)
Yes
Yes
Yes
7 mg
See leaflet ; Batch 1 is valid until 30 April 2014
0976,20702
Yes
-20C
79
Y0000434 Boldine
30 mg
98.8% CHNO
1396, 1816
Yes
+5C
79
B1142000 Bordetella pertussis mouse antiserum BRP
0.5 mg
Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial

Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial
See leaflet,
20716
Yes
-20C
90
60 mg
B1143000 Bromazepam - * psy

10
79
0778,0879
+5C
j

Order
Reference Standard
Code
Y0000645 Bromazepam for system suitability - * psy

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
0879
B1145000 Bromhexine hydrochloride
100 mg
Y0000200 Bromhexine impurity C
15 mg
B1150000 Bromocriptine mesilate
30 mg
Y0000677 Bromocriptine mesilate for system suitability
5 mg
0596
B1152000 Bromperidol
100 mg
0616,1178
B1152050 Bromperidol decanoate
60 mg
B1153000 Brompheniramine maleate
100 mg
Y0000468 Brotizolam - * psy
10 mg
Y0000470 Brotizolam impurity B
10 mg
B1155000 Brucella melitensis Rev. 1 strain BRP - * MOT (Biotox)
1 mg
B1157300 Budesonide
110 mg
Y0001148 Budesonide for system suitability
10 mg
B1156000 Bufexamac
100 mg
B1157400 Buflomedil hydrochloride
100 mg
Y0001529 Buflomedil for peak identification
0.45 mg
20 mg
B1158000 Bumetanide
150 mg
Y0000309 Bumetanide impurity A
5 mg
Y0000310 Bumetanide impurity B
5 mg
B1160000 Bupivacaine hydrochloride
100 mg
Y0000088 Bupivacaine impurity B
20 mg
(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Y0000089 Bupivacaine impurity E
20 mg
6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide
Y0001108 Buprenorphine - * psy
10 mg
Y0001109 Buprenorphine hydrochloride - * psy
10 mg
1181
Y0001122 Buprenorphine for system suitability - * psy
10 mg
1180,1181
B1168000 Buserelin
2 mg
B1168020 D-His-Buserelin
0.5 mg
Y0000131 Buspirone hydrochloride
5 mg
Y0000471 Buspirone for system suitability
2 mg
B1170000 Busulfan
50 mg
Y0001487 Butyl methacrylate
100 mg
Y0001304 Butyl methanesulfonate
30 L
20537,2053
8, 20539
New B1157410 Buflomedil impurity B
N-(2-aminobenzyl)-N-methylcyclohexanamine ; Batch 2 is valid until 1 June

2013
2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)
99.7% CHO
Yes
Storage
+5C
Extra
Price
charges
79
j
0706
+5C
79
0706
+5C
79
0596
-20C
g(c)
79
-20C
g(c)
79
+5C
79
1397,1431
+5C
79
0977,1196
+5C
79
2197
+5C
79
2197
+5C
79
Yes
0793
Yes
+5C
e(b)
79
1075
Yes
+5C
79
1075
Yes
+5C
79
1179
+5C
79
1398
+5C
79
1398
+5C
79
1398
+5C
79
1076
+5C
79
3-nitro-4-phenoxy-5-sulphamoylbenzoic acid
1076
+5C
79
3-amino-4-phenoxy-5-sulphamoylbenzoic acid
1076
+5C
79
0541
+5C
79
0541
+5C
79
0541
+5C
79
1180
+5C
79
+5C
79
+5C
79
1077
-20C
79
1077
-20C
79
+5C
79
+5C
79
0542
+5C
79
1975
+5C
79
+5C
79
4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one ; Batch 2
is valid until 28 February 2014
2.00 mg per vial of CHNO
Yes
Yes
1711
11
1711
Yes
Yes

Order
Reference Standard
Code
B1217000 Butyl parahydroxybenzoate
Y0001357 Butyl parahydroxybenzoate impurity E

Information
per vial Unit
2
100 mg
1 See leaflet
1
15 mg
1 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)
Monograph Leaflet
0881,1216
Yes
Storage
+5C
Extra
Price
charges
79
a
0881
+5C
79
0880
+5C
79
Plastic additive 07
0581,30103,
30105,3010
6, 30107
+5C
79
99.8% CHNO
1773
Yes
-20C
79
70 mg
See leaflet
0267,0268,1
504,2412
Yes
+5C
79
10 mg
Batch 2 is valid until 30 November 2013
0267, 0268
Yes
+5C
79
5 mg
95.3% CHO ; Batch 3 is valid until 28 February 2013
1295
Yes
-20C
e(d)
150
C0166001 Calcifediol - reference spectrum
n/a
1295
79
Y0000499 Calcipotriol (anhydrous) - reference spectrum
n/a
2011
79
Y0000473 Calcipotriol monohydrate
10 mg
79
Y0000474 Calcipotriol monohydrate - reference spectrum
n/a
79
C0200000 Calcitonin (salmon)
1 mg

0471
-20C
79
Y0000632 Calcitonin-Gly
1 ml
About 0.9 mg per ml
0471
-20C
79
C0200010 N-acetyl-cys1-calcitonin
0.1 mg
about 0.1mg N-acetyl-cys-1-calcitonin per vial
0471
-20C
79
C0225000 Calcitriol
10 mg
99.8% CHO
0883
-20C
e(d)
C0226000 Calcitriol - reference spectrum
n/a
C0249000 Calcium ascorbate - reference spectrum
n/a
130 mg
60 mg
100 mg
C0340000 Calcium levulinate dihydrate
250 mg
C0350000 Calcium oxalate monohydrate
500 mg
C0400000 Calcium pantothenate
60 mg
0470
C0405000 Camphor (racemic)
50 mg
Y0001388 Candesartan cilexetil
60 mg
Y0001387 Candesartan cilexetil for peak identification
10 mg
2375
Y0001389 Candesartan cilexetil for system suitability
10 mg
2573
C0410000 Canrenone
50 mg
C0426000 Caprylic acid
200 mg
B1212000 Butylhydroxyanisole
60 mg
B1215000 Butylhydroxytoluene
50 mg
Y0000472 Cabergoline
100 mg
C0100000 Caffeine
Y0000787 Caffeine for system suitability

C0166000 Calcifediol
New C0250000 Calcium folinate

C0299000 Calcium glucoheptonate
New C0300000 Calcium gluconate
94.3% CHO ; Batch 1 is valid until 31 August 2013
2011,2284
Yes
+5C
2284
Yes
Yes
0883
1182
See leaflet ; Batch 5 is valid until 31 March 2014
Calcium digluconate ; Batch 1 is valid until 31 March 2014
Loss of 12.1% m/m (U= 0.2%, n=10, k=2.23)
12
0978,1606
Yes
1000
79
79
+5C
79
1399
+5C
79
0172,0658,0
979,1399,21
61,2162,216
4,2364
+5C
79
1296
+5C
79
+5C
79
+5C
79
0655,1600
+5C
79
2375
+5C
79
Yes
+5C
79
Yes
+5C
79
0688
+5C
79
1401,1471
+5C
79
20234
Yes

Order
Code
Y0000671 Capsaicin
Reference Standard

Information
per vial Unit
2
50 mg
1 98,7% CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide ; Batch 1 is valid until 1 April 2013
C0430000 Captopril
10 mg
Y0001182 Captopril for system suitability
20 mg
Y0001219 Captopril impurity B
10 mg
Y0001220 Captopril impurity C
10 mg
Y0001221 Captopril impurity D
Y0000435 Captopril impurity E
Y0001450 Captopril impurity J
Y0000113 Carbachol
C0450000 Carbamazepine
Monograph Leaflet
1859,2336,2
337, 2529
Yes
Storage
+5C
Extra
Price
charges
79
g
1079
+5C
79
1079
+5C
79
87.4% CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2carboxylic acid
1079
+5C
79
84.8% CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid
1079
Yes
+5C
79
10 mg
85.4% CHBrO; (2RS)-3-bromo-2-methylpropanoic acid
1079
Yes
+5C
79
10 mg
(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid
1079
+5C
79
10 mg
92.5% CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]

pyrrolidine-2-carboxylic acid (acetylcaptopril)
1079
+5C
79
50 mg
+5C
79
200 mg
99.9% CHNO ; Batch 4 is valid until 31 October 2013
0543
+5C
79
Y0000033 Carbamazepine impurity A
10 mg
10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)
0543
+5C
79
C0451000 Carbasalate calcium - reference spectrum
n/a
1185
79
Y0001161 Carbasalate impurity B
5 mg
1185
+5C
79
C0455000 Carbenicillin sodium
50 mg
0956
+5C
79
C0460000 Carbidopa
50 mg
0755
+5C
79
C0465000 Carbimazole
120 mg
+5C
79
C0470000 Carbocisteine
60 mg
0885
+5C
79
C0499900 Carbon dioxide - reference spectrum
n/a
0375
79
C0550000 Carboplatin - reference spectrum
n/a
1081
79
Y0000475 Carboprost trometamol
40 mg
79
Y0000536 Carboprost trometamol - reference spectrum
n/a
79
Y0000035 Carisoprodol
50 mg
Y0000036 Carisoprodol impurity A
10 mg
Y0001214 Carmellose
10 mg
C0580004 Carmustine - reference spectrum
n/a
C0580010 Carmustine impurity A
20 mg
Y0000846 Carprofen
30 mg
Y0000884 Carprofen for system suitability
5 mg
Y0000192 Carteolol hydrochloride - reference spectrum
Y0000193 Carteolol for system suitability
Y0001427 Carvedilol
Y0000075 Carvedilol - reference spectrum
Yes
1971
99.7% CHNOS
99.1% CHNO
0884
Yes
Yes
1712
-20C
1712
1689
+5C
79
1689
+5C
79
2360
+5C
79
79
1187
-20C
g(c)
79
2201
+5C
79
2201
+5C
79
n/a
1972
79
30 mg
1972
+5C
79
50 mg
1745
+5C
79
n/a
1745
79
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate
1187
1,3-bis(2-chloroethyl)urea
13
Yes

Order
Reference Standard
Code
Y0000103 Carvedilol impurity C

Information
Monograph Leaflet
per vial Unit
2
15 mg
1 (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
1745
propan-2-ol
Y0001426 Carvedilol for system suitability
10 mg
1745
C0600000 Casein BRP
100000 mg
0350
C0630000 Cefaclor
450 mg
94.9% CHClNOS ; Batch 2 is valid until 30 November 2013
0986
New C0640000 Delta-3-Cefaclor
20 mg
Batch 3 is valid until 31 March 2014
C0650000 Cefadroxil
250 mg
93,8% CHNOS ; Batch 2 is valid until 1 July 2013
C0675000 Cefalexin monohydrate
150 mg
94.2% CHNOS
C0682000 Cefalotin sodium
100 mg
98.8% CHNNaOS
Y0000505 Cefalotin for impurity B identification
10 mg
C0682300 Cefamandole nafate
125 mg
99.0% CHNNaOS
1402
Y0000240 Cefapirin sodium
100 mg
98.5% CHNNaOS
1650
C0682400 Cefatrizine propylene glycol
150 mg
81.8% CHNOS
C0682410 Cefatrizine impurity A
60 mg
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
C0682800 Cefazolin
150 mg
99.6% CHNOS
0988
Y0000633 Cefepime dihydrochloride monohydrate
150 mg
95.2% CHClNOS
2126
15 mg
2126
Y0001336 Cefepime impurity E
10 mg
(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2126
C0684000 Cefixime
200 mg
88.8% CHNOS
1188
C0684750 Cefoperazone dihydrate
100 mg
94.2% CHNOS
1404
C0684800 Cefoperazone sodium - reference spectrum
n/a
Y0000420 Cefotaxime acid
80 mg
C0685000 Cefotaxime sodium
30 mg
Y0000506 Cefotaxime for peak identification
10 mg
C0688000 Cefoxitin sodium
100 mg
Y0001496 Cefoxitin sodium for peak identification
15 mg
Y0001305 Cefpodoxime proxetil
70 mg
Y0001318 Cefpodoxime proxetil for impurity H identification
10 mg
Y0001306 Cefpodoxime proxetil for peak identification
10 mg
Y0001371 Cefprozil
120 mg
Y0001368 Cefprozil impurity mixture
10 mg
Y0001372 Cefprozil impurity A
20 mg
Y0001367 Cefprozil for peak identification
10 mg
New Y0000634 Cefepime dihydrochloride monohydrate for system

suitability
Yes
Yes
0986
Storage
+5C
+5C
79
+5C
131
+5C
79
-20C
79
0260,0577,0
813,2342
Yes
+5C
79
0708,0814
Yes
+5C
79
0987
+5C
79
0987
+5C
79
+5C
79
+5C
79
1403
+5C
79
1403
+5C
79
+5C
79
+5C
79
+5C
79
-20C
g(c)
79
Yes
-20C
79
Yes
+5C
79
79
Yes
Yes
Yes
1404
94.3% CHNOS
Extra
Price
charges
79
g
0989
+5C
79
0708,0989
+5C
79
0989
Yes
+5C
79
0990
Yes
+5C
79
0990
Yes
+5C
79
2341
Yes
-20C
79
2341
Yes
-20C
79
2341
Yes
-20C
79
2342
Yes
+5C
79
2342
Yes
+5C
79
+5C
79
+5C
79
97.4% CHNNaOS
97.1% CHNOS
See leaflet CHNOS

(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)
2342
2342
14
Yes

Order
Code
C0690000 Cefradine
Reference Standard

per vial Unit
4
300 mg
1 93.9%
Information
Monograph Leaflet
Storage
0167,0168,0
578,
0708,0814
Yes
+5C
Extra
Price
charges
79
a
Y0000568 Cefradine for peak identification
15 mg
Must be used with Cefradine impurity mixture CRS Y0001174
0814
Yes
+5C
79
Y0001174 Cefradine impurity mixture
0.04 mg
Must be used with Cefradine for peak identification Y0000568
0814
Yes
+5C
79
C0690500 Ceftazidime
200 mg
85.3% CHNOS
Y0001111 Ceftazidime for peak identification
10 mg
C0691000 Ceftriaxone sodium
100 mg
C0692000 Ceftriaxone impurity A
10 mg
C0694990 Cefuroxime axetil
60 mg
97.3% CHNOS ; Batch 3 is valid until 31 December 2013
1300
C0695000 Cefuroxime sodium
150 mg
96.7% CHNNaOS
0988,0992
Y0001445 Celecoxib
200 mg
99.9% CHFNOS
2591
Y0001446 Celecoxib impurity A
10 mg
4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
2591
Y0001447 Celecoxib impurity B
10 mg
4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
Y0000311 Celiprolol hydrochloride
10 mg
Y0000312 Celiprolol impurity I
0.02 mg
Y0000239 Celiprolol for peak identification
20 mg
1632
Y0000784 Cellulose acetate
40 mg
Y0001054 Cellulose acetate phthalate
10 mg
C0700000 Cephaline hydrochloride
15 mg
C0980650 Cetirizine dihydrochloride
100 mg
C0980651 Cetirizine impurity A
10 mg
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine ; Batch 4 is valid until 31

July 2013
Y0001197 Cetirizine for peak identification
1.01 mg
Replaces Cetirizine impurity mixture CRS
1084
C0984100 Cetostearyl isononanoate - reference spectrum
n/a
C0990000 Cetyl alcohol
300 mg
Y0000073 Cetyl palmitate 15
60 mg
Y0000074 Cetyl palmitate 95
50 mg
C1000000 Cetylpyridinium chloride
20 mg
C1050000 Chenodeoxycholic acid
125 mg
Y0000104 Chitosan hydrochloride
30 mg
1405
Yes
+5C
79
1405, 2344
Yes
+5C
79
90.4% CHNNaOS
0991
Yes
+5C
79
E-isomer
0991
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
2591
+5C
79
1632
+5C
79
+5C
79
+5C
79
0887
+5C
79
0314
+5C
79
0080,0081,0
093,
0094,1530,1
875
+5C
79
1084
+5C
79
1084
+5C
79
Yes
+5C
79
79
Yes
+5C
79
1906
+5C
79
1906
+5C
79
0379
+5C
79
1189,1275
+5C
79
1774
+5C
79
1632
1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
Yes
1085
99.7% CHO ; Batch 1 is valid until 30 November 2013
15
0540,0702,0
801,
0802,0847,0
969, 1411

Order
Code
C1100000 Chlorambucil
Reference Standard

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
0137
Storage
+5C
Y0001298 Chlorambucil for system suitability
10 mg
0137
+5C
79
Y0001299 Chlorambucil with impurity G
10 mg
0137
+5C
79
C1200000 Chloramphenicol
500 mg
0071,0473,0
709
+5C
79
C1300000 Chloramphenicol dipalmitate
100 mg
0473
+5C
79
C1350000 Chloramphenicol disodium disuccinate
25 mg
0709
+5C
79
C1400000 Chloramphenicol palmitate isomer
100 mg
0473
+5C
79
C1425000 Chloramphenicol sodium succinate
1500 mg
0709
+5C
79
C1435000 Chlorcyclizine hydrochloride
100 mg
1086
+5C
79
C1450000 Chlordiazepoxide - * psy
50 mg
0656,1974
+5C
79
C1500000 Chlordiazepoxide hydrochloride - * psy
100 mg
Y0000476 Chlordiazepoxide impurity A
10 mg
C1510000 Chlorhexidine
50 mg
C1520000 Chlorhexidine diacetate
10 mg
C1540000 Chlorhexidine dihydrochloride
Y0001545 Chlorhexidine for system suitability
C1530000 Chlorhexidine for performance test

New Y0000569 Chlorogenic acid
0474
+5C
79
0474,0656
+5C
79
0658
+5C
79
0657
+5C
79
50 mg
0659
+5C
79
15 mg
0658
Yes
+5C
79
50 mg
0657,0658,0
659
Yes
+5C
79
25 mg
97% CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,51821,1822,1

trihydroxycyclohexanecarboxylic acid ; Batch 1 is valid until 28 February 2014
823,
1824,1866,1
897, 2389
Clemastine fumarate impurity C
1190
Yes
+5C
79
C2223030 1-(4-Chlorophenyl)-1-phenylethanol
15 mg
C1650000 Chloroquine sulfate
200 mg
C1700000 Chlorothiazide
100 mg
C1800000 Chlorphenamine maleate
100 mg
New Y0000436 Chlorphenamine impurity A
0.01 mg
Y0000437 Chlorphenamine impurity C
10 mg
C1900000 Chlorpromazine hydrochloride
200 mg
Y0000507 Chlorpromazine impurity A
15 mg
Y0000479 Chlorpromazine impurity D
10 mg
Y0000508 Chlorpromazine impurity E
Y0001449 Chlorpromazine impurity F
91.1% CHClNNaO
Yes
Extra
Price
charges
79
g
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide
-20C
g(c)
79
0544,0545
+5C
79
0394
+5C
79
0386,0977,1
084, 1196
+5C
79
2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile ; Batch 3 is valid until 31 March 2014
0386
+5C
79
(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine
0386
+5C
79
0475,20303
+5C
79
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)
0475
+5C
79
3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)
0475
+5C
79
10 mg
2-chloro-10H-phenothiazine
0475
+5C
79
2 mg
3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
0475
+5C
79
16

Order
Reference Standard
Code
C1905000 Chlorpropamide

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
1087
C1905020 Chlorpropamide impurity B
50 mg
1,3-Dipropylurea
C1915000 Chlorprothixene hydrochloride
50 mg
2.0% E-isomer
C1950000 Chlortalidone
150 mg
Y0000779 Chlortalidone for peak identification
1.017 mg
C2000000 Chlortetracycline hydrochloride
100 mg
Y0001451 Chlortetracycline for system suitability
20 mg
C2100000 Cholecalciferol
480 mg
C2150000 Cholecalciferol for system suitability
1 mL
C2155000 Cholesterol
100 mg
C2158000 Cholic acid
60 mg
Y0000280 Chondroitin sulfate sodium
250 mg
Y0000593 Chondroitin sulfate sodium (marine)
100 mg
C2160000 Chymotrypsin BRP
100 mg
Y0001553 Ciclesonide
Y0001554 Ciclesonide containing impurity A
Y0001555 Ciclesonide impurity B
Storage
+5C
1087
Extra
Price
charges
79
a
+5C
79
0815,1365
Yes
+5C
79
99.7% CHClNOS ; Batch 2 is valid until 31 August 2013
0546
Yes
+5C
79
0546
Yes
+5C
79
92.4% of of CHClNO ; Batch 4 is valid until 31 December 2012
0173
Yes
+5C
79
0173
Yes
+5C
79
0072,0574,0
575,
0598,1192,1
193
Yes
-20C
g(c)
79
-20C
g(c)
79
+5C
79
+5C
79
+5C
79
100% CHO ; Vitamin D3
0072,0082,0
574,
0575,0598
99.5% CHO
0593,0993
99.6 % HO(CHNNaOS) ; Batch 1 is valid until 1 May 2013
2064,2090
+5C
79
6.01 microkatals per mg
0476,0694
Yes
+5C
79
150 mg
99.8 % CHO
2703
Yes
+5C
79
15 mg
(2S)-2-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide)
2703
+5C
79
10 mg
(2R)-2-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-3,20-dione
2703
+5C
79
Y0001556 Ciclesonide impurity C
10 mg
(2R)-2-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo
[4,5:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate
2703
+5C
79
Y0000040 Ciclopirox
100 mg
1407
+5C
79
C2162701 Ciclopirox impurity A
40 mg
()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid
1302,1407
+5C
79
C2162702 Ciclopirox impurity B
20 mg
6-cyclohexyl-4-methyl-2H-pyran-2-one
1302,1407
-20C
79
C2162700 Ciclopirox olamine
150 mg
+5C
79
C2163000 Ciclosporin
120 mg
+5C
79
Y0000361 Ciclosporin for system suitability
5 mg
0994
+5C
79
C2170000 Cilastatin sodium
10 mg
1408
+5C
79
C2174000 Cilazapril
50 mg
1499
+5C
79
C2174002 Cilazapril impurity A
25 mg
1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate
1499
+5C
79
C2174005 Cilazapril impurity D
10 mg
(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid
1499
+5C
79
Yes
1189
Yes
2064
1302
0994
98.5% CHNO
17
Yes

Order
Code
C2175000 Cimetidine
Reference Standard

per vial Unit
1
50 mg
1
Information
Monograph Leaflet
0756
Storage
+5C
Extra
Price
charges
79
a
C2175500 Cimetidine hydrochloride
100 mg
1500
+5C
79
Y0001130 Cimetidine for peak identification
10 mg
0756
Yes
+5C
79
Y0001146 Cimetidine for system suitability
0.5085 mg
756
Yes
+5C
79
C2177000 Cinchocaine hydrochloride
60 mg
1088
+5C
79
Y0000176 Cineole
180 mg
1973
+5C
79
C2180000 Cinnarizine
100 mg
0816
+5C
79
Y0000362 Ciprofibrate
5 mg
2013
+5C
79
Y0000363 Ciprofibrate for system suitability
5 mg
2013
+5C
79
Y0000198 Ciprofloxacin
20 mg
100 mg
Y0000199 Ciprofloxacin hydrochloride for peak identification
15 mg
C2190050 Ciprofloxacin impurity A
25 mg
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)
C2210000 Cisplatin
100 mg
99.7% [PtCl(NH)]
0599
Y0001018 Cisplatin impurity A
15 mg
trans-diamminedichloroplatinum (II)
0599
Y0001019 Cisplatin impurity B
15 mg
94.1% [PtCl(NH)]-; amminetrichloroplatinate(-)
0599
Y0001008 Citalopram hydrobromide
5 mg
Y0001007 Citalopram hydrochloride
5 mg
Y0000855 Citalopram for system suitability
0.065 mg
2203,2288
A1202000 Citric acid (anhydrous)
50 mg
0455
C2219000 Citric acid monohydrate
50 mg
Y0000639 Cladribine
50 mg
Y0000609 Cladribine for peak identification
10 mg
Y0000610 Cladribine impurity C
5 mg
2-chloro-7H-purin-6-amine
2174
Y0000320 Clarithromycin
160 mg
97.7% CHNO
1651
Y0000321 Clarithromycin for peak identification
40 mg
1651
Y0000269 Clazuril for system suitability
10 mg
1714
Y0001193 Clazuril
10 mg
1714
C2221000 Clebopride malate
100 mg
C2223000 Clemastine fumarate
100 mg
New Y0001613 Clemastine for system suitability
0.165 mg
1190
C2248000 Clenbuterol hydrochloride
30 mg
1409
C2248010 Clenbuterol impurity B
10 mg
1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
C2250000 Clindamycin hydrochloride
200 mg
94.4% CHClNOS
0582,0583,0
996
Yes
C2269000 Clindamycin phosphate
250 mg
95.7% CHClNOPS
0996
Yes
New C2190000 Ciprofloxacin hydrochloride
Yes
+5C
79
0888,1353
1089
Yes
+5C
79
0888,1089
Yes
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
2288
+5C
79
2203
+5C
79
+5C
79
+5C
79
0888,1089,2
229
Yes
Yes
Yes
0456
99.1% CHClNO
18
+5C
79
2174
Yes
+5C
g(b)
79
2174
Yes
+5C
g(b)
79
+5C
g(b)
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
1303
+5C
79
1190
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
1409

Order
Code
Y0000364 Clioquinol
Reference Standard

per vial Unit
1
5 mg
1
Information
Monograph Leaflet
2111
Y0000205 Clobazam - reference spectrum
n/a
Y0000241 Clobazam impurity A
10 mg
7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
1974
Y0000559 Clobetasol propionate
40 mg
99.6% CHClFO
2127
Y0000570 Clobetasol for peak identification
2 mg
2127
Y0000571 Clobetasol impurity J
0.4 mg
C2285000 Clobetasone butyrate
50 mg
1090
Y0001137 Clobetasone butyrate for system suitability
30 mg
1090
Y0000888 Clodronate disodium tetrahydrate
5 mg
Y0000885 Clodronate impurity D
5 mg
Y0000313 Clofazimine
150 mg
2054
Y0000358 Clofazimine for system suitability
10 mg
2054
C2300000 Clofibrate
0.5 ml
C2320000 Clomifene citrate
50 mg
C2332000 Clomifene citrate for performance test
50 mg
0997
C2360000 Clomipramine hydrochloride
100 mg
0889
Y0000132 Clomipramine impurity C
10 mg
94.5% CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
0889
Y0000133 Clomipramine impurity D
10 mg
3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine ; Batch 1 is valid until 31 December 2012
0889
Y0000134 Clomipramine impurity F
5 mg
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
C2385000 Clonazepam - * psy
50 mg
Y0000286 Clonazepam - reference spectrum
n/a
C2385015 Clonazepam impurity B
5 mg
C2400000 Clonidine hydrochloride
100 mg
Y0000801 Clonidine impurity B
20 mg
Y0000833 Clopamide
40 mg
1747
Y0000848 Clopamide for system suitability
10 mg
1747
Y0001333 Clopidogrel hydrogen sulfate
60 mg
Y0001335 Clopidogrel impurity A
10 mg
Y0001334 Clopidogrel for system suitability
100 mg
2531
Y0000392 Closantel sodium dihydrate
20 mg
1716
Y0000393 Closantel for system suitability
20 mg
C2424400 Clostridia (multi-component) rabbit antiserum(for

vaccines-vet.use)BRP
1 mg
see information on the accompanying leaflet
C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP
1 mg
0.20 IU per vial (determined using toxin neutralisation test)
Storage
+5C
1974
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
(chloromethylene)bis(phosphonic acid)
44% of Z-isomer CHClNO
79
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
1777
+5C
79
1777
+5C
79
+5C
79
+5C
79
0318
+5C
79
0997,1046
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
0889
+5C
79
1974,0415
+5C
79
79
0890
+5C
79
0477
+5C
79
0477
+5C
79
+5C
79
+5C
79
2531
+5C
79
2531
+5C
79
+5C
79
+5C
79
2127
Yes
Yes
Yes
0890
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one
1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole
(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid
19
Extra
Price
charges
79
g
Yes
Yes
1716
Yes
+5C
79
0362,0363,0
364, 0697
Yes
-20C
90
20708
Yes
-20C
90

Order
Reference Standard
Code
C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP

per vial Unit
1
1 mg
1 34 IU per vial
Information
Monograph Leaflet
Storage
Extra
Price
charges
90
c
See leaflet,
0697
Yes
-20C
See leaflet,
0697
Yes
-20C
90
+5C
79
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.

use) BRP
1 mg
C2430000 Clotrimazole
100 mg
0757
Y0000818 Clotrimazole impurity E
15 mg
0757
+5C
79
Y0000849 Clotrimazole for peak identification
1.005 mg
0757
Yes
+5C
79
C2450000 Cloxacillin sodium
200 mg
0661,0663,0
668, 2260
Yes
+5C
79
C2460000 Clozapine
60 mg
1191
Y0000758 Clozapine for peak identification
0.41 mg
1191
Y0001472 Coagulation Factors V, VIII, XI and XIII plasma
1 mg
Y0000162 Cocaine hydrochloride - reference spectrum
n/a
0073
C2480000 Cocoyl caprylocaprate
40 mg
1411
Y0000722 Codeine - * narc
20 mg
C2500000 Codeine - reference spectrum
n/a
Y0000334 Codeine impurity A
15 mg
C2500100 Codeine hydrochloride dihydrate - reference spectrum
n/a
C2510000 Codergocrine mesilate
60 mg
Y0001500 Coix seed HRS
1300 mg
C2580000 Colchicine
15 mg
Y0000209 Colchicine for system suitability
Y0000374 Colestyramine
C2600000 Colistimethate sodium
15 IU per vial
93.9% CHClNNaOS
+5C
79
Yes
+5C
79
Yes
-20C
90
79
+5C
79
+5C
79
79
+5C
79
79
1416,2060
+5C
79
2454
+5C
79
0758
+5C
79
10 mg
0758
+5C
79
10 mg
1775
+5C
79
20 mg
285000 IU per vial CHNNaOS
0319,20702
Yes
+5C
79
25 mg
See leaflet ; Batch 3 is valid until 28 February 2014
0320
Yes
-20C
79
C2700000 Colistin sulfate for microbiological assay
25 mg
576 000 IU per vial; For microbiological assay only
0320
Yes
-20 C
79
C2725000 Copovidone - reference spectrum
n/a
0891
79
C2800000 Cortisone acetate
250 mg
0321,0736,0
767
+5C
79
Y0000438 Coumarin
110 mg
+5C
79
C2900000 Cotton wool standard for neps
1000 mg
+5C
79
Y0001053 Crospovidone
5 mg
C2970000 Crotamiton
100 mg
99.2% CHNO (sum of E and Z-isomers); 3.5% Z-isomers CHNO
1194
C2970005 Crotamiton impurity A
70 mg
N-ethyl-N-(2-methylphenyl)but-3-enamide
1194
New Y0000277 Colistin sulfate
Factor V : 0.73 IU per vial, Factor VIII : 0.74 IU per vial, Factor XI : 0.59 IU per 0903,1646,2
vial, Factor XIII : 0.79 IU per vial
0740,20722
0076,1839,1
841
See leaflet
Yes
0074,0075,0
076
7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan
0074,0075,0
076, 1412
1412
2120
99.9% CHO
Yes
Yes
0036
0892
20
Yes
+5C
79
-20C
79
-20C
79

Order
Reference Standard
Code
Y0001061 Cyanidin chloride
C3000000 Cyanocobalamin

Information
per vial Unit
2
25 mg
1 93.3% CHClO ; Batch 1 is valid until 31 August 2013
4
20 mg
1 Vitamin B12
Monograph Leaflet
2394
Yes
Storage
+5C
Extra
Price
charges
79
a
0269,0270,0
547,
0710,1505
+5C
79
1092
+5C
79
C3090000 Cyclizine hydrochloride
50 mg
Y0000886 Cyclizine impurity A
15 mg
1-methylpiperazine
1092
+5C
g(b)
79
Y0000887 Cyclizine impurity B
10 mg
diphenylmethanol (benzhydrol)
1092
+5C
79
C3200000 Cyclobenzaprine hydrochloride
100 mg
C3230000 Cyclohexa-1,4-dienylglycine
15 mg
C3245000 Cyclopentolate hydrochloride
50 mg
1093
Y0001088 Cyclopentolate for system suitability
60 mg
1093
C3250000 Cyclophosphamide
50 mg
0711
C3280000 Cyproheptadine hydrochloride
30 mg
Y0001095 Cyproheptadine impurity C
5 mg
C3283000 Cyproterone acetate
30 mg
1094
Y0001390 Cyproterone acetate for peak identification
5 mg
1094
Yes
Y0001223 Cyproterone impurity mixture
0.01 mg
1094
Yes
C3290000 Cysteine hydrochloride monohydrate
100 mg
C3300000 Cystine
100 mg
C3350000 Cytarabine
150 mg
Y0000733 Dacarbazine
20 mg
Y0000734 Dacarbazine impurity A
20 mg
89.4% CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine)
1691
Yes
Y0000735 Dacarbazine impurity B
10 mg
87.9% CHO; 5-amino-1H-imidazole-carboxamide
1691
Yes
D0070000 Dalteparin sodium
250 mg
Y0000600 Danaparoid sodium
10 mg
D0100000 Dapsone
100 mg
D0125000 Daunorubicin hydrochloride
120 mg
98.5% CHClNO
0662
D0120000 Daunorubicinone
10 mg
Daunorubicin aglycone
D0160000 Deferoxamine mesilate
30 mg
D0201000 Dehydrohexetidine
50 mg
Y0000611 Dembrexine hydrochloride monohydrate
10 mg
D0300000 Demeclocycline hydrochloride
100 mg
D0350000 N-Demethylerythromycin A
10 mg
0408,0464
86.7% CHNO; (2R)-amino(cyclohexa-1,4-dienyl)acetic acid (ddihydrophenylglycine)
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
0817,0846
+5C
79
0817
+5C
79
+5C
79
+5C
79
0814
Yes
Yes
+5C
79
0895
+5C
79
0998
+5C
79
0760
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0662
+5C
79
0896
-20C
79
1221
+5C
79
+5C
79
+5C
79
+5C
79
1691
0828
147 anti-factor Xa units per ampoule, 4.3 anti-factor IIa units per ampoule
2090
Yes
0077
2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine
Yes
2169
92.4% CHClNO
0176
0179,0274,0
490,
0552,1098
21
Yes

Order
Reference Standard
Code
Y0000228 Demethylflumazenil - reference spectrum

per vial Unit
1
n/a
1
Information
Monograph Leaflet
Storage
1917
Extra
Price
charges
79
l
D0406200 Deptropine citrate
60 mg
1308
+5C
79
D0430000 Dequalinium chloride
50 mg
1413
+5C
79
D0431000 Dequalinium chloride for performance test
50 mg
Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate
1 mL
D0480000 Desacetylvinblastine
1 mg
Y0000879 Desflurane - reference spectrum
n/a
Y0000807 Desflurane impurity A
1 ml
D0500000 Desipramine hydrochloride
100 mg
D0600000 Deslanoside
150 mg
Y0001584 Desloratadine
100 mg
2570
D0630000 Desmethylmetrifonate
30 mg
1133
Y0001582 Desloratadine for system suitability
5 mg
2570
D0650000 Desmopressin
0.94 mg
0.94 mg per vial of CHNOS ; Batch 7 is valid until 1 March 2013
0712
Y0000509 Desogestrel
50 mg
99.9% CHO
10 mg
D0400000 Desoxycortone acetate
100 mg
Y0000001 Detomidine hydrochloride
100 mg
D0660020 Detomidine impurity B
20 mg
D0700000 Dexamethasone
50 mg
Y0001593 Dexamethasone for peak identification
10 mg
0388
D0710000 Dexamethasone acetate
100 mg
0548,0933,0
975, 2237
Y0001169 Dexamethasone acetate impurity E
0.013 mg
0548
Y0001177 Dexamethasone for system suitability
10 mg
0388
Y0000538 Dexamethasone isonicotinate
10 mg
2237
Y0000511 Dexamethasone isonicotinate for impurity C identification
10 mg
2237
D0718000 Dexamethasone pivalate
50 mg
D0720000 Dexamethasone sodium phosphate
100 mg
Y0001477 Dexamethasone sodium phosphate for peak

identification
10 mg
D0720800 Dexchlorpheniramine maleate
60 mg
New Y0000510 Desogestrel for system suitability
1413
+5C
79
-20C
79
-80C
g(d)
79
79
1666
+5C
79
0481
+5C
79
0482
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
-20C
79
1717
Yes
+5C
79
1717
Yes
+5C
79
0322,0809,0
850, 1327
+5C
79
1414
+5C
79
1414
+5C
79
0312,0388,0
548,
0768,1376,2
237,0549
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0332,0333
Dermatan sulfate 10 mg/mL

Oversulfated chondroitin sulfate 2.5 mg/mL
Yes
1276
1666
1,1'-oxybis(1,2,2,2-tetrafluoroethane)
98.8% CHO
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol
9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate
Yes
Yes
Yes
Yes
+5C
79
0549,0735,0
810
1327
Yes
+5C
79
0549
Yes
+5C
79
1196
+5C
79
88.3 % CHFNaOP
22

Order
Code
D0730000 Dexpanthenol
Reference Standard

per vial Unit
4
5 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0761
+5C
0999,1000,1
001
+5C
79
+5C
79
+5C
79
D0731000 Dextran
25 mg
D0731005 Dextran 1
50 mg
D0732000 Dextran Vo
10 mg
D0733000 Dextran 4 for calibration
50 mg
M 3050-M 3850
20239
Yes
+5C
79
50 mg
M 8800 - M 10450
20239
Yes
+5C
79
50 mg
M 30500- M 40900
20239
Yes
+5C
79
50 mg
M 58900- M 70300
20239
Yes
+5C
79
50 mg
M 121800- M 238200
20239
Yes
+5C
79
D0738000 Dextran 40 for performance test
50 mg
20239
+5C
79
D0739000 Dextran 60/70 for performance test
50 mg
20239
+5C
79
Y0000744 Dextranomer
50 mg
2338
+5C
79
D0740000 Dextromethorphan hydrobromide
100 mg
0020
+5C
79
5 mg
ent-3-methoxymorphinan ; Batch 1 is valid until 30 April 2014
0020
+5C
79
Y0001058 Dextropropoxyphene hydrochloride - * narc
10 mg
0713
+5C
79
Y0001150 Dextropropoxyphene for system suitability - * narc
5 mg
0713
+5C
79
D0940000 Diazepam - * psy
30 mg
0022
+5C
79
Y0000596 Diazepam for system suitability - * psy
0.5 mg
0022
+5C
79
D0950000 Diazoxide
50 mg
0550
+5C
79
D0970000 Dibenzocycloheptene
20 mg
0817
+5C
79
D1000000 Dibenzosuberone
100 mg
0464,0817,0
941
+5C
79
Y0000480 Dibrompropamidine diisetionate
10 mg
2300
+5C
79
Y0000481 Dibrompropamidine for system suitability
20 mg
2300
+5C
79
D1010000 Dibutyl phthalate
1 ml
0762
+5C
79
Y0000275 Dichlorodiaminocyclohexaneplatinum
15 mg
2017
+5C
79
Y0000264 Diclazuril for veterinary use - reference spectrum
n/a
1718
79
Y0000259 Diclazuril for system suitability
20 mg
1718
+5C
79
D1039990 Diclofenac potassium
100 mg
1508
+5C
79
D1040000 Diclofenac impurity A
0.005 mg
1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 7 is valid until 31

December 2013
1002,1281,1
508
+5C
79
D1050000 Dicloxacillin sodium
250 mg
94.7% CHClNNaOS
0661,0663,0
668
+5C
79
D1060000 Dicycloverine hydrochloride
100 mg
1197
+5C
79
Y0000439 Didanosine
10 mg
2200
+5C
79
New Y0000261 Dextromethorphan impurity A
1506
Average molecule mass : 930-1000

Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
Yes
20239
23
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000440 Didanosine for system suitability

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
2200
Yes
Storage
+5C
Extra
Price
charges
79
a
Y0000441 Didanosine impurity A
10 mg
1,7-dihydro-6H-purin-6-one (hypoxanthine)
2200
+5C
79
Y0000442 Didanosine impurity G
10 mg
9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)
2200
+5C
79
D1200000 Dienestrol
150 mg
100% CHO
0484
+5C
79
D1300000 Diethylcarbamazine citrate
250 mg
99.9% CHNO
0271
+5C
79
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum
n/a
79
D1410000 Diethyl phthalate
1 ml
D1500000 Diethylstilbestrol
100 mg
D1600000 Diethylstilbestrol dimethyl ether
10 mg
D1700000 Diethylstilbestrol monomethyl ether
10 mg
Y0001423 Difloxacin hydrochloride
60 mg
Y0001429 Difloxacin impurity G
15 mg
D1750000 Diflunisal
30 mg
D1800000 Digitoxin
200 mg
Y0000640 Digoxigenin
5 mg
D1900000 Digoxin
30 mg
Y0000554 Digoxin for peak identification
10 mg
0079
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum
n/a
1310
Y0000232 Dihydralazine for system suitability
10 mg
1310
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum
n/a
Y0000053 17 alpha-dihydroequilin
10 mg
D1945000 Dihydroergocristine mesilate
250 mg
D1950000 Dihydroergotamine mesilate
100 mg
Y0000831 Dihydroergotamine for peak identification
10 mg
0551
D1952000 Dihydroergotamine tartrate
150 mg
100.0% CHNO. Dried at 100-105C at constant weight
0600
D1954000 Dihydrostreptomycin sulfate
25 mg
23.9 mg per vial of CHNOS
Y0000544 Dihydrotachysterol
30 mg
99.6% CHO
Y0000482 Dihydrotachysterol for system suitability
5 mg
D1980000 Diltiazem hydrochloride
300 mg
Y0001141 Diltiazem for system suitability
10 mg
Y0001439 Diltiazem impurity F
10 mg
D2000000 Dimenhydrinate
100 mg
Y0000234 N,N-Dimethylacetamide - reference spectrum
Y0001103 Dimenhydrinate for peak identification
Yes
1198
0897
+5C
79
0483,0484
+5C
79
0484
+5C
79
0484
+5C
79
2239
+5C
79
2239
+5C
79
0864
+5C
79
+5C
79
+5C
79
Dried at 100-105C for 2 h. 100% CHO
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
0078,0117
99.4% CHO
Yes
0079
0079
+5C
79
Yes
+5C
79
79
Yes
+5C
79
79
1512
-20C
79
1416,2060
+5C
79
0551
+5C
79
Yes
+5C
79
Yes
+5C
79
0485
Yes
-20C
79
2014
Yes
-20C
g(d)
79
2014
Yes
-20C
g(d)
79
1004
+5C
79
Replaces Diltiazem impurity A CRS ; Batch 1 is valid until 31 August 2013
1004
+5C
79
(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3dihydro-1,5-benzothiazepin-4(5H)-one
1004
+5C
79
0601
+5C
79
n/a
1667
79
1 mg
0601
+5C
79
98.5% CHO
1776
98.2% CHO
24
Yes

Order
Reference Standard
Code
D2050000 Dimethyl sulfoxide

per vial Unit
2
1 ml
1
Information
Monograph Leaflet
0763
+5C
Y0001489 2-(Dimethylamino)ethyl methacrylate
50 mg
D2200000 Dimeticone
200 mg
D2205000 Dimetindene maleate
50 mg
D2255000 Dinoprost trometamol
60 mg
98.2% CHNO
D2250000 Dinoprostone
100 mg
99.8% CHO
D2250015 Dinoprostone impurity C
10 mg
(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)
Y0000094 Diosmin
70 mg
90.9% CHO
Y0000095 Diosmin for system suitability
5 mg
D2600000 Diphenhydramine hydrochloride
100 mg
Y0000135 Diphenhydramine impurity A
10 mg
0023,0601
D2630000 Diphenoxylate hydrochloride - reference spectrum
n/a
0819
Y0001415 Diphenoxylate hydrochloride - * narc
15 mg
0819
Y0001430 Diphenoxylate for system suitability - * narc
10 mg
Y0000258 Diphtheria toxin BRP
1 ml
Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml)

Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge
test in guinea pigs)
Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig
intradermal skin test)
Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below
cause cytotoxic effects.
See leaflet,
0443
Yes
D2700000 Diphtheria vaccine (adsorbed) BRP
32 mg
97 IU per vial
See leaflet,
20706
Yes
Y0000376 Dipivefrine hydrochloride
100 mg
99.3% CHClNO
Y0000394 Dipivefrine for system suitability
10 mg
D2750100 Dipotassium clorazepate - reference spectrum
n/a
0898
D2800000 Diprophylline
100 mg
0486
D2850000 Dipyridamole
50 mg
1199
Y0000802 Dipyridamole for peak identification
2.04 mg
1199
D2880000 Dirithromycin
100 mg
D2900000 Disodium edetate
100 mg
D2920000 Disopyramide
100 mg
D2922000 Disopyramide phosphate
100 mg
D2950000 Disulfiram
100 mg
D2953000 Dithranol
55 mg
Storage
1975
Extra
Price
charges
79
a
+5C
79
Yes
+5C
79
+5C
79
1312
Yes
-20C
79
1311
Yes
-20C
79
-20C
240
+5C
79
1611
+5C
79
0023,0601,1
190
+5C
79
+5C
79
79
+5C
79
+5C
79
+5C
g(b)
90
-20C
90
1719
+5C
79
1719
+5C
79
79
+5C
79
+5C
79
+5C
79
1313
+5C
79
0232
+5C
79
1006
+5C
79
1005
+5C
79
0603
+5C
79
1007
+5C
79
0138,1470
99.9% dimeticone
1417
1311,1488
1611
2-(diphenylmethoxy)-N-methylethanamine
Yes
0819
97.4% CHNO
25
Yes

Order
Reference Standard
Code
D2953025 Dithranol impurity C

Information
per vial Unit
3
15 mg
1 Dithranol-dimer
4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 2 is
valid until 1 June 2013
Monograph Leaflet
1007
Yes
D2953050 Dithranol impurity D
20 mg
D2954000 Dobutamine hydrochloride
100 mg
1200
Y0001239 Dobutamine impurity mixture
0.1 mg
1200
Yes
Y0001133 Docetaxel trihydrate
160 mg
93.5% CHNO ; Batch 1 is valid until 30 November 2013
2449,2593
Y0001155 Docetaxel for system suitability
10 mg
2449,2593
Y0001452 Docetaxel impurity E
15 mg
5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl
benzoate (10-desacetyl-baccatin III)
D2954600 Docosahexaenoic acid ethyl ester
150 mg
93.1% DHA ethyl ester
D2954500 Docusate sodium - reference spectrum
n/a
1418
Y0000365 Dodecyl gallate
30 mg
2078
D2955000 Domperidone
150 mg
1009
D2957000 Domperidone maleate
150 mg
D2960000 Dopamine hydrochloride
50 mg
Y0000612 Dopexamine dihydrochloride
10 mg
Y0000613 Dopexamine impurity B
10 mg
2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol
Y0000614 Dopexamine impurity F
10 mg
4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol
Y0000726 Dorzolamide hydrochloride
50 mg
Y0000727 Dorzolamide impurity A
5 mg
Y0000750 Dorzolamide for system suitability
5 mg
2359
D2962000 Dosulepin hydrochloride
100 mg
1314
30 mg
Y0001385 Angelica pubescent root
500 mg
D2963000 Doxapram hydrochloride
50 mg
Y0000208 Doxapram impurity B
10 mg
(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one
1201
Y0000553 Doxazosin mesilate
60 mg
See leaflet CHNOS
2125
Y0000551 Doxazosin impurity D
10 mg
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
2125
New Y0000552 Doxazosin impurity F
15 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine ; Batch 1 is valid until 30 April 2014
2125
Y0000838 Doxepin hydrochloride
5 mg
1096
Y0000851 Doxepin for system suitability
1 mg
1096
Yes
D2975000 Doxorubicin hydrochloride
150 mg
99.4% CHClNO
0714,0662,1
590
D3000000 Doxycycline hyclate
50 mg
92.9% CHClNO corresponding to 85.9% CHNO
0272,0820
New D2962005 Dosulepin impurity A
94.9% CHO; 1-hydroxyanthracen-9(10H)-one ; Batch 3 is valid until 31

December 2013
1007
(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide
+5C
Extra
Price
charges
79
g
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
-20C
79
79
+5C
79
+5C
79
1008
+5C
79
0664,1200
+5C
79
1748
+5C
79
1748
-20C
79
1748
-20C
79
2359
+5C
79
2359
+5C
79
+5C
79
+5C
79
2593
2063,20429
Storage
Yes
Yes
1314
Yes
+5C
79
2557
Yes
+5C
79
1201
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
-20C
g(c)
79
Yes
+5C
79
(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide ; Batch 1 is valid until 30 April 2014
26
Yes
Yes

Order
Reference Standard
Code
Y0001492 Doxylamine for system suitability

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
1589
Yes
Storage
+5C
Extra
Price
charges
79
a
Y0000163 Doxylamine hydrogen succinate - reference spectrum
n/a
1589
79
D3100000 Droperidol
150 mg
1008,1009,1
010, 1172
+5C
79
Y0001105 Drospirenone
60 mg
99.9% CHO
2404
+5C
79
Y0001115 Drospirenone impurity E
0.06 mg
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)
2404
+5C
79
Y0001453 Duloxetine hydrochloride
120 mg
99.8 % CHClNOS
2594
Yes
+5C
79
Y0001454 Duloxetine for system suitability
40 mg
2594
Yes
+5C
79
Y0001455 Duloxetine impurity A
10 mg
(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine ;
2594
+5C
79
Y0001004 Dydrogesterone
50 mg
99.5% CHO
2357
+5C
79
Y0001005 Dydrogesterone impurity A
6 mg
9,10-pregna-4,6,8(14)-triene-3,20-dione
2357
+5C
79
Y0001006 Dydrogesterone impurity B
5 mg
pregna-4,6-diene-3,20-dione
2357
+5C
79
Y0000249 Ebastine - reference spectrum
n/a
79
Y0000247 Ebastine impurity C
10 mg
4-(diphenylmethoxy)piperidine
2015
+5C
79
Y0000248 Ebastine impurity D
10 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one
2015
+5C
79
Y0001236 Econazole
10 mg
2049
+5C
79
E0050000 Econazole nitrate
100 mg
0513,0665,0
921, 0935,
1017,1018
+5C
79
Y0000254 Econazole for system suitability
20 mg
200 mg
Y0000537 Emedastine difumarate
10 mg
Y0000512 Emedastine impurity E
10 mg
E0100000 Emetine hydrochloride
100 mg
E0110000 Enalapril for system suitability
Y0001211 Enalapril impurity mixture

E0109000 Enalapril maleate
2015
0665,2049
Yes
+5C
79
2063,20429
Yes
-20C
79
2242
+5C
79
2242
+5C
79
0081,0093,
0094,1530,1
875
+5C
79
20 mg
1420
+5C
79
0.06 mg
+5C
79
50 mg
1420
+5C
79
Y0000615 Enalaprilat dihydrate
100 mg
1749
+5C
79
Y0000629 Enalaprilat for system suitability
10 mg
1749
+5C
79
Y0000678 Enalaprilat impurity G
0.005 mg
1749
+5C
79
Y0000136 Enilconazole
60 mg
1720
+5C
79
Y0000137 Enilconazole impurity E
20 mg
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol
1720
+5C
79
E0150000 Endotoxin standard BRP
10 mg
10 000 IU per vial ; Batch 4 is valid until 31 December 2012
20614
-20C
79
New E0085000 Eicosapentaenoic acid ethyl ester
97.5% CHO ; Batch 3 is valid until 17 December 2013

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.
1420
(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
27
Yes
Yes
Yes

Order
Reference Standard
Code
E0180000 Enoxaparin sodium

Information
per vial Unit
5
200 mg
1 Batch 4 is valid until 30 November 2013
Monograph Leaflet
0828,1097
Yes
Storage
+5C
Extra
Price
charges
79
a
E0180500 Enoxolone
100 mg
1511
+5C
79
Y0001259 Enrofloxacin
5 mg
2229
+5C
79
Y0001160 Enrofloxacin for system suitability
10 mg
2229
Yes
+5C
79
Y0001249 Entacapone
160 mg
99.9% CHNO
2574
Yes
+5C
79
Y0001250 Entacapone impurity A
10 mg
Z isomer of entacapone
2574
+5C
79
E0200000 Enterokinase BRP
200 mg
0350
+5C
79
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor
50 mg
E0300000 Ephedrine hydrochloride - * Drug Precursor
150 mg
99.8% CHClNO
E0400000 4-Epianhydrotetracycline hydrochloride
20 mg
87.1% CHNO.HCl
E0440000 4-Epidemeclocycline hydrochloride
20 mg
E0500000 6-Epidoxycycline hydrochloride
50 mg
Y0001139 Epinastine hydrochloride
20 mg
Y0001128 Epinastine hydrochloride for system suitability
10 mg
E0530000 4-Epioxytetracycline
40 mg
81.1% CHNO
E0550000 Epirubicin hydrochloride
100 mg
96.4% CHClNO
E0600000 4-Epitetracycline hydrochloride
30 mg
Y0000052 Equilin
15 mg
Y0001325 Equisetum palustre
200 mg
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77

Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE

Strain A/eq/Newmarket/77
See leaflet,
0249
E0850021 Eq Influenza Subtype 2 American-like/Newmarket

Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/1/93
E0850022 Eq Influenza Subtype 2 European-like/Newmarket

Horse Antiserum BRP
1 mg
Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/2/93
Y0000712 Eq Influenza Subtype 2 American-like/South Africa

Horse Antiserum BRP
1 mg
E0900000 Ergocalciferol
500 mg
E1000000 Ergometrine maleate - * Drug Precursor
50 mg
0223
E1100000 Ergosterol
20 mg
0082
E1200000 Ergotamine tartrate - * Drug Precursor
100 mg
0224, 0551
+5C
Y0000051 Erysipelas ELISA coating antigen BRP
0.4 mg
0715
+5C
79
Yes
+5C
79
Yes
+5C
79
0176
+5C
79
0272,0820
+5C
79
2411
+5C
79
0487,0488,0
489,1367,24
51
0210,0211,1
654
2411
Yes
+5C
79
0198,0199
Yes
+5C
79
0662,0714,1
590
Yes
-20C
79
+5C
79
-20C
79
+5C
79
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
0082,0574,0
575,
0598,1192,1
193
Yes
-20C
g(c)
79
+5C
79
-20C
g(c)
79
79
0210,0211,1
654
1512
99.7% CHO
Yes
1825
99.7% CHO ; Vitamin D2 ; Batch 7 is valid until 31 August 2013
0.5ml Freeze dried (0.367g protein)

28
90
See leaflet,
Yes
-20C
c
0064

Order
Code
Y0000177 Erythritol
Reference Standard
E1300000 Erythromycin for microbiological assay

per vial Unit
1
1000 mg
1 99.8% CHO
4
250 mg
1 960 IU per mg
Information
Monograph Leaflet
Storage
1803
Yes
+5C
Extra
Price
charges
79
a
20702
Yes
-20C
79
E1305000 Erythromycin A
250 mg
97.0% CHNO
0179,0274,0
293,
0490,0552,1
098
Yes
-20C
79
E1310000 Erythromycin B
50 mg
98.4% CHNO
0179,0274,0
490,
0552,1098
Yes
-20C
79
E1320000 Erythromycin C
50 mg
97.6% CHNO
0179,0274,0
490,
0552,1098
Yes
-20C
79
E1400000 Erythromycin estolate
100 mg
0552
+5C
79
E1500000 Erythromycin ethylsuccinate
10 mg
0274
+5C
79
E1500800 Erythromycin stearate
50 mg
0490
+5C
79
E1515000 Erythropoietin BRP
37.5 mg
-20C
150
Y0000324 Esketamine hydrochloride - reference spectrum
n/a
79
Y0000338 Esketamine impurity D
10 mg
1742
+5C
79
Y0001028 Esomeprazole magnesium trihydrate
10 mg
2372
+5C
79
Y0000749 Essential oil
1000 mg
2098
+5C
79
E1600000 Estradiol benzoate
250 mg
0139
+5C
79
Y0000852 Estradiol benzoate for system suitability
10 mg
0139
+5C
79
Y0000045 Estradiol butyrate
10 mg
1614
+5C
79
E1620000 Estradiol hemihydrate
100 mg
0821,1203
+5C
79
Y0000314 Estradiol for peak identification
10 mg
0821
+5C
79
Y0000046 Estradiol valerate
50 mg
1614
+5C
79
E1680000 Estriol
50 mg
1203
+5C
79
E1680005 Estriol impurity A
20 mg
See leaflet; 9,11-didehydroestriol ; Batch 1 is valid until 31 August 2013
E1700000 Estrone
15 mg
100.0% CHO
E1800000 Etacrynic acid
100 mg
0457
Y0001263 Etacrynic acid for system suitability
10 mg
0457
E1830000 Etamsylate
30 mg
E1840000 Ethacridine lactate monohydrate
50 mg
E1850000 Ethambutol hydrochloride
250 mg
Y0000803 Ethambutol for system suitability
10 mg
A1202800 Ethanol (anhydrous) - reference spectrum
E1860100 Ethanol 96% - reference spectrum
1316
35280 IU per vial
Yes
1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)
Yes
Yes
Yes
1203
Yes
+5C
79
1512,0140
Yes
+5C
79
+5C
79
+5C
79
1204
+5C
79
1591
+5C
79
0553
+5C
79
0553
+5C
79
n/a
1318
79
n/a
1317
79
29
Yes

Order
Reference Standard
Code
E1900000 Ethinylestradiol

per vial Unit
4
200 mg
1 99.8% CHO
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
g
0140,0821,0
940
Yes
+5C
0140
Yes
+5C
79
Y0001124 Ethinylestradiol for system suitability
1.0124 mg
E2000000 Ethionamide
100 mg
0141
+5C
79
E2150000 Ethosuximide
30 mg
0764
+5C
79
E2250000 Ethosuximide impurity A
30 mg
0764
+5C
79
E2195000 Ethyl acetate - reference spectrum
n/a
79
E2195900 Ethylcellulose - reference spectrum
n/a
E2202000 1-N-Ethylgaramine sulfate
50 mg
77.6% of 1-N-Ethylgaramin sulphate
E2205500 1,1'-Ethylidenebistryptophan
0.002 mg
0.00182 mg per vial of CHNO ; Batch 4 is valid until 1 May 2013
Y0000617 Ethyl indole-3-carboxylate
10 mg
2102
E2300000 Ethylmorphine hydrochloride - reference spectrum
n/a
0491
E2400000 Ethylnicotinamide
150 mg
0233
E2425000 Ethyl parahydroxybenzoate
150 mg
E2450000 Etifenin
25 mg
75 mg
E2451010 Etilefrine impurity A
20 mg
2-ethylamino-1-(3-hydroxyphenyl)ethanone
Y0000572 Etidronate disodium
10 mg
E2470000 Etodolac
60 mg
E2470050 Etodolac impurity H
10 mg
Y0000768 Etodolac for peak identification
10 mg
1422
E2499900 Etofenamate
40 mg
1513
E2499901 Etofenamate for peak identification
20 mg
E2499914 Etofenamate impurity G
25 mg
E2500000 Etofylline
100 mg
E2503000 Etomidate
50 mg
E2503004 Etomidate impurity B
25 mg
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate
97,8% CHO
0823
0823
New E2451000 Etilefrine hydrochloride
New E2600000 Etoposide
(2RS)-2-ethyl-2-methylbutanedioic acid
0899
0822
79
1351
Yes
+5C
79
1272,1383
Yes
+5C
79
+5C
79
79
+5C
79
+5C
79
0585
+5C
79
1205
+5C
79
1205
+5C
79
1778
+5C
79
1422
+5C
79
1422
+5C
79
+5C
79
+5C
79
0409,0431,0
900,
1262,1263,2
134
100.0% CHO
2-(7-ethylindol-3-yl)ethanol
1513
2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate ; Batch 1 is
valid until 30 November 2013
Yes
Yes
+5C
79
1513
Yes
+5C
79
0486
+5C
79
1514
+5C
79
1514
+5C
79
Yes
+5C
79
Yes
+5C
79
150 mg
Y0001365 Etoposide for system suitability
10 mg
E5000000 Eugenol
500 l
1100
+5C
79
F0005000 Famotidine
100 mg
1012
+5C
79
Y0000382 Famotidine for system suitability
10 mg
+5C
79
Y0000409 Famotidine impurity D
10 mg
3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide
+5C
79
110 mg
99.9% CHNOS
30
Y0000556 Febantel
1012
1012
Yes
79
2176
+5C
a

Order
Reference Standard
Code
Y0000660 Febantel for system suitability

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
+5C
2304
+5C
79
2304
+5C
79
10 mg
Y0000732 Felbinac impurity A
20 mg
F0030000 Felodipine
120 mg
Y0000415 Felypressin
0.994 mg
F0040000 Fenbendazole
150 mg
F0040010 Fenbendazole impurity A
20 mg
methyl(1-benzimidazol-2-yl)carbamate
F0040020 Fenbendazole impurity B
25 mg
methyl[5(6)-chlorobenzimidazol-2-yl]carbamate
F0041000 Fenbufen
100 mg
F0048000 Fenofibrate
100 mg
100.0% CHClO
1322
F0048005 Fenofibrate impurity A
20 mg
(4-chlorophenyl)(4-hydroxyphenyl)methanone
1322
F0048010 Fenofibrate impurity B
10 mg
2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)
F0048035 Fenofibrate impurity G
25 mg
1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate
Y0000756 Fenoterol for peak identification
1.2 mg
F0050000 Fenoterol hydrobromide
100 mg
F0054990 Fentanyl - reference spectrum
n/a
1210
Y0001509 Fentanyl for system suitability - * narc
25 mg
1210,1103
F0055000 Fentanyl citrate - reference spectrum
n/a
1103
F0060000 Fenticonazole nitrate
50 mg
F0060040 Fenticonazole impurity D
0.01 mg
F0100000 Ferrous gluconate
100 mg
Y0001013 Ferulic acid
20 mg
99.8% CHO
1834,2558
Y0000789 Fexofenadine hydrochloride
60 mg
99.8% CHClNO
2280
Y0000751 Fexofenadine impurity A
5 mg
2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid
Y0000752 Fexofenadine impurity B
0.01 mg
Y0000753 Fexofenadine impurity C
5 mg
Y0001173 Filgrastim
Y0000090 Finasteride
Y0000091 Finasteride for system suitability
Y0000736 Flavoxate hydrochloride
Y0000737 Flavoxate impurity A

Y0000738 Flavoxate impurity B
F0120000 Flecainide acetate
1013
+5C
79
-20C
79
1208,1458
+5C
79
1208
+5C
79
1208
+5C
79
1209
+5C
79
+5C
79
+5C
79
1322
+5C
79
1322
+5C
79
0901
+5C
79
+5C
79
79
79
79
1634
0.994 mg CHNOS
0901
contains 1.3% of impurity A
Extra
Price
charges
79
a
2176
Y0000731 Felbinac
4-acetyl biphenyl
Storage
Yes
Yes
Yes
Yes
+5C
1211
+5C
79
1211
+5C
79
0493
+5C
79
Yes
+5C
79
Yes
+5C
79
2280
+5C
79
2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid
2280
+5C
79
(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol
2280
+5C
79
0.2 ml
1.95 mg per ml of CHNOS
2206
Yes
-80C
79
60 mg
99.7% CHNO
1615
Yes
+5C
79
120 mg
Contains 0.9% of impurity A ; Batch 2 is valid until 31 August 2013
1615
Yes
10 mg
10 mg
10 mg
10 mg

31
()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate ; Batch 1 is valid until 30 November 2013
+5C
79
1692
+5C
79
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid
1692
+5C
79
ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
1692
+5C
79
79
1324
Yes
+5C
a

Order
Reference Standard
Code
F0120005 Flecainide impurity A

Information
per vial Unit
3
50 mg
1 3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine ; Batch 2 is valid until 1 May 2013
F0120010 Flecainide impurity B
Y0001274 Flecainide for system suitability

Y0001606 Fleeceflower root HRS
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1324
+5C
1324
+5C
79
25 mg
10 mg
1324
Yes
+5C
79
300 mg
2433
Yes
+5C
79
Y0000138 Flubendazole
25 mg
1721
+5C
79
Y0000139 Flubendazole for system suitability
20 mg
1721
+5C
79
Y0000892 Flucloxacillin magnesium octahydrate
5 mg
2346
+5C
79
Y0000889 Flucloxacillin impurity C
5 mg
6-aminopenicillanic acid
2346
+5C
79
Y0000890 Flucloxacillin impurity D
5 mg
3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
2346
+5C
79
Y0000891 Flucloxacillin impurity E
5 mg
6-aminopenicillanic acid flucloxacillin amide
2346
Yes
+5C
79
F0150000 Flucloxacillin sodium
250 mg
95.1% CHClFNNaOS
0661,0663,0
668,2346
Yes
-20C
79
Y0000557 Fluconazole
50 mg
2287
+5C
79
Y0000558 Fluconazole for peak identification
10 mg
2287
Yes
+5C
79
Y0000573 Fluconazole impurity B
10 mg
See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 triazol-1-yl)propan-2-ol ; Batch 2 is valid until 31 March 2014
2287
Yes
+5C
79
Y0000574 Fluconazole impurity C
5 mg
1,1'-(1,3-phenylene)di-1H-1,2,4-triazole
2287
+5C
79
F0175000 Flucytosine
100 mg
0766
+5C
79
Y0001262 Flucytosine for system suitability
0.3 mg
Y0000419 Fludarabine phosphate
120 mg
Y0001536 Fludarabine for system suitability
15 mg
F0180000 Fludrocortisone acetate
100 mg
F0188000 Flumazenil - reference spectrum
n/a
Y0000335 Flumazenil impurity B
5 mg
F0189000 Flumequine
60 mg
F0189020 Flumequine impurity B
0.1 mg
F0188500 Flumetasone pivalate
100 mg
F0189900 Flunarizine dihydrochloride
100 mg
Y0000265 Flunarizine dihydrochloride - reference spectrum
Y0000266 Flunarizine dihydrochloride for system suitability
F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine

Y0000444 Flunixin impurity B
New Y0000445 Flunixin impurity C
(RS)-(piperidin-2-yl)methanamine
Yes
0766
+5C
79
1781
Yes
+5C
79
1781
Yes
+5C
79
0767
+5C
79
79
1326
+5C
79
1517
+5C
79
1517
+5C
79
1327
+5C
79
0816
+5C
79
n/a
1722
79
20 mg
1722
+5C
79
100 mg
1280
+5C
79
n/a
0717
79
10 mg
10 mg
2-methyl-3-(trifluoromethyl)aniline
55 mg
ethyl 2-chloropyridine-3-carboxylate ; Batch 1 is valid until 30 April 2014

79
1696
+5C
f
32
98.3% CHFNOP
1326
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate
Yes
1696
+5C
79
1696
+5C
79

Order
Reference Standard
Code
F0200000 Fluocinolone acetonide

per vial Unit
3
100 mg
1
Information
Monograph Leaflet
Storage
0494
+5C
Extra
Price
charges
79
f
F0230000 Fluocortolone pivalate
100 mg
1212
+5C
79
Y0000796 Fluorescein
120 mg
99.2% CHO
2348
+5C
79
Y0000804 Fluorescein impurity C
0.01 mg
2-(2,4-dihydroxybenzoyl)benzoic acid
2348
+5C
79
Y0000454 Diacetylfluorescein
100 mg
99.6% CHO
1213
+5C
79
F0245000 Fluoresceine sodium - reference spectrum
n/a
1213
79
F0250000 Fluorouracil
40 mg
0611,0766
+5C
79
Y0000762 Fluorouracil impurity A
10 mg
pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
0611
+5C
79
Y0000763 Fluorouracil impurity B
15 mg
dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)
0611
+5C
79
Y0000764 Fluorouracil impurity C
10 mg
pyrimidine-2,4(1H,3H)-dione (uracil)
0611
+5C
79
Y0000765 Fluorouracil impurity F
10 mg
2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)
0611
+5C
79
Y0000791 Fluorouracil impurity mixture
0.0002 mg
0611
Yes
+5C
79
F0253000 Fluoxetine hydrochloride
250 mg
99.9% CHClFNO
1104
Yes
+5C
79
F0253020 Fluoxetine impurity B
10 mg
methyl(3-phenylpropyl)amine
1104
+5C
79
F0253030 Fluoxetine impurity C
5 mg
()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine
1104
+5C
79
Y0000064 Flupentixol dihydrochloride
100 mg
43.6% of Z-isomer CHClFNOS
1693
+5C
79
Y0000067 Flupentixol impurity D
15 mg
2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol
1693
+5C
79
Y0000078 Flupentixol impurity F
25 mg
80.9% CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
1693
+5C
79
F0260000 Fluphenazine decanoate
60 mg
1014,1015
+5C
g(b)
79
Y0000009 Fluphenazine enantate
100 mg
F0280000 Fluphenazine dihydrochloride
50 mg
Y0000708 Fluphenazine impurity mixture
0.07 mg
20 mg
Y0000299 Fluphenazine sulfoxide
10 mg
Y0000211 Flurazepam monohydrochloride - reference spectrum
F0285200 Flurbiprofen
F0285202 Flurbiprofen impurity A
25 mg
Y0000236 Fluspirilene
20 mg
Y0000375 Fluspirilene impurity C
10 mg
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one
100 mg
See leaflet ; Batch 1 is valid until 31 December 2013
1423
New Y0000298 Fluphenazine octanoate
New F0285600 Flutamide
Yes
Yes
1014,1015
+5C
79
0904,1014
+5C
79
+5C
79
1014,1015
+5C
79
0904,1014,1
015
+5C
79
n/a
0905
79
50 mg
1519
+5C
79
1519
+5C
79
1723
+5C
79
1723
+5C
79
+5C
79
+5C
79
+5C
79
0904
(2RS)-2-(biphenyl-4-yl)propanoic acid ; Batch 1 is valid until 30 November

2013
F0285603 Flutamide impurity C
20 mg
N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
1423
Y0000284 Fluticasone propionate
100 mg
99.6% CHFOS
1750
Yes
33
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000221 Fluticasone impurity D

Information
per vial Unit
2
20 mg
1 S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative)
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1750
+5C
1424
+5C
79
1424
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
F0290000 Flutrimazole
100 mg
F0290010 Flutrimazole impurity B
60 mg
Y0001090 Fluvastatin sodium
110 mg
2333
Y0001082 Fluvastatin for system suitability
0.5 mg
2333
Y0000854 Fluvoxamine maleate
5 mg
1977
Y0000853 Fluvoxamine for system suitability
1.004 mg
1977
Y0000916 Fluvoxamine impurity D
10 mg
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
1977
+5C
79
Y0000386 Foeniculin for peak identification
100 mg
Anise oil
0804
Yes
+5C
79
F0300000 Folic acid
300 mg
91.3 % CHNO
0067
Yes
+5C
79
Y0001242 Folic acid impurity A
15 mg
(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)
0067
+5C
79
Y0001243 Folic acid impurity D
70 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid)
0067
+5C
79
F0372000 Formoterol fumarate dihydrate
10 mg
1293,1724
+5C
79
Y0000339 Formoterol for impurity I identification
10 mg
1724
+5C
79
Y0000340 Formoterol fumarate for system suitability
10 mg
1724
Yes
+5C
79
F0380000 Formylfolic acid
30 mg
0978,1606
Yes
F0389000 Foscarnet sodium hexahydrate
50 mg
F0389004 Foscarnet impurity B
10 mg
Y0001222 Foscarnet impurity D
50 mg
Y0001213 Foscarnet impurity mixture
0.012 mg
1520
Y0000782 Fosfomycin calcium
10 mg
1328
F0399950 Fosfomycin sodium - reference spectrum
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol
91.4% CHNO; 10-Formylfolic acid

disodium (ethoxyoxydophosphanyl)formate
Yes
Yes
Yes
-20C
79
1520
+5C
79
1520
+5C
79
1520
+5C
79
+5C
79
+5C
79
79
+5C
79
Yes
n/a
New F0400000 Fosfomycin trometamol
1500 mg
Y0001227 Fosinopril sodium
60 mg
1751
+5C
79
Y0001228 Fosinopril impurity A
5 mg
(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid
1751
+5C
79
Y0001229 Fosinopril impurity B
5 mg
(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
Y0001230 Fosinopril impurity C
10 mg
mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
Y0001231 Fosinopril impurity D
10 mg
(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
1329
1425
34
Yes

Order
Reference Standard
Code
Y0001232 Fosinopril impurity I

Information
Monograph Leaflet
per vial Unit
1
5 mg
1 [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
1751
acetic acid
Y0001233 Fosinopril impurity K
5 mg
Y0001212 Fosinopril impurity mixture
0.02 mg
25 mg
F0550000 Fructose
100 mg
Y0001399 Fulvestrant
120 mg
2443
Y0001413 Fulvestrant for system suitability
40 mg
2443
F0600000 Fumaric acid
120 mg
0365,0902,1
190, 1592
F0700000 Furosemide
100 mg
Y0001493 Furosemide for peak identification
10 mg
F0702000 Furosemide impurity A
5 mg
Y0001411 Fusidic acid
10 mg
Y0001394 Fusidic acid for peak identification
5 mg
0798,0848
Y0001384 Fusidic acid impurity mixture
0.0475 mg
0798,0848
Y0001280 Gabapentin
300 mg
99.9% CHNO
2173
Y0001281 Gabapentin impurity A
20 mg
2-azaspiro[4.5]decan-3-one
2173
Y0001348 Gabapentin impurity B
20 mg
(1-cyanocyclohexyl)acetic acid
2173
Y0001349 Gabapentin impurity D
10 mg
[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid
2173
G0049000 Galactitol
50 mg
G0050000 Galactose
60 mg
Y0001279 Galantamine hydrobromide
10 mg
2366
Y0001190 Galantamine natural for system suitability
10 mg
2366
Y0001201 Galantamine racemic mixture
10 mg
2366
Y0001191 Galantamine synthetic for system suitability
5 mg
2366
Yes
G0150000 Gammacyclodextrin
60 mg
1070,1487
Yes
Y0001129 Ganciclovir
220 mg
Y0001144 Ganciclovir impurity mixture
0.005 mg
1752
Y0000675 Gemcitabine hydrochloride
50 mg
99.9% CHClFNO
2306
Y0000676 Gemcitabine impurity A
20 mg
4-aminopyrimidin-2(1H)-one (cytosine)
Y0000513 Gemfibrozil
5 mg
New F0450000 Framycetin sulfate
(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid
1751
91,2% CHO ; Batch 1 is valid until 1 June 2013
79
+5C
79
0180,0197,2
0702
Yes
-20C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0391
+5C
79
0798
-20C
79
Yes
-20C
79
Yes
-20C
79
Yes
+5C
79
+5C
79
-20C
79
+5C
79
1381
+5C
79
1215
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2306
+5C
79
1694
+5C
79
0391,2185
Yes
Yes
1752
35
+5C
Yes
0391
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid
+5C
Extra
Price
charges
79
a
1751
0177,0178,0
187,
0188,0204,0
209,
0924,1061,1
570
98.8% CHFOS
Storage

Order
Reference Standard
Code
New Y0000514 Gemfibrozil for system suitability
G0200000 Gentamicin sulfate

Information
per vial Unit
2
0.196 mg 1 Batch 1 is valid until 11 December 2013
8
25 mg
2 16500 IU per vial ; Batch 7 is valid until 31 January 2013
Monograph Leaflet
Storage
Extra
Price
charges
79
g
1694
Yes
+5C
0331,20702
Yes
-20C
79
1726
Yes
+5C
79
Y0001112 Gestodene
100 mg
Y0001363 Gentamicin for peak identification
10 mg
0331
Yes
-20C
79
Y0001110 Gestodene for system suitability
10 mg
1726
Yes
+5C
79
Y0001116 Gestodene impurity I
0.01 mg
+5C
79
Y0001012 Ginkgo dry extract for peak identification
150 mg
Y0001010 Ginkgolic Acids
20 mg
Y0001029 Ginseng dry extract HRS
500 mg
Y0001347 Ginsenoside Rb1
30 mg
G0300000 Gitoxin
30 mg
0078,0079,2
168
G0325000 Glibenclamide
100 mg
0718
Y0001511 Glibenclamide for peak identification
30 mg
0718
G0325010 Glibenclamide impurity A
10 mg
4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide ; Batch 2

is valid until 31 December 2012
0718
Y0000242 Glibenclamide impurity B
20 mg
methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]
sulphonyl]carbamate
0718
G0326000 Gliclazide
20 mg
G0326004 Gliclazide impurity B
25 mg
2-nitroso-octahydrocyclopenta[c]pyrrole
G0326012 Gliclazide impurity F
50 mg
Y0000515 Glimepiride
60 mg
Y0000516 Glimepiride for system suitability
0.012 mg
G0340000 Glipizide
50 mg
G0342000 Glipizide impurity A
10 mg
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide
Y0000523 Glipizide impurity C
10 mg
Y0000643 Glipizide impurity D
10 mg
Y0001140 Glipizide impurity mixture
0.002 mg
0906
Y0001406 Glucosamine hydrochloride
10 mg
2446
Y0000191 Human glucagon
2.94 mg
Y0001381 Glucosamine for system suitability
40 mg
2446,2447
Y0001407 Glucosamine sulfate sodium chloride
15 mg
2447
99.4%
13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20yn-3-one
1726
1827
Yes
-20C
79
1827
Yes
-20C
79
2356
Yes
-20C
79
2356
Yes
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1524
+5C
79
1524
+5C
79
1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea
1524
+5C
79
99.4% CHNOS
2223
+5C
79
2223
+5C
79
0906
+5C
79
0906
+5C
79
ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate
0906
+5C
79
6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
0906
+5C
79
+5C
79
+5C
79
-20C
79
+5C
79
+5C
79
0.37% of ginkgolic acid C17

88.1 % CHO
2.94 mg pure human glucagon per vial CHNOS
36
1635
Yes
Yes
Yes
Yes
Yes

Order
Code
G0350500 Glucose
Reference Standard

per vial Unit
2
100 mg
1
Information
Monograph Leaflet
Storage
0177,0178,0
187,
0188,0204,0
209,
1061,1215,1
570
+5C
Extra
Price
charges
79
a
G0355000 Glutamic acid
50 mg
0750,0797,1
445, 2076
+5C
79
Y0000517 Glutathione
10 mg
1670
+5C
79
G0360000 Glutethimide - * psy
50 mg
1291
+5C
79
Y0001391 Glycerol formal
20 mg
1671
+5C
79
Y0000794 Glycerol monocaprylate
500 mg
Y0000795 Glycerol monocaprylocaprate
500 mg
G0400006 Glycerol monolinoleate
2000 mg
G0400007 Glycerol mono-oleate
2500 mg
G0400008 Glycerol monostearate 40-55
2000 mg
G0400101 Glyceryl trinitrate - reference spectrum
n/a
G0400100 Glyceryl trinitrate solution
0.5 ml
G0450000 Glycine
50 mg
Y0001308 Glycopyrronium bromide
10 mg
Y0001309 Glycopyrronium for peak identification
10 mg
Y0001358 Glycopyrronium impurity N
10 mg
Y0000433 Ammonium glycyrrhizate
70 mg
G0460000 Glycyrrhizate (monoammonium)
300 mg
78.6% CHNO
G0525000 Gonadorelin
5 mg
4.96 mg per vial of CHNO
Y0000125 Goserelin
1.87 mg
1636
Y0000126 Gosereline - reference spectrum
n/a
1636
Y0000019 4-D-Ser-goserelin
0.1 mg
1636
Y0000194 Goserelin validation mixture
1 mg
Supplied with the Ph. Eur. reference chromatogram
1636
Y0001473 Goserelin for NMR identification
14 mg
replace Y0000126
1636
G0550000 Gramicidin
250 mg
1081 IU per mg
Y0000396 Granisetron hydrochloride
120 mg
Y0000477 Granisetron impurity A
1 mg
In the chromatogram supplied within the leaflet (Rev 02) of the current CRS
batch 1, some peaks have been mislabelled, the correct version of the leaflet
(Rev 03) is now available on the website. The quality of the product itself is
not questioned and can still to be used.
2213
Yes
+5C
79
2392
Yes
+5C
79
1429
+5C
79
1430
+5C
79
0495
+5C
79
79
+5C
79
0614,0752
+5C
79
1783
+5C
79
1331
1331,1355
1% m/m in ethanol CHNO
94.0% CHNO+; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)

oxy]-1,1-dimethylpyrrolidinium
Yes
1783
Yes
+5C
79
1783
Yes
+5C
79
+5C
79
1772
0277,1536,
2378
Yes
+5C
79
0827
Yes
-20C
79
-20C
79
79
-20C
79
-20C
79
-20C
79
Yes
0907,1662,2
0702
Yes
+5C
79
99.8% CHClNO
1695
Yes
+5C
79
2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide
1695
+5C
79
37

Order
Reference Standard
Code
Y0000478 Granisetron impurity B

Information
per vial Unit
2
1 mg
1 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide
Y0000395 Granisetron impurity E
15 mg
G0600000 Griseofulvin
Y0000619 Guaiacol
50 mg
1500 mg
G0700000 Guaifenesin
100 mg
Y0000117 Halofantrine hydrochloride
125 mg
99.6% CHClFNO
Y0000118 Halofantrine impurity C
10 mg
[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
H0100000 Haloperidol
60 mg
Batch 1 is valid until 1 July 2013
H0100100 Haloperidol decanoate
60 mg
Y0001518 Haloperidol for peak identification
Y0001517 Haloperidol for system suitability
H0150000 Halothane - reference spectrum

Y0000673 Harpagoside
Monograph Leaflet
1695
Yes
1695
(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
0182
99.6% CHO ; Batch 1 is valid until 30 November 2013
Storage
+5C
Extra
Price
charges
79
a
+5C
79
+5C
79
1978
Yes
+5C
79
0615
Yes
+5C
79
1979
+5C
79
1979
+5C
79
0616,0995,1
178, 1503
+5C
79
1397,1431
+5C
79
25 mg
0616
Yes
+5C
79
25 mg
0616
Yes
+5C
79
n/a
79
1.03 mg
1.01mg per vial CHO
1095, 1871
Yes
+5C
79
H0185000 Heparin Low-Molecular-Mass for assay BRP
1 mg
Anti-IIa activity : 31 IU per vial; Anti-Xa activity : 104 IU per vial ; Batch 7 is
valid until 30 November 2013
0828
Yes
+5C
90
H0190000 Heparin Low-Molecular-Mass for calibration CRS
25 mg
Mna = 3800 ; Batch 2 is valid until 30 November 2013
H0200000 Heparin sodium BRP
2 ml
1010 IU per ml
Y0001287 Heparin calcium for NMR identification
30 mg
Y0001283 Heparin sodium for NMR identification
30 mg
New Y0001282 Heparin for physico-chemical analysis
0393
0828
Yes
+5C
90
0569, 20705
Yes
+5C
79
0332
Yes
+5C
79
0333
Yes
+5C
79
300 mg
+5C
79
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
0.5 ml
262 IU per ml; Please contact us for information on the type needed for your
use
See leaflet,
20714
Yes
+5C
90
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP
0.8 ml
To be stored below -50C
20714,1526,
1935, 1107
Yes
-80C
90
Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR
1 mL
Yes
-20C
79
Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA BRR
420 L
Yes
-20C
79
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal

free)
0.5 ml
16.6 micrograms per ml
See leaflet,
20715
Yes
+5C
90
H0210010 Hepatitis B vaccine (rDNA) BRP method B
1 ml
20 micrograms per ml
See leaflet,
1056
Yes
+5C
90
H0220000 Heptadecanol
600 mg
97.9% CHO
0801,0802,0
847
+5C
79
Y0000063 Heptaminol hydrochloride
150 mg
1980
+5C
79
Y0000057 Heptaminol impurity A
20 mg
93.4% CHN; (2RS)-6-methylhept-5-en-2-amine
1980
+5C
79
Y0001203 Hesperidin
20 mg
89,9% CHO
2430
+5C
79
H0330000 Hexamidine diisetionate
20 mg
1436
+5C
79
38
0333
Yes

Order
Code
H0325000 Hexetidine
Reference Standard

per vial Unit
2
100 mg
1
Information
Monograph Leaflet
Storage
1221
+5C
Extra
Price
charges
79
a
H0420000 Hexylresorcinol
100 mg
1437
+5C
79
H0500000 Hide powder
500 mg
20814
+5C
79
H0600000 Histamine dihydrochloride
250 mg
0143
+5C
79
H0750000 Histidine
100 mg
0911
+5C
79
H0755000 Histidine hydrochloride monohydrate
100 mg
0910
+5C
79
H0800000 Homatropine hydrobromide
100 mg
0500,0720
+5C
79
H0830000 Homatropine methylbromide
25 mg
0720
+5C
79
Y0001383 Homatropine methylbromide for system suitability
5 mg
0720
+5C
79
H0837000 L-Homocysteine thiolactone hydrochloride - reference

spectrum
n/a
1617
79
Y0001290 Honokiol
20 mg
99.6% CHO
H0900000 Human albumin for electrophoresis BRP
1 ml
96,7% to 99,2% of the total protein is the main band (albumin), protein
content : 5%
Y0000219 Human anti-D immunoglobulin BRP
40 mg
Y0000667 Human coagulation factor VII concentrate BRP
25 mg
H0920000 Human coagulation factor VIII concentrate BRP
H0920500 Human coagulation factor IX concentrate BRP

Yes
2567,2568
Yes
-20C
g(c)
79
0255
Yes
-20C
79
285 IU anti-D immunoglobulin per ampoule

1uc=40 mg
See leaflet,
20713
Yes
-20C
90
9.9 IU per vial
See leaflet,
20710
Yes
-20C
79
37 mg
10.4 IU per vial
See leaflet,
20704
Yes
-20C
90
30 mg
7.9 IU/vial; Common standard with FDA and WHO (4th IS)
See leaflet,
20711, 1223
Yes
-20C
90
H0950000 Human hepatitis A immunoglobulin BRP
10 mg
10.2 IU per vial
See leaflet,
0338, 0769
Yes
-20C
90
Y0001504 Human immunoglobulin BRP (ACA and Molecular size)
1 uc
See leaflet,
0338, 0918
Yes
+5C
90
Y0001512 Human Immunoglobulin BRP (Fc Function and

Molecular size)
9000 mg
See leaflet,
0338, 0918
Yes
+5C
90
H1000000 Human immunoglobulin for electrophoresis BRP
96 mg
75.7% to 80.9% of the total protein is the main band (Ig),

protein content: 5%
0338,0918
Yes
+5C
79
Y0000488 Human immunoglobulin (molecular size) BRP
700 mg
Each vial contains 0.7 gram of immunoglobulin G
See leaflet,
0338,
0918,1928
Yes
+5C
90
H1005000 Human Plasma Pools for NAT validation
3502 mg
Set of 103 plasma pool samples
See leaflet,
20621
Yes
-20C
400
H1100000 Human rabies immunoglobulin BRP
170 mg
91 IU per vial
See leaflet,
0723
Yes
-20C
90
H1110000 Human tetanus immunoglobulin BRP
87 mg
120 IU per vial
0398
Yes
-20C
90
Y0000502 Human vaccinia immunoglobulin
1 ml
23 IU per vial
See leaflet
Yes
-20C
270
H1115000 Hyaluronidase BRP
50 mg
328 IU per mg
0912
Yes
+5C
79
39

Order
Reference Standard
Code
H1120000 Hydralazine hydrochloride

per vial Unit
1
20 mg
1
Information
Monograph Leaflet
0829
Storage
+5C
Extra
Price
charges
79
g
Y0001151 Hydrastine hydrochloride
20 mg
91,7% CHClNO
1831,2500
Yes
-20C
79
H1200000 Hydrochlorothiazide
300 mg
99.8% CHClNOS ; Batch 6 is valid until 31 August 2013
0394
Yes
+5C
79
0394
Yes
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
New Y0001494 Hydrochlorothiazide for peak identification
10 mg
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc
10 mg
Y0000710 Hydrocodone for peak identification - * narc
10 mg
1784
H1300000 Hydrocortisone
100 mg
0335,0353,0
561
Y0001092 Hydrocortisone for peak identification
5 mg
H1400000 Hydrocortisone acetate
125 mg
99% CHO; Hydrocortisone acetate CRS 8 is suitable for monographs

0321,0334,0
01/2011:0335, 01/2008:334, 01/2008:0321, 01/2008:0767 and 01/2008:0734
335,
only.
0734,0767
Y0001482 Hydrocortisone acetate for peak identification
15 mg
0334
H1425000 Hydrocortisone hydrogen succinate
100 mg
0768,1131
-20C
79
H1426000 Hydrogenated wool fat
250 mg
0969
+5C
79
Y0000446 Hydromorphone hydrochloride - * narc
10 mg
2099
+5C
79
B0650000 Hydrous benzoyl peroxide - reference spectrum
n/a
0704
79
H1428000 Hydroxocobalamin
10 mg
0913,0914,0
915
+5C
79
Y0000119 Hydroxycarbamide
175 mg
1616
+5C
79
H1429400 Hydroxyethyl salicylate
125 mg
1225
+5C
79
H1429700 4-Hydroxyphenoxymethylpenicillin potassium
20 mg
98.4% CHKNOS
-20C
79
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine
50 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A
0813
+5C
79
Y0001277 Hydroxyethyl starch (medium MW)
1200 mg
Average Mw 130100 Da
1785
Yes
+5C
79
Y0001322 Hydroxyethyl starch (high Mw)
800 mg
507900 Da
1785
Yes
+5C
79
Y0000186 Hydroxypropylbetadex
200 mg
1804
+5C
79
H1435000 Hydroxyzine hydrochloride
600 mg
0916,1086,1
092
+5C
79
Y0000011 Hymecromone
100 mg
1786
+5C
79
Y0000012 Hymecromone impurity A
25 mg
Resorcinol
1786
+5C
79
Y0000013 Hymecromone impurity B
25 mg
7-hydroxy-2-methyl-4H-1-benzopyran-4-one.
1786
+5C
79
Y0000483 Hyoscine
10 mg
2167
+5C
79
Y0000484 Hyoscine impurity A
10 mg
2167
+5C
79
H1450000 Hyoscine butylbromide
20 mg
0737
+5C
79
Y0000447 Hyoscine butylbromide impurity E
10 mg
0737
+5C
79
H1500000 Hyoscine hydrobromide
50 mg
0106,0500
+5C
79
1784
0335
99.9% CHNO
0148,0149
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
(1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3hydroxy-2-phenylpropanoate (N-butylhyoscine)
40
Yes
Yes

Order
Reference Standard
Code
Y0000448 Hyoscine hydrobromide impurity B

Information
per vial Unit
1
10 mg
1 (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0106
+5C
0501
+5C
79
0501
+5C
79
H1600000 Hyoscyamine sulfate
100 mg
Y0000449 Hyoscyamine impurity E
10 mg
Y0000915 Hypromellose phthalate
10 mg
347
+5C
79
I0020000 Ibuprofen
250 mg
0721
+5C
79
B1220000 Ibuprofen impurity B
1.1 mL
solution of 0.06% m/V in acetonitrile - to be diluted as appropriate. CHO;

(2RS)-2-(4-Butylphenyl)propanoic acid ; Batch 6 is valid until 31 August 2013
0721
+5C
79
Y0000140 Ibuprofen impurity F
5 mg
3-[4-(2-methylpropyl)phenyl]propanoic acid
0721
+5C
79
Y0000881 Ibuprofen for peak identification
0.09 mg
+5C
79
I0050000 Idoxuridine
50 mg
0669
+5C
79
I0060000 Ifosfamide
50 mg
1529
+5C
79
I0060100 Ifosfamide - reference spectrum
n/a
79
I0060002 Ifosfamide impurity A
100 mg
3-[(2-chloroethyl)amino]propyl dihydrogen phosphate
1529
-20C
g(c)
79
I0060004 Ifosfamide impurity B
40 mg
bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate ; Batch 1 is valid

until 31 January 2014
1529
+5C
79
I0060010 Ifosfamide impurity E
20 mg
3-chloro-N-(2-chloroethyl)propan-1-amine
1529
+5C
79
I0060012 Ifosfamide impurity F
10 mg
(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide
1529
+5C
79
I0086000 Imidazole
100 mg
0757,1424,
2270
+5C
79
I0090000 Imipenem
100 mg
1226
-20C
79
I0100000 Imipramine hydrochloride
50 mg
0029,0408,0
817,
0889,1787
+5C
79
Y0000893 Imipramine for system suitability
10 mg
0029
+5C
79
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test

BRP
45 mg
20620
Yes
-20C
79
Y0001152 Immunoglobulin panel for anti-A, anti-B antibodies test
96 mg
20620
Yes
-20C
120
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP
2000 mg
See leaflet,
20626
Yes
-20C
90
Y0001205 Imperatorin
20 mg
98.8 % CHO
2556
Yes
+5C
79
I0150000 Indapamide
150 mg
97.6% CHClNOS
1108
Yes
+5C
79
I0150020 Indapamide impurity B
5 mg
4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide
1108
+5C
79
Y0000788 Indinavir
100 mg
97.2% CHNO
2214
+5C
79
Y0000880 Indinavir sulfate - reference spectrum
n/a
2214
79
Y0000746 Indinavir for system suitability
20 mg
2214
+5C
79
I0200000 Indometacin
50 mg
0092,0922,1
686
+5C
79
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate
0721
100.0% CHClNOP
Yes
1529
92.9% CHNOS
41
Yes
Yes

Order
Code
Y0000349 Insulin aspart
Reference Standard

Information
per vial Unit
2
8 mg
1 7.45 mg of insulin aspart + B28iso insulin aspart + A21Asp insulin aspart +
B3Asp insulin
8 aspart + B3iso Asp insulin aspart per vial
Monograph Leaflet
Storage
2084
Yes
-20C
Extra
Price
charges
90
c
I0305000 Insulin (bovine)
7.99 mg
7.99 mg insulin + A21 desamido per vial CHNOS
0854,1637
Yes
-20C
90
I0310000 Insulin (human)
8 mg
6.94 mg insulin + A21 desamido per vial CHNOS
0838,0854,1
637, 1638
Yes
-20C
90
Y0000348 Insulin lispro
5.75 mg
5.75 mg per vial of CHNOS ; Batch 1 is valid until 1 June 2013
2085
Yes
-20C
90
Y0001542 Insulin glargine
15 mg
14,98 mg
1571
Yes
-20C
79
Y0001544 Insulin glargine for peak identification
3.2 mg
-20C
79
I0320000 Insulin (porcine)
8.61 mg
8.61 mg insulin + A21-desamido per vial

see recommandations for use on accompagnying leaflet CHNOS
I0320301 Interferon alfa-2b
200 L
Y0001101 Interferon beta-1a
0.5 mL
I0320330 Interferon gamma 1b
0.5 mL
I0320331 Interferon gamma-1b validation solution
I0328000 Iobenguane sulfate
2571
0838,0854,1
637, 1638
Yes
-20C
90
About 9.74 mg per mL
1110
Yes
-80C
90
335 g of interferon beta-1a per mL CHNOS ; Batch 1 is valid until

30 November 2012
1639
Yes
-80C
90
about 1 mg per ml
1440
Yes
-80C
90
0.6 mg
The CRS is available in the freeze-dried form.

About 1 mg per ml after reconstitution following instructions provided in the
leaflet. ; Batch 2 is valid until 31 December 2013
1440
Yes
-20C
79
25 mg
97.2% CHINOS
+5C
79
Y0000839 Iobenguane sulfate - reference spectrum
n/a
79
Y0001294 Iodixanol
60 mg
2215
+5C
79
Y0001292 Iodixanol impurity C
10 mg
5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C
79
Y0001291 Iodixanol impurity E
10 mg
5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
2215
+5C
79
Y0001293 Iodixanol impurity H
10 mg
5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
+5C
79
I0320800 Iohexol
150 mg
1114
+5C
79
I0320810 Iohexol impurity A
50 mg
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide
1114
+5C
79
I0320820 Iohexol impurity J
125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide
1114,2215
+5C
79
Y0000672 Iohexol for peak identification
10 mg
+5C
79
I0329000 Iopamidol
50 mg
I0329010 Iopamidol impurity A
10 mg
1111,1112,11
13,2351
2351
1114
Yes
79
1115
+5C
a
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-tri79
1115, 1754
+5C
a
iodoisophthalamide
42

Order
Reference Standard
Code
Y0000406 Iopamidol impurity H

Information
per vial Unit
1
10 mg
1 4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
I0330000 Iopanoic acid
Y0001297 Iopentol
Y0001020 Iopromide
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1115
+5C
0700
+5C
79
+5C
79
+5C
79
100 mg
10 mg
100 mg
98.7% CHINO
1753
Y0001077 Iopromide impurity A
0.125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide
1753
+5C
79
Y0001021 Iopromide for system suitability 1
5 mg
1753
+5C
79
Y0001022 Iopromide for system suitability 2
5 mg
1753
+5C
79
Y0000555 Iotrolan
100 mg
+5C
79
Y0000658 Iotrolan for system suitability
5 mg
+5C
79
Y0000141 Ioxaglic acid
125 mg
Y0000142 Ioxaglic acid impurity A
20 mg
I0360000 Ipratropium bromide
120 mg
Y0000276 Ipratropium impurity A
10 mg
(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane
I0361000 Ipratropium bromide impurity B
10 mg
(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane
Y0001166 Irbesartan
60 mg
Y0001156 Irbesartan impurity A
10 mg
Y0001616 Irisflorentin
15 mg
I0375000 Isoconazole
200 mg
I0380000 Isoconazole nitrate
200 mg
I0400000 Isoemetine hydrobromide
25 mg
Y0000858 Isoflurane
Y0000037 Isoflurane - reference spectrum
I0460000 Isoleucine
I0465000 Isomalt
Y0000070 Isomaltooligosaccharide
I0500000 Isoniazid
I0599990 Isoprenaline hydrochloride
I0600000 Isoprenaline sulfate
2215
97.2%
1754
Yes
Yes
1754
2009
+5C
79
2009
+5C
79
0919
+5C
79
0772
+5C
79
0919
+5C
79
2465
+5C
79
1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide ; Batch 1 is valid until 31 October 2013
2465
+5C
79
99,5% CHO
2561
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
Yes
+5C
79
1018
+5C
79
1017
+5C
79
0080,0081
+5C
79
1.4 ml
1666
+5C
g(b)
79
n/a
1673
79
50 mg
+5C
79
3000 mg
+5C
79
0.9 mg
1506
+5C
79
100 mg
0146
+5C
79
50 mg
1332
+5C
79
500 mg
0502
+5C
79
I0725000 Isopropyl hexadecanoate
100 mg
94.3% CHO
0839
Yes
+5C
79
I0750000 Isopropyl tetradecanoate
2 ml
97.9% CHO
0725
Yes
+5C
79
Y0001568 Isoquercitroside
15 mg
97% CHO
2528,2667
Yes
+5C
79
I0775000 Isosorbide dinitrate
350 mg
40,8% CHNO ; Batch 2 is valid until 1 June 2013
1117,1118
Yes
+5C
79
150 mg
99.9% CHNO; Isosorbide-5-nitrate ; Batch 3 is valid until 31 January 2013

79
1117,1118
Yes
+5C
h
43
I0775010 Isosorbide mononitrate

Yes
0770
97.0 % CHO ; Batch 4 is valid until 1 May 2013
1531
Yes

Order
Reference Standard
Code
I0775020 Isosorbide-2-nitrate

per vial Unit
3
50 mg
1
Information
Monograph Leaflet
1118
+5C
I0800000 Isotretinoin
60 mg
0693,1019
Y0001218 Isotretinoin for peak identification
10 mg
1019
I0900000 Isoxsuprine hydrochloride
50 mg
Y0000366 Isradipine
125 mg
99.2% CHNO
2110
Y0000367 Isradipine impurity D
5 mg
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)

-2,6-dimethylpyridine-3,5-dicarboxylate
2110
I7000000 Itraconazole
20 mg
1335
Y0001100 Itraconazole for system suitability
25 mg
Batch 1 is valid until 30 September 2013
1335
Yes
I8000010 Ivermectin
150 mg
90.6% of CHO (component H2B1a)
1336
Yes
Y0000575 Ivy leaf standardised tincture
2 ml
0.20% (m/m) of hederacoside C; Ivy leaf standardised tincture CRS has been
replaced with Ivy leaf dry extract HRS Y0001592. ; Batch 1 is valid until 31
October 2013
2148
Y0000041 Josamycin
150 mg
1000 Ph. Eur. units per mg
1982,1983,2
0702
Y0000042 Josamycin propionate
150 mg
975 Ph. Eur. units per mg
Y0001315 Josamycin for peak identification
25 mg
K0100000 Kanamycin B sulfate
20 mg
K0200000 Kanamycin monosulfate
150 mg
Y0000450 Ketamine hydrochloride - * narc
10 mg
K0551000 Ketamine impurity A
50 mg
Y0000246 Ketobemidone hydrochloride - reference spectrum
n/a
Y0000244 Ketobemidone impurity B
5 mg
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
Y0000245 Ketobemidone impurity C
5 mg
1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one
K0600000 Ketoconazole
150 mg
K2000000 Ketoprofen
50 mg
K2000010 Ketoprofen impurity A
10 mg
K2000015 Ketoprofen impurity C
15 mg
Y0000486 Ketorolac trometamol
10 mg
Y0000626 Ketorolac trometamol for peak identification
5 mg
Y0000164 Ketotifen hydrogen fumarate - reference spectrum
n/a
Storage
Yes
1119
Yes
Extra
Price
charges
79
g
+5C
g(b)
79
+5C
g(b)
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
-20C
g(c)
79
Yes
-20C
79
1982,1983,2
0702
Yes
+5C
79
1983
Yes
+5C
79
0032,0033,0
645
+5C
79
+5C
79
799 IU per mg of CHNOS,HO
0032,0033,0
053,
0485,0645,1
289,
1290,20702
Yes
1020
+5C
79
1020,1742
+5C
79
79
1746
+5C
79
1746
+5C
79
0921,1067,1
270
+5C
79
0922,1157,1
209
+5C
79
1-(3-benzoylphenyl)ethanone
0922
+5C
79
3-[(1RS)-1-carboxyethyl]benzoic acid
0922
+5C
79
1755
+5C
79
+5C
79
79
1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol
1746
1755
1592
44
Yes

Order
Reference Standard
Code
Y0000161 Ketotifen impurity G

Information
per vial Unit
4
0.0225 mg 1 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione ; Batch 3 is valid until 31 August 2013
Monograph Leaflet
Storage
Extra
Price
charges
79
g
1592
Yes
+5C
2434,2483
Yes
-20C
79
Yes
+5C
79
+5C
79
+5C
79
Y0001200 Kudzuvine root dry extract
200 mg
See leaflet
L0050000 Labetalol hydrochloride
120 mg
99.6 % CHClNO ; Batch 1 is valid until 31 March 2013
0923
Y0001548 Labetalol impurity A
10 mg
2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic
acid
0923
L0129000 Lactitol monohydrate
60 mg
93.8% CHO
1337
Y0000257 Lactobionic acid
100 mg
1647
+5C
79
A1206000 Lactose (anhydrous)
100 mg
1061
+5C
79
L0100000 Lactose
100 mg
0177,0178,0
187,
0188,0204,0
209,
1215,1570
+5C
79
L0130000 Lactulose
3000 mg
Y0001510 Lactulose for peak identification
2600 mg
Y0000188 Lactulose for system suitability
12 mg
Y0000425 Lamivudine
150 mg
Y0000518 Lamivudine for system suitability 1
10 mg
Y0000426 Lamivudine for system suitability 2
10.3 mg
Y0001030 Lamotrigine
10 mg
Y0001031 Lamotrigine for peak identification
Y0001085 Lamotrigine for system suitability
Y0001032 Lamotrigine impurity E

Y0000773 Lansoprazole
Y0000774 Lansoprazole for peak identification
Y0001474 Lauric acid
Yes
0924,1230
Yes
+5C
79
0924
Yes
+5C
79
1230
Yes
+5C
79
2217
+5C
79
2217
+5C
79
2217
+5C
79
1756
+5C
79
20 mg
1756
Yes
+5C
79
10 mg
1756
Yes
+5C
79
15 mg
1756
+5C
79
60 mg
2219
+5C
79
1.01 mg
2219
Yes
+5C
79
1500 mg
97.9%
1848
Yes
+5C
79
Y0000654 Leflunomide
100 mg
100,0% CHFNO
2330
+5C
79
Y0000487 Leflunomide impurity A
25 mg
4-(trifluoromethyl)aniline
2330
+5C
79
Y0000674 Leflunomide for peak identification
1 mg
Y0000685 Letrozole
70 mg
L0375000 Leucine
50 mg
L0376000 Leuprorelin
1 mg
L0376001 Leuprorelin - reference spectrum
n/a
Y0000047 Levamisole hydrochloride for system suitability
60 mg
L0380000 Levamisole hydrochloride
50 mg
0726
Y0000048 Levamisole - reference spectrum
n/a
1728
Y0001253 Levetiracetam
110 mg
99.7% CHO
99.7% CHNOS
2,3-dichlorobenzoic acid
99.7% CHN
0.99 mg per vial of pure leuprorelin peptide CHNO
2330
Yes
+5C
79
2334
Yes
+5C
79
0771,0874
+5C
79
1442
-20C
79
79
+5C
79
+5C
79
79
79
1442
100.0% CHNO
45
0726,1728
2535
Yes
Yes
+5C

Order
Reference Standard
Code
Y0001254 Levetiracetam impurity A

Information
per vial Unit
2
10 mg
1 (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid ; Batch 1 is valid until 1 March
2013
Monograph Leaflet
Storage
2535
+5C
Extra
Price
charges
79
a
New Y0001255 Levetiracetam impurity B
15 mg
(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide ; Batch 1 is valid until 31 March

2014
2535
+5C
79
New Y0001256 Levetiracetam impurity C
15 mg
pyridin-2-ol ; Batch 1 is valid until 30 April 2014
2535
+5C
79
Y0001257 Levetiracetam impurity D
15 mg
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) ; Batch 1 is valid

until 1 October 2013
2535
+5C
79
L0390000 Levocabastine hydrochloride
125 mg
1484
+5C
79
L0390008 Levocabastine impurity D
20 mg
1484
+5C
79
L0399900 Levocarnitine
125 mg
1339
+5C
79
L0399905 Levocarnitine impurity A
50 mg
1339
+5C
79
L0400000 Levodopa
100 mg
0038
+5C
79
L0420000 Levodropropizine
60 mg
1535
+5C
79
L0420002 Levodropropizine impurity A
25 mg
(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine) ; Batch

2 is valid until 30 November 2013
1535
+5C
79
Y0001033 Levodropropizine impurity B
50 mg
1-phenylpiperazine
1535
+5C
79
Y0001048 Levodropropizine impurity C
300 mg
2,3-epoxypropan-1-ol
1535
-20C
g(c)
79
L0500000 Levomepromazine hydrochloride
100 mg
0505
+5C
79
L0505000 Levomepromazine maleate
50 mg
0925
+5C
79
L0551000 Levonorgestrel
30 mg
0926
+5C
79
Y0001379 Levonorgestrel impurity B
10 mg
+5C
79
Y0001431 Levonorgestrel for system suitability
10 mg
+5C
79
Y0001618 Levonorgestrel for system suitability 2
10 mg
L0570000 Levothyroxine sodium
100 mg
Y0001382 Levothyroxine for peak identification
10 mg
L0595000 Lidocaine
50 mg
L0600000 Lidocaine hydrochloride
L0650000 Lincomycin hydrochloride
1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic
acid
(E)- or (Z)-4-(trimethylammonio)but-2-enoate
13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one
0926
0926
Yes
0926
Yes
+5C
79
0401,0728
Yes
-20C
79
0401
Yes
-20C
79
0727
+5C
79
100 mg
0227,1242,1
363
+5C
79
250 mg
Y0001393 Lincomycin hydrochloride for system suitability
10 mg
L0700000 Liothyronine sodium
50 mg
Y0000860 Liothyronine for peak identification
0.0046 mg
0728
L0702000 Lisinopril dihydrate
50 mg
1120
Y0001235 Lisinopril for system suitability
2 mg
89.3% CHINNaO
95.4% CHClNOS
0582,0583,0
996
Yes
+5C
79
0583
Yes
-20C
79
96.6 % CHINNaO
0401,0728
Yes
-20C
79
-20C
79
+5C
79
+5C
79
Lisinopril for performance test CRS 3 renamed as lisinopril for system

suitability CRS 1 for the implementation of 01/2011:1120 ; Batch 1 is valid
until 30 November 2013
46
1120
Yes

Order
Reference Standard
Code
Y0001234 Lisinopril impurity F

Information
per vial Unit
1
0.01 mg
1 (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
L0720000 Lithium clavulanate
125 mg
L0720800 Lithocholic acid
60 mg
Y0000112 Lobeline hydrochloride
50 mg
L0745000 Lomustine
50 mg
Y0001438 Long pepper for system suitability HRS
600 mg
L0750000 Loperamide hydrochloride
Y0000322 Loperamide hydrochloride for system suitability

Y0000341 Loperamide oxide monohydrate
Monograph Leaflet
1120
+5C
79
1189,1275
+5C
79
1988
+5C
79
0928
+5C
79
2477, 2453
+5C
79
50 mg
0921,0929,1
729
+5C
79
15 mg
0929
+5C
79
20 mg
1729
+5C
79
Y0001498 Lopinavir
200 mg
2615
Yes
+5C
79
Y0001506 Lopinavir for peak identification
10 mg
2615
Yes
+5C
79
Y0001505 Lopinavir for system suitability
10 mg
2615
Yes
+5C
79
Y0000688 Loratadine
60 mg
2124
+5C
79
Y0000603 Loratadine for system suitability
20 mg
+5C
79
Y0000604 Loratadine impurity F
10 mg
ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
2124
+5C
79
Y0000605 Loratadine impurity H
50 mg
ethyl 4-oxopiperidine-1-carboxylate
2124
+5C
79
L0750500 Lorazepam - * psy
100 mg
1121
+5C
79
Y0000576 Lorazepam for system suitability - * psy
0.8032 mg
1121
+5C
79
Y0000718 Lorazepam impurity D
10 mg
(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
1121
+5C
79
Y0001062 Losartan potassium
50 mg
2232
+5C
79
Y0001072 Losartan impurity D
6 mg
2232
+5C
79
Y0001076 Losartan for system suitability
0.0015 mg
L0790000 Lovastatin
60 mg
Y0001136 Lovastatin for peak identification
20 mg
Y0001284 Lufenuron
140 mg
Y0001261 Lufenuron for peak identification
0.4028 mg
Y0001265 Lufenuron impurity G
15 mg
L0800000 Lynestrenol
50 mg
Y0001034 Lynestrenol for peak identification
Y0000397 Lysine acetate
L0900000 Lysine hydrochloride

Y0000745 Macrogol 40 sorbitol heptaoleate
95.3 % CHNO
2124
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde
99.5% CHO
99.5% CHClFNO
Yes
Extra
Price
charges
79
a
+5C
97.6% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO
1140,1653
Storage
Yes
Yes
2232
Yes
+5C
79
1538,1563
Yes
-20C
79
1538
Yes
-20C
79
2177
Yes
+5C
79
2177
Yes
+5C
79
2177
+5C
79
0558
+5C
79
20 mg
0558
+5C
79
60 mg
2114
+5C
79
50 mg
0805,0806,0
930, 1654
+5C
79
20 mg
2396
+5C
79
2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate
47
Yes

Order
Reference Standard
Code
Y0001157 Macrogol polyvinyl alcohol grafted copolymer

per vial Unit
1
400 mg
1
Information
Monograph Leaflet
Storage
2523
+5C
Extra
Price
charges
79
a
Y0001369 Macrogol 30 dipolyhydroxystearate
100 mg
2584
+5C
79
M0088000 Magnesium aspartate dihydrate
60 mg
1445
+5C
79
Y0001289 Magnolol
20 mg
99.5% CHO
2567,2568
Yes
-20C
g(c)
79
M0120000 Malathion
250 mg
99.4% CHOPS
1343
Yes
+5C
79
M0120005 Malathion impurity A
10 mg
diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate
1343
-20C
g(c)
79
M0120010 Malathion impurity B
10 mg
diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate
1343
-20C
g(c)
79
M0100000 Maleic acid
100 mg
0365,0925
+5C
79
Y0000143 Malic acid - reference spectrum
n/a
2080
79
M0160000 Maltitol
1200 mg
99.7% CHO
M0200000 Mannitol
1200 mg
98.8% CHO
M0206000 Maprotiline hydrochloride
100 mg
M0206040 Maprotiline impurity D
25 mg
Y0000819 Marbofloxacin
10 mg
Y0000820 Marbofloxacin for peak identification
20 mg
M0210000 Measles vaccine (live) BRP
80 mg
M0215000 Mebendazole
20 mg
1208,1254
Y0000144 Mebendazole for system suitability
20 mg
0845
Y0001086 Mebrofenin
120 mg
2393
M0220000 Meclozine dihydrochloride
150 mg
Renamed for 01/2011:0622 ; Batch 1 is valid until 1 May 2013
Y0001310 Meclozine impurity B
15 mg
4-chlorobenzhydrol
Y0001311 Meclozine impurity H
15 mg
1-(4-chlorobenzhydryl)piperazine
M0240000 Medronic acid
20 mg
Y0001107 Medronic acid impurity A
60 l
Y0001106 Medronic acid impurity B
40 l
M0250000 Medroxyprogesterone acetate
100 mg
Y0000598 Medroxyprogesterone acetate for system suitability
10 mg
M0252600 Mefenamic acid
50 mg
Y0001081 Mefenamic acid impurity A
100 mg
2,3-dimethylaniline
M0253000 Mefloquine hydrochloride
100 mg
1241
Y0001514 Megestrol acetate
120 mg
99.1 % CHO
1593
Yes
Y0001524 Megestrol acetate for system suitability
50 mg
1593
Y0001507 Megestrol acetate for peak identification
25 mg
1593
Y0001209 Meglumine
10 mg
Y0001080 Meloxicam
50 mg
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine
4.3 log (ie 20000) infective viral units per vial
1235,1236
Yes
+5C
79
0435,0559,1
381, 1531
Yes
+5C
79
1237
+5C
79
1237
+5C
79
2233
+5C
79
2233
Yes
+5C
79
1057,0213,2
442
Yes
-20C
90
+5C
79
+5C
79
+5C
79
0622
+5C
79
0622
+5C
79
Yes
0622
+5C
79
0641, 2350
+5C
79
Tris(1-methylethoxy)phosphane
2350
+5C
79
Tetrakis(1-methylethyl)methhylenediphosphonate
2350
+5C
79
0673
+5C
79
-20C
79
1240
+5C
79
1240
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2055
+5C
79
2373
+5C
79
0673
48
Yes

Order
Reference Standard
Code
Y0001035 Meloxicam impurity A
Y0001036 Meloxicam impurity B

Information
per vial Unit
1
5 mg
1 ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
1
5 mg
1 5-methylthiazol-2-amine
Monograph Leaflet
Storage
2373
Yes
+5C
Extra
Price
charges
79
g
2373
Yes
+5C
79
Y0001037 Meloxicam impurity C
5 mg
N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C
79
Y0001039 Meloxicam impurity D
5 mg
N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C
79
Y0001158 Melphalan hydrochloride
100 mg
99.4% CHClNO
1698
Yes
+5C
79
Y0001513 Melphalan - reference spectrum
1 uc
1698
79
Y0001457 Melphalan for system suitability
10 mg
1698
Yes
+5C
79
M0300000 Menadione
100 mg
0507
+5C
79
M0350000 Menthol
150 mg
0619,0623
+5C
79
M0370000 Mepivacaine hydrochloride
100 mg
1242
+5C
79
M0370020 Mepivacaine impurity B
60 mg
1242
+5C
79
M0400000 Meprobamate - * psy
100 mg
0407,1689
+5C
79
M0500000 Mepyramine maleate
1000 mg
0278
+5C
79
Y0000679 Mepyramine impurity A
10 mg
N-(4-methoxybenzyl)pyridin-2-amine
0278
+5C
79
Y0000680 Mepyramine impurity C
10 mg
pyridin-2-amine
0278
+5C
79
Y0001252 Meropenem trihydrate
110 mg
87.0% CHNOS,3HO
+5C
79
Y0000297 Mesalazine
125 mg
1699,1993
+5C
79
Y0001563 Mesalazine impurity A
15 mg
1699
+5C
79
Y0001569 Mesalazine impurity C
15 mg
1699
+5C
79
Y0001040 Mesityl oxide
100 mg
2358
+5C
g(b)
79
Y0000337 Mesna - reference spectrum
n/a
1674
79
Y0000316 Mesna impurity C
10 mg
2-(acetylsulphanyl)ethanesulphonic acid
1674
+5C
79
Y0000317 Mesna impurity D
10 mg
2,2'-(disulphanediyl)bis(ethanesulphonic acid)
1674
+5C
79
Y0000227 Meso-rich exametazime
0.5 mg
1925
Yes
+5C
79
Y0000097 Mesterolone
120 mg
99.8% CHO
1730
Yes
+5C
79
Y0000096 Mesterolone impurity A
30 mg
17-hydroxy-1alpha-methylandrost-4-en-3-one
1730
+5C
79
M0600000 Mestranol
100 mg
0509
+5C
79
Y0000301 Metacresol - reference spectrum
n/a
2077
79
M0600500 Metacycline hydrochloride
50 mg
0272,0820
+5C
79
M0600900 Metamizole sodium
100 mg
1346
+5C
79
M0600905 Metamizole impurity A
15 mg
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
1346
+5C
79
Y0001481 Metamizole impurity E
0.01 mg
4-N-demethylanalgin ; Batch 1 is valid until 31 August 2013
1346
M0605000 Metformin hydrochloride
50 mg
Y0001590 Metformin impurity A
25 mg
(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Cyanoguanidine
49
2234
Yes
+5C
79
0931
Yes
+5C
79
0931
+5C
79

Order
Reference Standard
Code
Y0001600 Metformin impurity F

per vial Unit
1
72 mg
1 Dimethylamine hydrochloride
N-methylmethanamine
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0931
+5C
1128
+5C
79
+5C
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A
200 mg
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B
200 mg
1128
79
M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) reference spectrum
n/a
1128
79
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),

dispersion 30%-ref.sp
n/a
1129
79
M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum
n/a
1127
79
M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum
n/a
1130
79
M0800000 Methadone hydrochloride - reference spectrum
n/a
0408,1787
79
Y0000428 Methanol - reference spectrum
n/a
1989
79
Y0000754 Methenamine
10 mg
1545
+5C
79
M0950000 DL-Methionine
50 mg
0624
+5C
79
M0960000 Methionine
50 mg
0788,1027
+5C
79
M1000000 Methotrexate
100 mg
88.2 % CHNO ; Batch 5 is valid until 31 January 2013
Y0000602 Methotrexate for peak identification
20 mg
Y0000663 Methotrexate impurity C
10 mg
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)
M1000008 Methotrexate impurity D
10 mg
Y0000664 Methotrexate impurity E
10 mg
M1300000 Methylatropine bromide
100 mg
M1450000 Methylcarbidopa
1 mg
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate
Y0001488 Methyl methacrylate
M1500000 Methyldopa
Y0001374 Racemic methyldopa
Y0001083 Methyldopa for system suitability

M1550000 Methylene chloride
0560
Yes
+5C
79
0560
Yes
+5C
79
0560
+5C
79
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic
acid (N10-methylpteroic acid)
0560
+5C
79
4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)
0560
+5C
79
0919
+5C
79
0755
+5C
79
0.5 ml
0318
+5C
79
50 mg
1975
+5C
79
50 mg
0045,0755
+5C
79
5 mg
0045
+5C
79
0.024 mg
0045
+5C
79
2 ml
0932
+5C
79
M1556000 Methyl 12-hydroxystearate
100 mg
1497
+5C
79
Y0000398 Methyl nicotinate
25 mg
2129
+5C
79
Y0000776 Methylergometrine maleate
10 mg
1788
+5C
79
Y0000777 Methylergometrine for system suitability
0.53 mg
1788
+5C
79
M1625000 Methylnitrosoindoline
110 mg
1108
+5C
79
50
Yes
Yes

Order
Reference Standard
Code
M1650000 Methyl parahydroxybenzoate

Information
per vial Unit
3
150 mg
1 100.0% CHO; batch 2 valid until 31/12/10 for use with monograph 2134
and 1999.
Y0001017 Methylphenidate hydrochloride - * narc
Y0001490 Methylphenidate impurity C

Y0000910 Methylphenidate impurity mixture
Monograph Leaflet
0409,1262,2
134,1999
40 mg
10 mg
0.04 mg
M1700000 Methylphenobarbital - * psy
500 mg
0189
M1750000 Methylprednisolone
150 mg
0312,0561
M1755000 Methylprednisolone acetate
100 mg
0933
Y0001602 Methylprednisolone for system suitability
10 mg
0561
M1755200 Methylprednisolone hydrogen succinate
125 mg
M1755220 Methylprednisolone hydrogen succinate for

performance test
50 mg
Y0001376 2-methylpyrazine
100 mg
Y0000190 N-Methylpyrrolidone - reference spectrum
n/a
1675
M1770180 Methyl ricinoleate
125 mg
0051,2367
Y0000418 Methylrosanilinium chloride
40 mg
1990
Y0000407 Methylrosanilinium for system suitability
10 mg
1990
M1770200 Methyl stearate
100 mg
M1800000 Methyltestosterone
100 mg
Y0000861 Methyltestosterone for system suitability
10 mg
0410
M1800900 Methylthioninium chloride
50 mg
1132
M1800902 Methylthioninium impurity A
20 mg
M1808000 Metixene hydrochloride
75 mg
M1824990 Metoclopramide
100 mg
M1825000 Metoclopramide hydrochloride
50 mg
M1824995 Metoclopramide impurity A
25 mg
M1825010 Metoclopramide impurity E
40 mg
Y0000701 Metolazone
Y0000702 Metolazone for system suitability
Y0000171 Metoprolol succinate - reference spectrum

M1830000 Metoprolol tartrate
Yes
2235
+5C
Extra
Price
charges
79
a
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0768,1131
+5C
79
1131
+5C
79
2446,2447
+5C
79
79
+5C
79
+5C
79
+5C
79
0051,1497
+5C
79
0410
+5C
79
+5C
79
+5C
79
2235
(2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide
Storage
2235
Yes
Yes
Yes
Yes
1132
+5C
79
1347
+5C
79
1348
+5C
79
0674,0856,1
303
+5C
79
4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide ;
1348
+5C
79
N,N-diethylethane-1,2-diamine
1575
+5C
79
80 mg
99.4% CHClNOS
1757
+5C
79
10 mg
1757
+5C
79
n/a
1448
79
60 mg
1028
+5C
79
Y0000145 Metoprolol impurity A
5 mg
+5C
79
M1845000 Metrifonate
100 mg
1133
+5C
79
M1850000 Metronidazole
50 mg
0675,0934
+5C
79
50 mg
M1851000 Metronidazole benzoate

3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium
(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol ; Batch 2 is
valid until 31 December 2013
51
1028,1448
Yes
Yes
79
1424
+5C
a

Order
Reference Standard
Code
Y0000069 Metronidazole benzoate - reference spectrum

per vial Unit
1
n/a
1
Information
Monograph Leaflet
0934
Y0000087 Metronidazole impurity A
10 mg
M1860000 Mexiletine hydrochloride
100 mg
Y0000202 Mexiletine impurity C
2 mg
Y0000203 Mexiletine impurity D
2 mg
M1875000 Mianserin hydrochloride
100 mg
Y0001041 Mianserin impurity B
10 mg
Y0000862 Mianserin for system suitability
1.01 mg
M1880000 Miconazole
70 mg
M1900000 Miconazole nitrate
100 mg
M2200000 Midazolam - * psy
50 mg
0.08 mg
Y0000599 Midazolam for system suitability - * psy
1 mg
Y0000539 Milk thistle standardised dry extract
120 mg
Content silibinin A and silibinin B: 26.9 % of ; Batch 2 is valid until 31

December 2012
M2280000 Minocycline hydrochloride
125 mg
90.9 % CHClNO ; Batch 2 is valid until 31 December 2012
M2300000 Minoxidil
50 mg
0937
Y0001432 Minoxidil for system suitability
10 mg
0937
Y0000705 Mirtazapine
10 mg
2338
Y0000721 Mirtazapine for system suitability
10 mg
Y0000490 Misoprostol
60 mg
Y0001162 Misoprostol for system suitability
5 mg
Y0000378 Mitomycin
120 mg
M2305000 Mitoxantrone hydrochloride
50 mg
M2305005 Mitoxantrone impurity A
5 mg
Y0000635 Modafinil
110 mg
Y0000636 Modafinil for system suitability
0.1 mg
Y0000251 Molgramostim
0.3 ml
Y0000821 Molsidomine
5 mg
1701
Y0000822 Molsidomine impurity B
10 mg
N-nitrosomorpholine
1701
Y0000823 Molsidomine impurity D
10 mg
morpholine-4-carbaldehyde
M2900000 Mometasone furoate
100 mg
Y0001436 Montelukast dicyclohexylamine
150 mg
99.4% CHClNOS
2583
Y0001433 Montelukast racemate
10 mg
2583
New Y0000562 Midazolam impurity C
Storage
Extra
Price
charges
79
l
0675, 0934
+5C
79
1029
+5C
79
1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine
1029
+5C
79
(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine
1029
+5C
79
0846
+5C
79
0846
+5C
79
+5C
79
0935
+5C
79
0513,1148
+5C
79
2-methyl-4-nitroimidazole
(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid
0846
Yes
0936,1065
acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique ; Batch 2 is valid until 30 April 2014
+5C
79
0936
Yes
+5C
79
0936
Yes
+5C
79
2071,1860
Yes
-20C
79
1030
Yes
+5C
79
+5C
79
+5C
79
+5C
79
Yes
2338
Yes
+5C
79
1731
Yes
-20C
g(c)
79
1731
Yes
-20C
g(c)
79
1655
Yes
+5C
79
97.7% CHClNO
1243
Yes
+5C
79
1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione
1243
+5C
79
100.0% CHNOS
2307
+5C
79
98.5% CHO
13.45 mg protein per ml CHNOS
52
2307
Yes
+5C
79
1641
Yes
-80C
79
+5C
79
+5C
g(b)
79
1701
+5C
79
1449
+5C
79
+5C
79
+5C
79
Yes

Order
Reference Standard
Code
Y0001434 Montelukast sodium
Y0001435 Montelukast for peak identification

Information
per vial Unit
2
20 mg
1 Batch 1 is valid until 31 August 2013
2
20 mg
1 Batch 1 is valid until 31 August 2013
Monograph Leaflet
2583
2583
+5C
Yes
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2254
Yes
+5C
79
2254
Yes
+5C
79
1758
+5C
79
1758
+5C
79
-80C
90
79
50 mg
Y0000451 Morphine hydrochloride (trihydrate) - * narc
25 mg
Y0000452 Morphine sulfate - * narc
40 mg
1244,1784
Y0000830 Morphine for system suitability - * narc
15 mg
1244, 0097
Yes
Y0000772 Moxidectin
70 mg
1656
Y0000747 Moxidectin for system suitability
10 mg
1656
Y0000703 Moxifloxacin hydrochloride
110 mg
Y0000717 Moxifloxacin for peak identification
10 mg
Y0000226 Moxonidine
50 mg
99.7% CHClNO
Y0000222 Moxonidine impurity A
10 mg
4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine
M3600000 Mumps vaccine (live) BRP
165 mg
4.6 log (ie40000) infective viral units per vial
M3805000 Mupirocin - reference spectrum
n/a
M3805500 Mupirocin calcium - reference spectrum
n/a
M3806000 Mupirocin lithium
100 mg
Y0000489 Mycophenolate mofetil
30 mg
1700
Y0000519 Mycophenolate mofetil for peak identification
10 mg
1700
Yes
Y0000692 Mycoplasma fermentans BRP
1 ml
20607
Y0000690 Mycoplasma hyorhinis BRP
1 ml
20607
Y0000691 Mycoplasma orale BRP
1 ml
Y0000689 Mycoplasma synoviae BRP
1 ml
Y0000485 Myo-inositol
1020 mg
99.8% CHO
1805
N0020000 Nabumetone
60 mg
99.8% CHO
1350
N0020020 Nabumetone impurity D
10 mg
(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one
N0020030 Nabumetone impurity F
10 mg
6,6'-dimethoxy-2,2'-binaphthalenyl ; Batch 3 is valid until 31 May 2013
Y0000146 Nadolol
100 mg
1789
Y0001215 Nadolol impurity mixture
0.01 mg
1789
N0025000 Nadroparin calcium
250 mg
Y0000077 Naftidrofuryl - reference spectrum
n/a
Y0000120 Naftidrofuryl impurity A
10 mg
2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid
1594
Y0000121 Naftidrofuryl impurity B
25 mg
ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate ; Batch

1 is valid until 31 December 2012
1594
Y0000331 Naftidrofuryl impurity F
10 mg
2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)

propanoate
N0050000 Nalidixic acid
100 mg
1546
0097,1839,1
841
97.4% CHNO
96.1 % CHClFNO
0538,1057
Yes
Yes
1450
1451
79
+5C
79
+5C
79
+5C
79
Yes
-80C
120
Yes
-80C
120
20607
Yes
-80C
120
20607
Yes
-80C
120
+5C
79
+5C
79
1350
+5C
79
1350
+5C
79
+5C
79
+5C
79
+5C
79
79
+5C
79
+5C
79
1594
+5C
79
0701
+5C
79
1450,1451
93.7% CHOLi
0828,1134
Yes
Yes
Yes
1594
53
Extra
Price
charges
79
a
+5C
Y0000028 Morantel hydrogen tartrate
See leaflet
Storage

Order
Reference Standard
Code
N0075000 Naloxone hydrochloride dihydrate

per vial Unit
2
100 mg
1
Information
Monograph Leaflet
0729,2099
+5C
Y0000695 Naloxone for peak identification
10 mg
0729
Y0000400 Naltrexone hydrochloride
50 mg
1790
Y0000410 Naltrexone impurity C
15 mg
Y0000542 Nandrolone decanoate
5 mg
Y0000547 Nandrolone decanoate for peak identification
10 mg
1992
Y0000548 Nandrolone decanoate for system suitability
10 mg
1992
N0080000 Naphazoline hydrochloride
50 mg
N0100000 Naphazoline nitrate
10 mg
N0200000 Naphazoline impurity A
15 mg
N0250000 Naproxen
100 mg
Y0000399 Naproxen (racemic)
10 mg
Y0000631 Naproxen impurity L
10 mg
1-(6-methoxynaphthalen-2-yl)ethanone
Y0001378 Naringin
20 mg
88.3% CHO
2563
Yes
Y0001437 Nateglinide
200 mg
99.9% CHNO
2575
Yes
Y0001440 Nateglinide impurity A
10 mg
trans-4-(1-methylethyl)cyclohexanecarboxylic acid
2575
Y0001441 Nateglinide impurity B
15 mg
N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)
2575
Y0001442 Nateglinide impurity C
10 mg
N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)
N0300000 Neamine
0.5 mg
76.3% CHNO
N0399000 Neohesperidin-dihydrochalcone
125 mg
N0399004 Neohesperidin-dihydrochalcone impurity B
10 mg
N0400000 Neomycin sulfate
50 mg
N0401000 Neomycin sulfate for microbiological assay
25 mg
N0500000 Neostigmine bromide
50 mg
N0550000 Neostigmine metilsulfate
50 mg
N0559000 Netilmicin sulfate
25 mg
14656 IU per vial
1351,20702
Y0000520 Nevirapine (anhydrous)
30 mg
99.8% CHNO
2255, 2479
Y0000521 Nevirapine for peak identification
0.058 mg
Y0001499 Nevirapine hemihydrate
15 mg
Y0000388 Newcastle Disease Vaccine (inactivated) BRP
40 mg
Storage
+5C
79
+5C
79
1790
+5C
79
1992
-20C
79
-20C
79
-20C
79
0730,1162
+5C
79
0147
+5C
79
N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)
0147,0730
+5C
79
0731,1702
+5C
79
0731,1702
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
N-(3-butenyl)-noroxymorphone
Yes
Extra
Price
charges
79
a
Yes
0731,1702
+5C
79
0180,0197
2575
Yes
+5C
79
89.9% CHO
1547
Yes
-20C
79
86.4% CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin)
1547
Yes
+5C
79
Not to be used for microbiological assay
0032,0033,0
053,
0180,0197,0
485, 0645
Yes
-20C
79
19850 IU per vial ; Batch 3 is valid until 31 August 2013
0197,20702
Yes
-20C
79
+5C
79
0046
0626
2255, 2479
Yes
54
0870
79
79
+5C
79
Yes
+5C
79
+5C
79
Yes
-20C
180
2479
The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
+5C
-20C

Order
Code
Y0001373 Nicergoline
Reference Standard

per vial Unit
1
50 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
g
1998
+5C
1998
+5C
79
1998
+5C
79
Y0001356 Nicergoline impurity D
20 mg
Y0001362 Nicergoline for peak identification
1 mg
Y0001352 Nicergoline for system suitability
10 mg
1998
+5C
79
N0560000 Niclosamide (anhydrous)
50 mg
0679,0680
+5C
79
N0600000 Nicotinamide
50 mg
0047
+5C
79
N0590000 Nicotine - reference spectrum
n/a
1452,1792
79
N0590200 Nicotine ditartrate
120 mg
+5C
79
Y0001425 Nicotine ditartrate dihydrate
15 mg
2599
+5C
79
Y0001023 Nicotine for system suitability
1 mg
1452, 1792,
2599
-20C
g(c)
79
N0700000 Nicotinic acid
100 mg
0459
+5C
79
Y0001268 Nicotinic acid impurity mixture
0.12 mg
0459
+5C
79
N0750000 Nifedipine
50 mg
0627,1013
+5C
79
N0750010 Nifedipine impurity A
20 mg
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
0627
+5C
79
N0750015 Nifedipine impurity B
25 mg
Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate
0627
+5C
79
Y0000824 Niflumic acid
10 mg
2115
+5C
79
Y0000825 Niflumic acid impurity A
10 mg
2-chloropyridine-3-carboxylic acid
2215
+5C
79
Y0000826 Niflumic acid impurity B
10 mg
2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide
2115
+5C
79
Y0000827 Niflumic acid impurity E
15 mg
6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid
Y0000836 Nifuroxazide
10 mg
N0800000 Nikethamide
1 ml
Y0000829 Nilutamide
110 mg
100.0% CHFNO
Y0000894 Nilutamide impurity B
5 mg
4-nitro-3-(trifluoromethyl)aniline
N0845000 Nimesulide
100 mg
Y0001237 Nimesulide for peak identification
10 mg
N0845008 Nimesulide impurity D
0.004 mg
N0850000 Nimodipine
50 mg
N0850010 Nimodipine impurity A
1 mL
N0900000 Nitrazepam - * psy
100 mg
N0905000 Nitrendipine
60 mg
Y0001456 Nitrendipine for peak identification
10 mg
N0905005 Nitrendipine impurity A
30 mg
N0930000 Nitric oxide - reference spectrum
n/a
5-bromopyridine-3-carboxylic acid
1792
92.8% CHN x 2 CHO ; Batch 3 is valid until 1 May 2013
Yes
Yes
Yes
Yes
2115
+5C
79
1999
+5C
79
0233
+5C
79
2256
+5C
79
2256
+5C
79
1548
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0415,0898,1
121
+5C
79
1246
+5C
79
+5C
79
+5C
79
79
1548
Yes
1548
4-nitro-2-phenoxyaniline
1245
1245
2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)

pyridine-3,5-dicarboxylate ; Batch 3 is valid until 1 June 2013
1246
ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;
(nitrophenylpyridine analogue)
1246
1550
55
Yes
Yes

Order
Code
N0950000 Nitrofural
Reference Standard

per vial Unit
1
100 mg
1 99.8% CHNO
Information
Monograph Leaflet
Storage
1135
+5C
Extra
Price
charges
79
a
Y0001377 Nitrofural for peak identification
0.11 mg
1135
+5C
79
N1000000 Nitrosotriaminopyrimidine
50 mg
0058
+5C
79
N1090000 Nizatidine
250 mg
+5C
79
Y0001278 Nizatidine for system suitability
10 mg
+5C
79
N1090060 Nizatidine impurity F
10 mg
(EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)]bis(N'methyl-2-nitroethene-1,1-diamine)
1453
+5C
79
New N1080000 Nomegestrol acetate
1453
99.3% CHNOS
1453
Yes
100 mg
1551
+5C
79
N1080005 Nomegestrol acetate impurity A
50 mg
6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate
1551
+5C
79
Y0001314 1-nonadecanol
400 mg
0801,0802,0
847
+5C
79
Y0000670 Nonivamide
10 mg
+5C
79
Y0000755 Nonoxinol 9
10 mg
1454
+5C
79
N1100000 Noradrenaline tartrate
200 mg
0254,0285,0
732, 2303
+5C
79
Y0000681 Noradrenaline impurity D
15 mg
+5C
79
Y0000682 Noradrenaline impurity E
10 mg
4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732

2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732
+5C
79
Y0000686 Noradrenaline impurity F
10 mg
N-benzyl-1-phenylmethanamine
0285,0732
+5C
79
N1130000 Norcyclobenzaprine
25 mg
0941
+5C
79
N1140000 Nordazepam -* psy
50 mg
Dipotassium clorazepate impurity B
0898,1466
+5C
79
N1200000 Norethisterone
50 mg
0234,1212,0
926
+5C
79
N1225000 Norethisterone acetate
100 mg
0850
Y0000522 Norethisterone for system suitability
10 mg
0234
N1230000 Norfloxacin
50 mg
N1230010 Norfloxacin impurity A
20 mg
Y0001015 Norfloxacin for system suitability
8 mg
1248
Y0001301 Norfloxacin for peak identification
10 mg
1248
Y0000724 Norgestimate
10 mg
1732
Y0000725 Norgestimate for system suitability
5 mg
1732
N1250000 Norgestrel
30 mg
0940
N1279000 Norpseudoephedrine hydrochloride - * psy
50 mg
0683
N1280000 Nortriptyline hydrochloride
10 mg
0941
Y0001296 Nortriptyline for system suitability
20 mg
N1300000 Noscapine
100 mg
1859,2336,2
337, 2529
99.1% CHNO
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)
Cathine hydrochloride
56
Yes
+5C
79
-20C
79
1248
+5C
79
1460
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0941
+5C
79
0102,0515,0
516
+5C
79
Yes
Yes

Order
Code
N1400000 Nystatin
Reference Standard

Information
per vial Unit
7
100 mg
1 5880 IU per mg ; Batch 6 is valid until 31 August 2013
O0100900 Octoxinol 10
Y0000368 Octyl gallate

O0101000 Octyldodecanol
Monograph Leaflet
0517,1292,2
0702
300 mg
30 mg
400 mg
O0120000 Ofloxacin
50 mg
O0120010 Ofloxacin impurity A
20 mg
(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA)
New O0120050 Ofloxacin impurity E
20 mg
Y0001370 Olanzapine
200 mg
Y0001392 Olanzapine impurity A
5 mg
Y0001380 Olanzapine for system suitability
10 mg
2258
Y0001204 Oleanolic acid
20 mg
90.9% CHO
2472
Y0001479 Oleic acid
2000 mg
98.3% CHO
2579
Y0001113 Triolein
30 mg
98.7 % CHO
2454
Y0000805 Oleuropein
20 mg
82.2% CHO
Y0001405 Olmesartan medoxomil
100 mg
99.3 % CHNO
Y0001424 Olmesartan medoxomil for system suitability
10 mg
O0146000 Olsalazine sodium
70 mg
O0146010 Olsalazine sodium for performance test
60 mg
1457
O0150000 Omeprazole
50 mg
0942,1032,2
372, 2374
Y0001043 Omeprazole magnesium
10 mg
2374
Y0001042 Omeprazole for peak identification
10 mg
0942,1032,2
372, 2374
O0151000 Omeprazole impurity D
10 mg
Omeprazole sulphone
Y0000218 Ondansetron hydrochloride dihydrate
200 mg
89,9% CHClNO ; Batch 3 is valid until 1 June 2013
Y0000197 Ondansetron for LC system suitability
10 mg
Y0000196 Ondansetron for TLC system suitability
30 mg
Y0001345 Ondansetron impurity A
10 mg
(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one
Y0000195 Ondansetron impurity D
10 mg
Y0001326 Ondansetron impurity E
10 mg
Y0001320 Ondansetron impurity F
10 mg
Y0001346 Ondansetron impurity G
10 mg
Yes
1553
Storage
-20C
Extra
Price
charges
79
c
+5C
79
+5C
79
+5C
79
1455
+5C
79
1455
+5C
79
(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid ; Batch 3 is valid until 30 April
2014
1455
+5C
79
99.8% CHNS
2258
+5C
79
5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2258
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
-20C
79
1878
Yes
+5C
79
2600
Yes
+5C
79
2600
Yes
+5C
79
+5C
79
Yes
+5C
79
Yes
-20C
79
+5C
79
-20C
79
-20C
79
2057
1136
94.8% CHO
Yes
Yes
1457
Yes
0942,1032,2
372, 2374
2016
+5C
79
2016
+5C
79
2016
+5C
79
2016
+5C
79
9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one
2016
+5C
79
Imidazole
2016
+5C
79
2016
+5C
79
2016
+5C
79
(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
57
Yes

Order
Code
Y0001125 Orbifloxacin
Reference Standard

per vial Unit
1
200 mg
1
Information
Monograph Leaflet
2259
Y0001147 Orbifloxacin impurity mixture
0.0008 mg
2259
O0180000 Orciprenaline sulfate
100 mg
1033,1332
Y0000895 Orciprenaline for system suitability
5 mg
1033
Y0001501 Orientvine stem HRS
600 mg
2450
Y0000100 Orphenadrine hydrochloride
100 mg
Y0000101 Orphenadrine citrate
100 mg
Y0001337 Oseltamivir phosphate (impurity B free)
300 mg
Y0001181 Orphenadrine for peak identification
0.42 mg
Y0001338 Oseltamivir impurity A
10 mg
(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
Y0000102 Orphenadrine impurity E
60 mg
(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer) ; Batch 1 is valid until 1 May 2013
Y0001339 Oseltamivir impurity B
10 mg
Y0001340 Oseltamivir impurity C
10 mg
Y0001341 Oseltamivir impurity H
Y0001207 Osthole
O0200000 Ouabain
Y0000638 Oxacillin sodium monohydrate
Y0000560 Oxacillin for peak identification
Y0000271 Oxaliplatin
Storage
+5C
Yes
Extra
Price
charges
79
a
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
1760
+5C
79
1759
+5C
79
2422
Yes
+5C
79
1759,1760
Yes
+5C
79
2422
+5C
79
1759,1760
+5C
79
ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate
2422
+5C
79
(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
+5C
79
30 mg
tributylphosphane oxide
2422
+5C
79
20 mg
98.3 % CHO
2557
Yes
+5C
79
150 mg
80.0% CHO
0048
Yes
+5C
79
110 mg
93.8% CHNNaOS
2260
Yes
+5C
79
10 mg
2260
Yes
+5C
79
250 mg
99.9% CHNOPt ; Batch 3 is valid until 1 June 2013
2017
Yes
+5C
79
Y0000272 Oxaliplatin impurity B
22 mg
94.4% CHNOPt; (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diaminekN,kN']

platinum (diaquodiaminocyclohexaneplatinum) ; Batch 7 is valid until 1 June
2013
2017
Yes
+5C
79
Y0000273 Oxaliplatin impurity C
25 mg
(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum ; Batch 4 is valid until 1 April 2013
2017
+5C
79
Y0000274 Oxaliplatin impurity D
10 mg
(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin) ; Batch 3 is valid

until 31 December 2013
2017
+5C
79
O0225000 Oxazepam - * psy
50 mg
+5C
79
Y0000543 Oxazepam for peak identification
0.008 mg
0778
Yes
+5C
79
Y0001576 Oxcarbazepine
120 mg
99.8 % CHNO
2577
Yes
+5C
79
Y0001549 Oxcarbazepine impurity mixture
0.008 mg
2577
Yes
+5C
79
Y0000350 Oxeladin hydrogen citrate
50 mg
1761
+5C
79
Y0000404 Oxeladin impurity C
10 mg
1761
+5C
79
99.7% CHNOP
0778
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate
58

Order
Reference Standard
Code
Y0000390 Oxeladin impurity D
O0225800 Oxfendazole for veterinary use

Information
per vial Unit
1
20 mg
1 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate
2
50 mg
10 mg
Y0000225 Oxfendazole with impurity D
10 mg
Y0000709 Oxitropium bromide
50 mg
Y0000715 Oxitropium bromide impurity B
15 mg
(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
Y0000713 Oxitropium bromide impurity D
10 mg
(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)
O0240000 Oxolinic acid
50 mg
O0240005 Oxolinic acid impurity A
20 mg
O0240010 Oxolinic acid impurity B
20 mg
O0250000 Oxprenolol hydrochloride
50 mg
O0260000 Oxibendazole
O0270000 Oxybuprocane hydrochloride
O0288000 Oxybutynin hydrochloride

O0288005 Oxybutynin impurity A
Y0000492 Oxycodone hydrochloride - * narc
Monograph Leaflet
1761
Storage
+5C
+5C
79
+5C
79
1458
+5C
79
2170
+5C
79
2170
+5C
79
2170
+5C
79
1353
+5C
79
8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
1353
+5C
79
ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate
1353
+5C
79
0628,0876,1
072
+5C
79
100 mg
1386
+5C
79
150 mg
1251
+5C
79
150 mg
+5C
79
20 mg
+5C
79
100 mg
1793
+5C
79
50 mg
1793
+5C
79
O0290000 Oxymetazoline hydrochloride
80 mg
0943
+5C
79
Y0001044 Oxymetazoline impurity A
15 mg
N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide
0943
+5C
79
O0400000 Oxytetracycline
100 mg
+5C
79
O0500000 Oxytetracycline hydrochloride
20 mg
+5C
79
O0700000 Oxytocin
1 mg
-20C
g(c)
90
O0770000 Oxytocin/Desmopressin validation mixture
20 mg
about 0.1 mg oxytocin + 0.1 mg desmopressin per vial ; Batch 3 is valid until
30 November 2013
-20C
79
Y0000698 Paclitaxel
40 mg
99.4% CHNO
1794
+5C
79
Y0000699 Paclitaxel impurity C
5 mg
N-debenzoyl-N-hexanoylpaclitaxel
1794
Y0000700 Paclitaxel natural for peak identification
10 mg
Y0000719 Paclitaxel semi-synthetic for peak identification
10 mg
Y0000739 Paclitaxel semi-synthetic for system suitability
1.013 mg
New Y0000224 Oxfendazole impurity B
New Y0000453 Oxycodone impurity D
1458
Extra
Price
charges
79
g
See leaflet; methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate ;

1458
Yes
1354
90.7% CHNO; 4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2cyclohexyl-2-hydroxyacetate ; Batch 3 is valid until 31 December 2013
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone) ; Batch 2 is valid until 31
March 2014
1354
0198,0199
Yes
Yes
0198,1030
59
0779,0780
Yes
0712,0779,0
780
Yes
+5C
79
1794
Yes
+5C
79
1794
Yes
+5C
79
1794
Yes
+5C
79

Order
Code
P0090000 Palmitic acid
Reference Standard

per vial Unit
4
100 mg
1
Information
Monograph Leaflet
0229,0882,1
474,
1663,2058,
Storage
+5C
Y0000524 Pamidronate disodium pentahydrate
10 mg
+5C
79
P0100000 Pancreas powder (amylase and lipase) BRP
2000 mg
41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity
per mg
0350
Yes
+5C
79
Y0001632 Pancreas powder (amylase) BRP
2000 mg
92.8 Ph. Eur. units/mg ; Batch 3 is valid until 28 February 2014
0350
Yes
+5C
79
Y0001631 Pancreas powder (lipase) BRP
2000 mg
65.4 Ph. Eur.units per mg ; Batch 3 is valid until 28 February 2014
0350
Yes
+5C
79
2000 mg
0350
Yes
+5C
79
P0250000 Pancuronium bromide
20 mg
Vecuronium impurity B
0681,1769
+5C
79
Y0000577 Pancuronium bromide for system suitability
20 mg
0681
+5C
79
Y0000835 Pantoprazole sodium sesquihydrate
20 mg
+5C
79
Y0001001 Pantoprazole for system suitability
0.5055 mg
+5C
79
P0270000 Papaverine hydrochloride
25 mg
0102,0573
+5C
79
P0300000 Paracetamol
50 mg
0049
+5C
79
Y0000780 Paraffin (hard)
10 mg
1034
+5C
79
Y0000058 Paraffin (liquid) - reference spectrum
n/a
0239,0240
79
Y0000913 Paraffin (White soft)
10 mg
1799
+5C
79
Y0000912 Paraffin (Yellow soft)
10 mg
1554
+5C
79
0828,1252
+5C
79
2283
+5C
79
New P0200000 Pancreas powder (protease) BRP
New P0305000 Parnaparin sodium
1779
Extra
Price
charges
79
a
2296
2296

Yes
200 mg
Y0000578 Paroxetine hydrochloride (anhydrous)
100 mg
Y0000281 Paroxetine hydrochloride hemihydrate
200 mg
97.4% CHClFNO
2018,2283
+5C
79
Y0000233 Paroxetine impurity A
15 mg
(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine)
2018,2283
+5C
79
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
10 mg
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)
piperidine (N-benzylparoxetine)
2283
+5C
79
Y0000256 Paroxetine impurity D
5 mg
(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
((+)-trans-paroxetine)
2018,2283
+5C
79
Y0000580 Paroxetine impurity E
5 mg
(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)
2283
+5C
79
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H
10 mg
[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol
2283
+5C
79
Y0000630 Paroxetine for system suitability
5 mg
2018
+5C
79
P0309000 Pefloxacin mesilate dihydrate
200 mg
1460
+5C
79
P0309020 Pefloxacin impurity B
10 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (chlorinated homologue of pefloxacin)
1460
+5C
79
P0309030 Pefloxacin impurity C
0.01 mg
1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (isopefloxacin)
1460
+5C
79
Y0001539 Pemetrexed disodium heptahydrate
200 mg
78.6 %
2637
+5C
79
Y0001538 Pemetrexed for system suitability
20 mg
+5C
79
2637
60
Yes
Yes

Order
Reference Standard
Code
Y0001535 Pemetrexed impurity mixture

per vial Unit
1
0.002 mg 1
Information
Monograph Leaflet
2637
Yes
Storage
+5C
P0307000 Penbutolol sulfate
100 mg
P0307005 Penbutolol impurity A
20 mg
P0310000 Penicillamine
100 mg
P0320000 Penicillamine disulfide
100 mg
93.0% CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid
P0400100 Pentaerythrityl tetranitrate diluted
600 mg
10.0% CHNO
P0405000 Pentamidine diisetionate
30 mg
P0405500 Pentazocine - reference spectrum
n/a
P0405510 Pentazocine hydrochloride - reference spectrum
n/a
Y0000417 Pentazocine lactate - reference spectrum
n/a
2000
Y0001051 Pentetate sodium calcium
100 mg
2353
+5C
P0500000 Pentobarbital - * psy
500 mg
0200,0419
P0510000 Pentoxifylline
100 mg
0851
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum
n/a
Y0000098 Pentoxyverine impurity A
10 mg
1-phenylcyclopentanecarboxylic acid
1621
Y0000099 Pentoxyverine impurity B
10 mg
2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)
1621
P0525000 Pepsin powder
2000 mg
0.99 Ph. Eur. U. per mg
0682
Yes
Y0000010 Pergolide mesilate
150 mg
99.9% CHNOS
1555
Yes
Y0000237 Perindopril impurity A
10 mg
(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid ; Batch 1 is valid until 1

May 2013
2019
Y0000207 Perindopril for stereochemical purity
40 mg
2019
Y0000238 Perindopril tert-butylamine
40 mg
2019
Y0000771 Perindopril for peak identification
5 mg
2019
P0550000 Perphenazine
100 mg
0629,0904
Y0001045 Perphenazine for system suitability
5 mg
0629
Yes
Y0000021 Pertussis toxin BRP
0.05 mg
See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329
Yes
P0600000 Pethidine hydrochloride - reference spectrum
n/a
P0600002 Pethidine impurity A
20 mg
P0800000 Phenazone
20 mg
Y0001138 Phenazone impurity A
20 mg
P0850000 Pheniramine maleate
250 mg
(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]
propan-2-ol ; Batch 1 is valid until 7 February 2013
1461
+5C
79
1461
+5C
79
0566
+5C
79
+5C
79
1355
+5C
79
1137,1436
+5C
79
1462
79
1463
79
0566
Yes
79
79
+5C
79
+5C
79
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
-20C
g(d)
90
79
0420
+5C
79
0421
+5C
79
0421
+5C
79
1357
+5C
79
1621
Yes
Yes
0420
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one
61
Extra
Price
charges
79
a

Order
Reference Standard
Code
Y0001428 Pheniramine impurity A

per vial Unit
1
20 mg
1 2-benzylpyridine
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1357
+5C
0189,0201,0
630
+5C
79
P0900000 Phenobarbital - * psy
200 mg
Y0001350 Phenobarbital impurity A
15 mg
+5C
79
Y0001351 Phenobarbital impurity B
15 mg
0201
+5C
79
P0950000 Phenoxyethanol
1 mL
0781
+5C
79
P1000000 Phenoxymethylpenicillin
250 mg
0148
+5C
79
P1100000 Phenoxymethylpenicillin potassium
250 mg
+5C
79
Y0001127 Phentolamine mesilate
10 mg
1138
+5C
79
Y0001251 Phentolamine mesilate for system suitability
10 mg
1138
+5C
79
P1109000 Phentolamine mesilate - reference spectrum
n/a
1138
79
P1150000 Phenylalanine
60 mg
0782,0796,1
161,2575
+5C
79
P1200000 Phenylbutazone
100 mg
0422,1574
+5C
79
Y0000147 Phenylbutazone impurity B
20 mg
0422
+5C
79
P1240000 Phenylephrine
60 mg
1035
+5C
79
P1250000 Phenylephrine hydrochloride
50 mg
0632,1205
+5C
79
Y0000683 Phenylephrine hydrochloride for peak identification
2 mg
0632,1035
+5C
79
Y0000229 Phenylmercuric acetate - reference spectrum
n/a
2042
79
P1255100 Phenylmercuric borate - reference spectrum
n/a
0103
79
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor
50 mg
0683
+5C
79
P1290000 Phenytoin
100 mg
1253,1988
+5C
79
Y0001167 Phenytoin for system suitability
20 mg
0521,1253
+5C
79
P1300000 Phenytoin sodium
250 mg
0521
+5C
79
Y0000493 Phloroglucinol (anhydrous)
210 mg
2301,2302
+5C
79
Y0000761 Pholcodine - * narc
10 mg
0522
+5C
79
Y0000798 Pholcodine for peak identification - * narc
10 mg
Y0000766 Phthalic acid
20 mg
P1500000 Phthalylsulfathiazole
100 mg
P1600000 Physostigmine salicylate
100 mg
New P1609000 Phytomenadione
150 mg
99.9 % phytomenadione C31H46O2 CHO; Vitamin K1 ; Batch 3 is valid

until 28 February 2014
1036
New P1609010 trans-Epoxyphytomenadione
0113,0114,0
148, 0149
99.2% CHKNOS
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
Norephedrin hydrochloride
Yes
Yes
Yes
+5C
79
+5C
79
0352
+5C
79
0286
+5C
79
+5C
79
1036
+5C
79
1358
+5C
79
+5C
79
+5C
79
5 mg
125 mg
P1645005 Picotamide impurity A
25 mg
Y0001508 Picrotin
40 mg
0522
Yes
2348
P1645000 Picotamide monohydrate
0201
79.1% CHNO
benzene-1,2-dicarboxylic acid
4-methoxybenzene-1,3-dicarboxylic acid
Yes
1358
2486
62
Yes
Yes

Order
Code
Y0001528 Picrotoxinin
Reference Standard
Y0000124 Pidolate impurity B

Information
per vial Unit
1
40 mg
1 98.3 % CHO
2
60 mg
1 (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid
Monograph Leaflet
2486
Yes
Storage
+5C
Extra
Price
charges
79
g
1619
+5C
79
Y0000123 Pidolic acid
125 mg
1619
+5C
79
P1650000 Pilocarpine hydrochloride
50 mg
0633
+5C
79
P1700000 Pilocarpine nitrate
50 mg
0104
+5C
79
Y0000106 Pilocarpine nitrate for system suitability
20 mg
0104,0633
+5C
79
Y0000525 Pimobendan
10 mg
2179
+5C
79
Y0000401 Pimobendan for system suitability
0.1 mg
2179
+5C
79
P1750000 Pimozide
150 mg
1254
+5C
79
P1800000 Pindolol
100 mg
0634,0871,1
789
+5C
79
Y0001520 Pioglitazone hydrochloride
120 mg
2601
Yes
+5C
79
Y0001519 Pioglitazone for system suitability
15 mg
2601
Yes
+5C
79
Y0001476 Pipemidic acid trihydrate
15 mg
1473
+5C
79
Y0000061 Pipemidic acid trihydrate - reference spectrum
n/a
1743
79
New P1890000 Piperacillin
99.8% CHClNOS
100 mg
+5C
79
P1900000 Piperazine adipate
250 mg
0423
+5C
79
P2000000 Piperazine citrate
250 mg
0424
+5C
79
P2100000 Piperazine hydrate
250 mg
0425
+5C
79
Y0001217 Piperine
30 mg
99.0% CHNO
+5C
79
Y0000288 Piracetam
150 mg
+5C
79
Y0000038 Pirenzepine dihydrochloride monohydrate
250 mg
2001
+5C
79
P2120000 Piretanide
100 mg
1556
+5C
79
Y0001458 Piretanide for system suitability
10 mg
+5C
79
P2130000 Piroxicam
50 mg
+5C
79
Y0001475 Piroxicam for system suitability
15 mg
Y0001475 replaces P2130100
P2150000 Pivampicillin
50 mg
99.2% CHNOS
P2152000 Pivmecillinam hydrochloride
100 mg
99.6% CHClNOS
1359
P2152015 Pivmecillinam impurity C
10 mg
methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)

methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
1359
P2155001 Plastic additive 01
2 ml
(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate
100 mg
E0800000 Plastic additive 04
500 mg
500 mg
500 mg
1168,1169
94.4% CHNOS ; Batch 3 is valid until 28 February 2014
Yes
2453,2477
1733
1556
Yes
Yes
0944
0944
Yes
+5C
79
0808,0852
Yes
+5C
79
-20C
79
+5C
79
90001,9000
2, 30114
+5C
79
N,N'-ethylenedialcanamide
90001,30114
+5C
79
Epoxidised soya oil
90001,30114
+5C
79
Epoxidised linseed oil
90001,30114
+5C
79
ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]
63
79
30103,3010
+5C
a
4,
30105,3010

Order
Reference Standard
Code

Information
per vial Unit
3
250 mg
1 pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
250 mg
4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]
500 mg
Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
250 mg
Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R
250 mg
1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione
250 mg
2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R
500 mg
Dioctadecyl disulphide
250 mg
Didodecyl 3,3'-thiodipropionate R
250 mg
Dioctadecyl 3,3'-thiodipropionate R
100 mg
Batch 1 is valid until 22 July 2013
O0140000 Plastic additive 20
100 mg
Oleamide R
E1260000 Plastic additive 21
100 mg
Erucamide R
100 mg
Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol

Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol
200 mg
P2160000 Poliomyelitis vaccine (inactivated) BRP
0.5 ml
P2161000 Poliomyelitis vaccine (oral) BRP
P2163920 Poloxamer 124

Monograph Leaflet
30103,3010
5,
30106,3010
30103,3010
Yes
Storage
+5C
Extra
Price
charges
79
a
+5C
79
+5C
79
+5C
79
+5C
79
30103,3010
5, 30106
+5C
79
30103,3010
4,
30105,3010
30103,3010
+5C
79
+5C
79
30103,3010
5, 30106
+5C
79
30103
+5C
79
30103,3010
5,
30106,3010
30103,30107
+5C
79
+5C
79
30103
+5C
79
di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
30110,30111
+5C
79
320-67-282 Ph. Eur. D-Antigen Units per ml for types 1-2-3, respectively
0214,2066,2
065,
2328,2061,2
067,
1934,2329,2
0720
Yes
-80C
90
1 ml
log CCID50/ml for types 1,2,3 and total virus content: 6.99, 6.06, 6.83 and
7.20, respectively
See leaflet,
0215
Yes
-20C
90
30 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5, 30106
5, 30106
64

Order
Reference Standard
Code
P2170000 Polyacrylate - reference spectrum

per vial Unit
1
n/a
1
Information
Monograph Leaflet
Storage
0733
Extra
Price
charges
79
l
P2400000 Polymyxin B sulfate
25.1 mg
65.1% polymyxin B1, 12.5% polymyxin, 3.3% polymyxin B3, 9.1% polymyxin
B1-I
0203
Yes
+5C
79
Y0000355 Polymyxin B sulfate for microbiological assay
25 mg
205000 IU per vial
20702
Yes
-20C
79
Y0000289 Polysorbate 20 - reference spectrum
n/a
0426
79
n/a
1914
79
n/a
0427
79
n/a
0428
79
Y0001557 Poly (vinyl acetate)
100 mg
1962
+5C
79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent
1500 mg
2152
+5C
79
Y0001550 Poly(vinyl alcohol)
100 mg
1961
+5C
79
P2600000 Poly(vinyl chloride)
100 mg
90001,9000
2, 30114
+5C
79
P2649610 Potassium clavulanate - reference spectrum
n/a
1140
79
Y0001168 Potassium clavulanate impurity G
5 mg
1653,1140
-20C
g(c)
79
Y0000315 Potassium hydrogen aspartate hemihydrate
50 mg
2076
+5C
79
P2650000 Potassium sorbate
100 mg
0618
+5C
79
Y0001275 Potassium sucrose octasulfate
100 mg
92.6% CHKOS
1796
P2660000 Povidone
50 mg
Y0000466 Povidone (iodinated)
10 mg
Y0001266 Pramipexole dihydrochloride monohydrate
5 mg
Y0001187 Pramipexole for system suitability
15 mg
Y0001267 Pramipexole impurity D
5 mg
Y0000215 Pravastatin sodium - reference spectrum
n/a
Y0000223 Pravastatin impurity A
0.1 mg
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)
2059
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine
30 mg
76.4% CHO
2059
P2669000 Prazepam -* psy
50 mg
P2670000 Praziquantel
200 mg
Y0001533 Praziquantel for system suitability
10 mg
P2675000 Praziquantel impurity A
10 mg
P2680000 Prazosin hydrochloride
50 mg
P2698000 Prednicarbate
100 mg
Y0001443 Prednicarbate for system suitability
10 mg
10 mg
New Y0001630 Prednicarbate for system suitability A

+5C
79
0685
+5C
79
1142
+5C
79
2416
+5C
79
+5C
79
+5C
79
79
-20C
79
-20C
79
+5C
79
2416
(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
Yes
Yes
2416
2059
Yes
1466
99.8% CHNO
(11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]
isoquinolin-4-one
0855
Yes
+5C
79
0855
Yes
+5C
79
+5C
79
0855
0856
+5C
79
1467
Yes
+5C
79
1467
Yes
+5C
79
1467
Yes
+5C
79
99.1% CHO
65

Order
Code
P2700000 Prednisolone
Reference Standard

Information
per vial Unit
7
150 mg
1 99.2% CHO; Prednisolone CRS 6 is suitable for monographs
01/2011:0335, 01/2008:0353, 01/2008:0354 and 01/2008:0735 only.
Y0001359 Prednisolone for peak identification
Y0001355 Prednisolone for system suitability

P2800000 Prednisolone acetate
Monograph Leaflet
Yes
+5C
0353
Yes
+5C
79
0353
Yes
+5C
79
+5C
79
+5C
79
10 mg
120 mg
Y0000582 Prednisolone acetate for peak identification
10 mg
P2804000 Prednisolone hexanoate
10 mg
100 mg
P2810000 Prednisolone sodium phosphate
100 mg
P2900000 Prednisone
100 mg
P2920000 Pregnenolone isobutyrate
200 mg
Y0000263 Prekallikrein activator in albumin BRP
1 mL
P2939000 Prilocaine
150 mg
P2939060 Prilocaine hydrochloride
100 mg
Y0001408 Prilocaine impurity B
80 mg
2-methylbenzenamine hydrochloride
P2939025 Prilocaine impurity E
25 mg
(RS)-N-(methylphenyl)-2-(propylamino)propanamide
P2940000 Primaquine diphosphate
500 mg
P2950000 Primidone
150 mg
99.9% CHNO
0584
Y0000369 Primidone for peak identification
5 mg
0584
P3000000 Probenecid
100 mg
P3050000 Procainamide hydrochloride
100 mg
P3090000 Procaine benzylpenicillin
250 mg
P3100000 Procaine hydrochloride
100 mg
0050
P3200000 Prochlorperazine maleate
100 mg
P3300000 Progesterone
50 mg
Y0000148 Progesterone impurity C
10 mg
Y0000179 Proguanil hydrochloride - reference spectrum
n/a
Y0000181 Proguanil impurity C
10 mg
1,5-bis(4-chlorophenyl)biguanide
2002
Y0000182 Proguanil impurity D
10 mg
1,5-bis(1-methylethyl)biguanide
2002
P3350000 Proline
60 mg
P3390000 Promazine hydrochloride
100 mg
New P2805000 Prednisolone pivalate
0734,0736,0
933,
0975,1467,0
334
0734
39.7% CHNO (procaine); 96.3% CHNOS
(20R)-20-hydroxypregn-4-en-3-one
Yes
1212
+5C
79
0734,0736
+5C
79
0549,0735,0
810
+5C
79
0354
+5C
79
0593,0993,2
397
-20C
79
-20C
90
1362
+5C
79
1363
+5C
79
1362,1363
+5C
79
1362,1363
+5C
79
0635
+5C
79
Yes
+5C
79
Yes
+5C
79
0243
+5C
79
0567
+5C
79
+5C
79
+5C
79
0244,20303
+5C
79
0429
+5C
79
0429
+5C
79
79
+5C
79
+5C
79
0785,0910,0
911, 1049
+5C
79
0475,1365,2
0303
+5C
79
See leaflet,
20615
30 IU per vial
0115
Yes
Yes
2002
66
Extra
Price
charges
79
a
0335,0353,0
354, 0735
10 mg
Storage

Order
Reference Standard
Code
P3400000 Promethazine hydrochloride

per vial Unit
2
50 mg
1
Information
Monograph Leaflet
0524
Storage
+5C
Extra
Price
charges
79
g
New Y0000769 Promethazine impurity D
15 mg
(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide ;
0524
Yes
+5C
79
New Y0000797 Promethazine for peak identification
0524
Yes
+5C
79
79
5 mg
P3490000 Propacetamol hydrochloride - reference spectrum
n/a
Y0000455 Propafenone hydrochloride
10 mg
Y0000456 Propafenone impurity B
10 mg
Y0000278 Propanol - reference spectrum
n/a
Y0000016 Propofol
370 mg
Y0000017 Propofol for peak identification
0.1 ml
Y0000018 Propofol impurity J
20 mg
P3500000 Propranolol hydrochloride
30 mg
P3600000 Propranolol hydrochloride for performance test
20 mg
0568
Y0001547 Propylene glycol
150 mg
1403,1804,2
645
Y0000318 Propylene glycol dilaurate
100 mg
Y0000319 Propylene glycol monolaurate
100 mg
P3640000 Propyl gallate
50 mg
P3650000 Propyl parahydroxybenzoate
150 mg
P3700000 Propylthiouracil
100 mg
P3750000 Propyphenazone
200 mg
P3760000 Protirelin
5.03 mg
P3760020 D-His-Protirelin
0.1 mg
P3800000 Proxyphylline
100 mg
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor
50 mg
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak

identification
100 mg
Y0001537 Purified quillaia saponins
30 mg
P3900000 Purpureaglycoside A
25 mg
P4000000 Purpureaglycoside B
25 mg
Y0000402 Pyrantel embonate
10 mg
New Y0000403 Pyrantel impurity A
20 mg
P4050000 Pyrazinamide
30 mg
P4099900 Pyridostigmine bromide
30 mg
P4099910 Pyridostigmine impurity A
20 mg
1366
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one
2103
+5C
79
2103
+5C
79
79
2036
1558
+5C
79
1558
+5C
79
1558
+5C
79
0568,0923
+5C
79
+5C
79
+5C
79
2087
+5C
79
1915
+5C
79
1039
+5C
79
+5C
79
0525
+5C
79
0636
+5C
79
5.03 mg per vial of pure protirelin peptide CHNO
1144
-20C
79
approx. 0.1 mg per vial
1144
-20C
79
0526
+5C
79
0487,1367
+5C
79
79
99.8% CHO ; Batch 4 is valid until 1 May 2013

2,6-bis (1-methylethyl)-1,4-benzoquinone
0431,0852,1
263
99.9% CHO
Yes
Yes
Yes
2108
Yes
+5C
1843
Yes
-20C
79
0117
+5C
79
0117
+5C
79
1680
+5C
79
1680
+5C
79
0859
+5C
79
1255
+5C
79
1255
+5C
79
Star anise oil
1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine ;
pyridin-3-yl-dimethylcarbamate
67

Order
Reference Standard
Code
Y0001486 Pyridostigmine impurity B

per vial Unit
1
10 mg
1 3-hydroxy-1-methylpyridinium
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
g
1255
+5C
0245
+5C
79
0245
+5C
79
P4100000 Pyridoxine hydrochloride
100 mg
Y0001226 Pyridoxine impurity A
5 mg
P4200000 Pyrimethamine
250 mg
0288
+5C
79
Y0000659 Pyrrolidone
20 mg
2180
+5C
79
Y0001009 Quercetin dihydrate
25 mg
1827
Yes
+5C
79
Y0001564 Quillaia saponin assay
30 mg
64.9 % CHNO; monoammonium glycyrrhizate
1843
Yes
+5C
79
Y0001491 Quinapril hydrochloride
30 mg
1763
+5C
79
Y0001502 Quinapril for peak identification
5.075 mg
1763
Yes
+5C
79
Y0001503 Quinapril for system suitability
5.125 mg
1763
Yes
+5C
79
Q0100000 Quinidine sulfate
300 mg
0017,0018,0
019
+5C
79
Q0200000 Quinine sulfate
300 mg
0017,0018,0
019
+5C
79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP
86 mg
11 IU per vial
Y0000896 Racecadotril
110 mg
Y0000897 Racecadotril impurity A
1.1 mL
Y0000898 Racecadotril impurity G
10 mg
Y0000902 Racecadotril for peak identification
5 mg
Y0001134 Raloxifene hydrochloride
110 mg
Y0001135 Raloxifene hydrochloride for peak identification
10 mg
2375
R0145000 Ramipril
20 mg
1368
R0145005 Ramipril impurity A
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)
R0145010 Ramipril impurity B
10 mg
R0145015 Ramipril impurity C
10 mg
R0145020 Ramipril impurity D
R0150000 Ranitidine hydrochloride
6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
See leaflet,
0451
Yes
-20C
90
99.9% CHNOS
2171
Yes
+5C
79
92,8% CHCOSH; ethanethioic acid ; Batch 1 is valid until 1 July 2013
2171
Yes
+5C
79
benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate
2171
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1368
+5C
79
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester)
1368
+5C
79
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril)
1368
+5C
79
10 mg
1368
+5C
79
100 mg
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril

diketopiperazine)
0946,1453
+5C
79
0.00025
mg
0946
-20C
79
Y0000411 Ranitidine for system suitability
20 mg
0946
+5C
79
Y0000457 Repaglinide
20 mg
2135
+5C
79
New Y0000416 Ranitidine impurity J
2171
1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine) ; Batch 5 is valid until 30 April 2014
68
Yes
2375
99.7% CHClNOS
Yes
Yes

Order
Reference Standard
Code
Y0000458 Repaglinide for system suitability

per vial Unit
2
6 mg
1
Information
Monograph Leaflet
2135
Yes
Y0000459 Repaglinide impurity E
10 mg
2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid
R0200000 Reserpine
100 mg
99.8% CHNO
0528
1.4 mL
20424
Y0000767 Resorcinol
20 mg
benzene-1,3-diol
2348
Y0001194 Resveratrol
20 mg
99.6% CHO
2433,2480
Yes
R0300000 Retinol acetate
1000 mg
1 050 000 IU per g
0218,0219,0
220,
1192,1193
Yes
R0290000 Retinol esters
100 mg
R0500500 Reviparin sodium
250 mg
Y0000377 Ribavirin
150 mg
99.9% CHNO
R0600000 Riboflavin
130 mg
Vitamin B2 ; Batch 3 is valid until 31 August 2013
Y0000757 Riboflavin for peak identification
0.12 mg
0292
R0630000 Riboflavin sodium phosphate
250 mg
0786
Y0000662 Ribonucleic acid
100 mg
100.0 %
2090
Y0000149 Rifabutin
150 mg
95.5% CHNO
1657
Y0000184 Rifabutin impurity A
20 mg
1-(2-methylpropyl)piperidin-4-one
R0700000 Rifampicin
100 mg
R0800000 Rifampicin quinone
100 mg
R0900000 Rifamycin B
50 mg
Rifamycin impurity A
New R0950000 Rifamycin S
50 mg
300 mg
856 IU per mg
New R0250000 Residual solvents solution class 1
R1000000 Rifamycin sodium

New Y0001074 Rifaximin
2135
Storage
+5C
Extra
Price
charges
79
a
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
-20C
79
0217,0218,0
219, 0220
+5C
79
0828
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1657
+5C
79
0052
+5C
79
0052
+5C
79
0432
+5C
79
2109
Yes
0292,0786
Yes
Yes
+5C
79
0432,20702
0432
Yes
-20C
79
160 mg
2362
Yes
+5C
79
Y0001075 Rifaximin for system suitability
10 mg
2362
Yes
+5C
79
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum
n/a
2020
79
Y0000187 Rilmenidine for system suitability
30 mg
2020
+5C
79
Y0001541 Risedronate sodium 2.5-hydrate
15 mg
+5C
79
Y0001558 Risedronate impurity A
15 mg
78.4 %
2572
+5C
79
Y0001540 Risedronate impurity E
15 mg
2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)
2572
+5C
79
R1000600 Risperidone
50 mg
1559
+5C
79
Y0000370 Risperidone for system suitability
20 mg
+5C
79
Y0001276 Risperidone impurity K
0.015 mg
3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone) ; Batch 1

is valid until 30 November 2013
1559
+5C
79
Y0000714 Ritonavir
80 mg
99.6% CHNOS
2136
+5C
79
2572
1559
69
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000706 Ritonavir for peak identification

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
2136
Yes
+5C
2629,2630
Yes
+5C
79
2629,2630
Yes
+5C
79
2629,2630
Yes
+5C
79
2585
Yes
+5C
79
2585
Yes
+5C
79
Yes
Liquid nitrogen
100
79
Y0001516 Rivastigmine hydrogen tartrate
350 mg
Y0001485 Rivastigmine for system suitability
1.0114 mg
Y0001515 Rivastigmine impurity D
10 mg
3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)enantiomer)
Y0001302 Rizatriptan benzoate
200 mg
99.8% CHNO
Y0001303 Rizatriptan for system suitability
15 mg
R1300000 RK 13 cells
1 ml
Y0000594 Rocuronium bromide - reference spectrum
n/a
1764
Y0000527 Rocuronium for peak identification
10 mg
1764
-20C
g(c)
79
Y0000742 Ropivacaine hydrochloride monohydrate
10 mg
2335
+5C
79
Y0000743 Ropivacaine impurity G
5 mg
(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)
2335
+5C
79
Y0000786 Rosmarinic acid
50 mg
R1500000 Roxithromycin
125 mg
96.7% CHNO
Y0000220 Roxithromycin for system suitability
5 mg
R2000000 Rubella vaccine (live) BRP
90 mg
3.6 log (ie 4000) infective viral units per vial
Y0000494 Ruscogenins
10 mg
38.2% ruscogenin
60.4% neoruscogenin
S0040000 Saccharin
30 mg
S0050000 Saccharin sodium
50 mg
S0100000 Salbutamol
50 mg
Y0000030 Salbutamol impurity B
10 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol
; Batch 4 is valid until 30 September 2013
Y0000071 Salbutamol impurity D
10 mg
5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde ; Batch 4 is valid until 31 January 2013
0529,0687
Y0000031 Salbutamol impurity F
10 mg
93.4% CHNO x HSO; 1,1'-[oxybis[methylene(4-hydroxy-1,3phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol]
0529,0687
Y0000034 Salbutamol impurity G
5 mg
2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]
ethanone
Y0000032 Salbutamol impurity I
0.006 mg
Y0001186 Salbutamol impurity J
S0150000 Salbutamol sulfate
50 mg
Y0001288 Salbutamol sulfate for system suitability
10 mg
Y0000669 Salicin
50 mg
S0200000 Salicylic acid
100 mg
10 mg
New Y0000405 Salicylic acid impurity B

99.9% CHNO
cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines 0162,1057
Yes
1447,2382,
2524
Yes
+5C
79
1146
Yes
+5C
79
+5C
79
1146
1057,0162
Yes
-80C
90
1847
Yes
+5C
79
0947
+5C
79
0787
+5C
79
0529,1033
+5C
79
0529
+5C
79
Yes
+5C
79
Yes
+5C
79
0529
+5C
79
(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol
0529
+5C
79
0687
+5C
79
0687
+5C
79
0.00045 mg 1
99,6% CHO
4-hydroxyisophthalic acid ; Batch 1 is valid until 31 March 2014
70
0687
Yes
+5C
79
2312,1583
Yes
+5C
79
0366,1185
+5C
79
0366
+5C
79

Order
Reference Standard
Code
Y0000422 Salmeterol xinafoate

per vial Unit
2
50 mg
1 99.6% CHNO
Y0000423 Salmeterol xinafoate for system suitability
25 mg
Y0001559 Salvianolic acid B
15 mg
92.2 % CHO
Y0001052 Santonin
20 mg
99.8% CHO
15 mg
New Y0001625 Salmeterol xinafoate for peak identification
Information
Monograph Leaflet
Yes
+5C
1765
Yes
+5C
79
2663
Yes
+5C
79
1391,1809
Yes
+5C
79
1765
Yes
+5C
79
+5C
79
+5C
79
70 mg
Y0001056 Saquinavir for system suitability
0.3033 mg
Y0001483 Saw palmetto extract HRS
8000 mg
Y0000814 Selamectin
100 mg
Y0000815 Selamectin for system suitability
5 mg
2268
S0360000 Selegiline hydrochloride
50 mg
1260
S0360090 (RS)-Selegiline hydrochloride
25 mg
S0400000 Senna extract
50 mg
S0450000 Serine
50 mg
0788,1027
S0460000 Sertaconazole nitrate
125 mg
Y0000828 Sertraline hydrochloride
200 mg
99.9% CHClN
1705
Yes
Y0001285 Sertraline impurity E
15 mg
Mandelic acid CRS has been labelled as sertraline impurity E CRS in

anticipation of 01/2011:1705 corrected 7.1
1705
Y0000866 Sertraline for peak identification
5.4 mg
Batch 2 is valid until 30 September 2013
1705
Y0000867 Sertraline for system suitability
6.18 mg
New Y0000371 Sestamibi labelling kit
22 mg
Y0001046 Sevoflurane
1 ml
Y0001578 Sildenafil citrate
100 mg
Y0001579 Sildenafil impurity A
10 mg
S0500000 Silicone elastomer
2000 mg
New S0600000 Silicone oil
2267
2267
Yes
1848
Yes
79
+5C
79
+5C
79
+5C
79
1260
+5C
79
0206,0207,0
208, 1261
-20C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
2268
97.6% CHNO
Yes
1148
1705
1926
Yes
+5C
79
2269
Yes
+5C
g(b)
79
98.8 % CHNOS
2270
Yes
+5C
79
5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one
2270
+5C
79
30109
+5C
79
1 mL
S0650000 Simvastatin
100 mg
Y0001066 Simvastatin for peak identification
10 mg
Y0001208 Sinomenine
20 mg
81.8 % CHNO
S0660000 Sisomicin sulfate
60 mg
Y0000014 Sodium alendronate
150 mg
S0695000 Sodium amidotrizoate
125 mg
1150
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum
n/a
1993
Y0000039 Sodium ascorbate
50 mg
1791
S0700000 Sodium calcium edetate
100 mg
0231
Extra
Price
charges
79
a
1765
Y0001049 Saquinavir mesilate
99.5% CHNOS
Storage
+5C
79
1538,1563
30108
Yes
-20C
g(c)
79
1563
Yes
-20C
g(c)
79
2450
Yes
+5C
79
77.7% CHNOS
0331,1351
Yes
-20C
79
83.3% CHNNaOP
1564
Yes
+5C
79
+5C
79
79
+5C
79
+5C
79
99.4% CHO
71

Order
Reference Standard
Code
S0710000 Sodium cetostearyl sulfate

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0847
+5C
Extra
Price
charges
79
a
S0750000 Sodium cromoglicate
10 mg
0562
+5C
79
Y0001300 Sodium cromoglicate for system suitability
20 mg
0562
+5C
79
S0760000 Sodium cyclamate
100 mg
S0765000 Diclofenac sodium
100 mg
Y0001410 Sodium fusidate
10 mg
S0781000 Sodium hyaluronate - reference spectrum
n/a
S0780000 Sodium hyaluronate BRP
Y0001468 Sodium iodohippurate
Y0000620 Sodium laurilsulfate

Y0000808 Sodium phenylbutyrate
Y0000809 Sodium phenylbutyrate impurity C
S0785000 Sodium picosulfate
0774
+5C
79
1002,1281
+5C
79
0848
+5C
79
1472
79
300 mg
0912
+5C
79
15 mg
2352
+5C
79
40 mg
0802
+5C
79
5 mg
2183
+5C
79
10 mg
2183
+5C
79
100 mg
1031
+5C
79
Y0001104 Picosulfate for system suitability
0.5 mg
1031
+5C
79
Y0000210 Sodium polystyrene sulfonate - reference spectrum
n/a
1909
79
Y0000268 Sodium propionate - reference spectrum
n/a
2041
79
S0800000 Sodium salicylate
100 mg
0413
+5C
79
S0808000 Sodium stearyl fumarate
50 mg
1567
+5C
79
S0808060 Sodium stearyl maleate
10 mg
1567
+5C
79
S0900000 Sodium taurocholate BRP
10000 mg
0350
+5C
79
S0930000 Sodium valproate
150 mg
0678
+5C
79
S0945000 Somatostatin
2.32 mg
2.32mg somatostatin peptide per vial CHNOS
-20C
90
S0947000 Somatropin
55 mg
3.86 mg somatropin monomer per vial
See leaflet,
0950,
0951,0952
Yes
-20C
150
Y0000711 Somatropin/desamidosomatropin resolution mixture
33 mg
1.7 mg somatropin per vial
0950,0951,0
952
Yes
-20C
150
S0950000 Sorbic acid
10 mg
Y0000385 1,4-Sorbitan
50 mg
99,7% CHO ; Batch 1 is valid until 1 April 2013
S1000000 Sorbitol
1250 mg
98,7% CHO ; Batch 3 is valid until 31 December 2013
Y0000114 Sotalol hydrochloride
25 mg
Y0000115 Sotalol impurity B
20 mg
Y0001011 Spanish sage oil for peak identification
250 mg
Batch 3 is valid until 31 October 2013
4-cyclohexylbutanoic acid
Yes
0949
0592
N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide
+5C
79
2048
Yes
+5C
79
0435,0436,0
437,
1235,1236,1
337,
1381,1531,2
048
Yes
+5C
79
2004
+5C
79
2004
+5C
79
+5C
79
1849
72
Yes

Order
Reference Standard
Code
Y0000597 Spectinomycin hydrochloride

Information
per vial Unit
2
100 mg
1 81.3% CHClNO and CHClNO
Monograph Leaflet
1152
-20C
Y0000549 Spectinomycin for system suitability
20 mg
1152
Y0000655 Spectinomycin sulfate tetrahydrate
10 mg
1658
Y0001126 Spike lavender oil
400 l
S1100000 Spiramycin
200 mg
4500 IU per mg
Spiramycin I: 87.3%, Spiramycin II: 0.2%, Spiramycin III: 4.4%
Y0000381 Spirapril hydrochloride monohydrate
60 mg
95.9% CHClNOS
Y0000332 Spirapril for system suitability
15 mg
160 mg
See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688

only. ; Batch 3 is valid until 30 April 2014
0688
Yes
Y0001295 Spironolactone for system suitability
2.057 mg
0688
Yes
Y0000185 Squalane
250 l
99.7% CH
1630
Y0001050 St. John's wort standardised dry extract
500 mg
0.050% of hypericin; St. John's wort standardised dry extract CRS has been
renamed as St. John's wort dry extract HRS in 01/2013:1874
1874
Y0001091 Artichoke leaf dry extract HRS
60 mg
2389
S1250000 Stanozolol
50 mg
S1250010 Stanozolol impurity A
10 mg
Y0001420 Stanozolol impurity B
10 mg
S1300000 Starch BRP
50000 mg
Y0000408 Stavudine
100 mg
Y0000421 Stavudine for system suitability
10 mg
S1340000 Stearic acid
100 mg
Plastic additive 19
S1350000 Stearyl alcohol
250 mg
99.5% CHO
Y0000868 Streptokinase for system suitability
30 l
S1400000 Streptomycin sulfate
100 mg
Y0001324 Sucralfate
10 mg
Y0001344 Sucralose
550 mg
100.0% CHClO
2368
Y0001342 Sucralose impurity B
0.5 mg
1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose)
2368
New S1200000 Spironolactone
Storage
Yes
Extra
Price
charges
79
a
-20C
79
-20C
79
2419
Yes
+5C
79
0179,0293,1
982,20702
Yes
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
-20C
79
Yes
-20C
79
1568
+5C
79
1568
+5C
79
1568
+5C
79
0350
+5C
79
+5C
79
+5C
79
+5C
79
1766
1766
(5,17)-17-hydroxy-17-methylandrostan-3-one
2130
99.6% CHNO
2130
0229,0882,1
474, 1663,
2058,
30105,
30106,3010
7,1663
0702,0753,0
Yes
+5C
79
0356
Yes
-20C
79
0032,0033,0
053,
0485,20702
Yes
-20C
79
+5C
79
+5C
79
+5C
79
801,
0802,0847,0
969,
1123,1340,1
411
77 000 IU per vial
Yes
1796
73
Yes

Order
Code
S1600000 Sucrose
Reference Standard

per vial Unit
1
100 mg
1
S1608100 Sufentanil - reference spectrum
S1609000 Sufentanil citrate - reference spectrum

Y0000529 Sulbactam sodium
Information
Monograph Leaflet
0177,0178,0
187,
0188,0204,0
209,
1061,1570,2
318
Storage
+5C
n/a
1569
n/a
1269
10 mg
2209
Y0000528 Sulbactam
150 mg
2209
Yes
Y0000550 Sulbactam for peak identification
20 mg
2209
Yes
S1700000 Sulfacetamide sodium
50 mg
S1800000 Sulfadiazine
100 mg
Y0001480 Sulfadiazine for identification of impurity F
15 mg
Y0001469 Sulfadiazine impurity A
20 mg
S1900000 Sulfadimidine
100 mg
0295
Y0001495 Sulfadimidine for peak identification
50 mg
0295
S1950000 Sulfadoxine
50 mg
S1975000 Sulfafurazole
100 mg
S1975600 Sulfaguanidine
60 mg
S2000000 Sulfamerazine
100 mg
S2050000 Sulfamethizole
100 mg
S2100000 Sulfamethoxazole
50 mg
Y0000412 Sulfamethoxazole impurity A
5 mg
Y0000413 Sulfamethoxazole impurity F
5 mg
S2150000 Sulfamethoxypyridazine
Extra
Price
charges
79
a
79
79
79
-20C
79
+5C
79
0107,0295
+5C
79
0294
+5C
79
0294
+5C
79
0294
+5C
79
+5C
79
+5C
79
0740
+5C
79
0741
+5C
79
0295,1476
+5C
79
0358,1571
+5C
79
0637
+5C
79
0108
+5C
79
N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide
0108
+5C
79
4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide
0108
+5C
79
0638
+5C
79
1571
+5C
79
+5C
79
+5C
79
0863
+5C
79
99.7% CHNOS
pyrimidin-2-amine
+5C
Yes
50 mg
New S2151000 Sulfanilamide
100 mg
S2159100 Sulfapyridine
20 mg
S2155000 Sulfasalazine
250 mg
98.1 % CHNOS ; Batch 3 is valid until 28 February 2013
S2155010 Sulfasalazine derivative for resolution
20 mg
2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid
S2158000 Sulfathiazole
100 mg
0742
+5C
79
S2159000 Sulfinpyrazone
30 mg
0790
+5C
79
Y0001238 Sulfinpyrazone for system suitability
0.5 mg
+5C
79
S2159010 Sulfinpyrazone impurity A
20 mg
1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
0790
+5C
79
S2159015 Sulfinpyrazone impurity B
20 mg
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
0790
+5C
79
S2180000 Sulindac
50 mg
Contains 0.3% m/m of E-isomer
0864
+5C
79
S2190000 Sulpiride
100 mg
1045,1348
+5C
79
0863
0863,1457
0790
74
Yes
Yes

Order
Reference Standard
Code
S2191000 Sulpiride impurity A
S2192000 Sulpiride impurity B

Information
per vial Unit
3
20 mg
1 [(2RS)-1-ethylpyrrolidin-2-yl]methanamine
2
20 mg
1 methyl 2-methoxy-5-sulphamoylbenzoate
Monograph Leaflet
+5C
1045
+5C
79
2211
+5C
79
10 mg
Y0000531 Sultamicillin tosilate
200 mg
Y0000532 Sultamicillin for peak identification
10 mg
Y0000022 Sumatriptan succinate
50 mg
Y0000026 Sumatriptan impurity mixture
3 mg
Y0000027 Sumatriptan for system suitability
2.02 mg
S2200000 Suxamethonium chloride
1000 mg
S2400000 Suxibuzone
50 mg
S2400004 Suxibuzone impurity B
10 mg
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
S2400006 Suxibuzone impurity C
10 mg
4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.

use) BRP
1 mg
6.5 x10 Cfu per vial
See leaflet,
0064
Yes
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.

use) BRP
1 mg
2.6 x10 Cfu per vial
See leaflet,
0064
Y0001417 Tadalafil
200 mg
99.9% CHNO
2606
T0010000 Talampicillin hydrochloride
50 mg
T0014000 Tamoxifen citrate
80 mg
T0015000 Tamoxifen citrate for performance test
10 mg
1046
Y0000650 Tamsulosin hydrochloride
10 mg
2131
New Y0000653 Tamsulosin racemate
15 mg
Y0000651 Tamsulosin impurity D
10 mg
2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide ; Batch 1 is valid until 1 June 2013
Y0000652 Tamsulosin impurity H
10 mg
Y0001102 Teicoplanin
52 mg
Y0001560 Tanshinone IIa
Y0001047 Teicoplanin for identification
Y0000648 Telmisartan
Y0000649 Telmisartan for peak identification
2211,2212
98.8% CHNOS
Extra
Price
charges
79
g
1045,1490
Y0000530 Sultamicillin
92.5% CHNOS
Storage
+5C
79
2211
Yes
+5C
79
1573
Yes
-20C
79
1573
Yes
-20C
79
1573
Yes
-20C
79
0248
+5C
79
1574
+5C
79
1574
+5C
79
+5C
79
+5C
e(b)
90
Yes
+5C
e(b)
90
Yes
+5C
79
0808,0852
+5C
79
1046
+5C
79
+5C
79
+5C
79
2131
+5C
79
2131
+5C
79
(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine ;
2131
+5C
79
51550 IU per ampoule
2358
Yes
-20C
79
15 mg
98.4 % CHO
2663
Yes
+5C
79
40 mg
2358
Yes
-20C
79
30 mg
+5C
79
10 mg
2154
Yes
+5C
79
Y0001003 Telmisartan for system suitability
0.26 mg
2154
Yes
T0040000 Temazepam - * psy
50 mg
Y0000344 Temazepam impurity C
5 mg
Y0000345 Temazepam impurity D
5 mg
1574
Yes
2154
+5C
79
0954
+5C
79
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate
0954
+5C
79
(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one
0954
+5C
79
75

Order
Reference Standard
Code
Y0000346 Temazepam impurity F

Information
per vial Unit
1
5 mg
1 (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0954
+5C
0954
+5C
79
1156
+5C
79
+5C
79
+5C
79
Y0000347 Temazepam impurity G
5 mg
T0040800 Tenoxicam
100 mg
Y0001114 Tenoxicam impurity mixture
0.0042 mg
1156
Y0000621 Terazosin hydrochloride dihydrate
40 mg
2021
Y0000666 Terazosin for system suitability
0.5 mg
+5C
79
Y0000622 Terazosin impurity A
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2021
+5C
79
Y0000665 Terazosin impurity E
10 mg
2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
2021
+5C
79
Y0000623 Terazosin impurity L
10 mg
1-(furan-2-ylcarbonyl)piperazine
2021
+5C
79
Y0000624 Terazosin impurity N
10 mg
93.1% CHNO; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine
2021
+5C
79
Y0000535 Terbinafine hydrochloride
10 mg
+5C
79
Y0001143 Terbinafine for system suitability
10 mg
+5C
79
100 mg
0690
+5C
79
1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone
0690
+5C
79
1270
+5C
79
New T0050000 Terbutaline sulfate
(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
2021
Yes
Yes
Yes
1734
1734
Yes
T0050015 Terbutaline impurity C
15 mg
T0060000 Terconazole
250 mg
T0071000 Terfenadine
100 mg
0955
+5C
79
T0080000 Terfenadine impurity A
20 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
butan-1-one
0955
+5C
79
T0100000 Testosterone
30 mg
1373
+5C
79
T0210000 Testosterone caproate
50 mg
T0240000 Testosterone decanoate
50 mg
Y0000696 Testosterone decanoate for system suitability
0.4 mg
1736
T0250000 Testosterone enantate
100 mg
1048
Y0001317 Testosterone enantate for system suitability
2 mg
1048
Y0001312 Testosterone enantate for peak identification
10 mg
1048
Y0001313 Testosterone enantate impurity H
10 mg
Y0000342 Testosterone for impurity D identification
20 mg
Y0000343 Testosterone for system suitability
20 mg
T0260000 Testosterone isocaproate
50 mg
Y0000716 Testosterone isocaproate for system suitability
5 mg
T0300000 Testosterone propionate
60 mg
Y0001409 Testosterone propionate for system suitability
5 mg
T0400000 Tetanus vaccine (adsorbed)
30 mg
490 IU per ampoule for challenge assays in guinea-pigs

260 IU per ampoule for challenge assays in mice
Y0001087 Tetra-O-acetyl-mannose triflate

60 mg
100.0% CHFOS
76
99.8% CHO
delta-5-testosterone-3,17-dienantate
99.9% CHO
99.8% CHO; Testosterone propionate CRS 1 is suitable for 01/2008:1048
only
1048
+5C
79
1048, 1736
-20C
g(c)
79
-20C
g(c)
79
-20C
g(c)
79
Yes
-20C
g(c)
79
Yes
-20C
g(c)
79
1048
-20C
g(c)
79
1373
+5C
79
1373
+5C
79
1048,1737
+5C
79
Yes
1737
Yes
+5C
79
0297
Yes
+5C
79
0297
Yes
+5C
79
See leaflet,
20708
Yes
-20C
90
79
2294
Yes
-20C
c

Order
Reference Standard
Code
T0500000 Tetracaine hydrochloride

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
0057
Y0001002 Tetracaine for system suitability
2 mg
T0550000 Tetracosactide
0.366 mg
366 g per vial of CHNOS
T0600000 Tetracycline hydrochloride
100 mg
97.1% CHClNO ; Batch 2 is valid until 31 December 2013
Y0001165 Tetrandrine
20 mg
99.7% CHNO
Y0000015 Tetrazepam - reference spectrum
n/a
Y0000008 Tetrazepam impurity C
20 mg
Y0000460 Tetryzoline hydrochloride
10 mg
Y0000723 Thebaine - * narc
15 mg
T0700000 Theobromine
100 mg
0298
Storage
+5C
0057
Yes
+5C
79
0644
Yes
-20C
79
0173,0198,0
199,
0210,0211,1
654
Yes
+5C
79
+5C
79
79
2478
1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
1738
+5C
79
2101
+5C
79
+5C
79
+5C
79
+5C
79
79
1839,1841
99.5% CHNO
Extra
Price
charges
79
g
Yes
T0800000 Theophylline
100 mg
0300,0301
Y0000294 Theophylline - reference spectrum
n/a
0299,0302
Y0000336 Thiamazole
125 mg
0884,1706
+5C
79
Y0000372 Thiamazole impurity A
15 mg
2,2-dimethoxy-N-methylethanamine
1706
+5C
79
Y0000373 Thiamazole impurity C
20 mg
1-methyl-2-(methylsulphanyl)-1H-imidazole ; Batch 1 is valid until 31 August

2013
1706
+5C
79
Y0000467 Thiamine hydrochloride
10 mg
Y0000059 Thiamine impurity E
10 mg
Y0000060 Thiamine nitrate
n/a
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
Yes
0303
+5C
79
0303,0531
+5C
79
0531
+5C
79
+5C
79
+5C
79
T1100000 Thiamphenicol
125 mg
Y0000546 Thioctic acid
110 mg
0109
Y0000592 Thioctic acid for system suitability
10 mg
1648
+5C
79
Y0000545 Thioctic acid containing impurity B
30 mg
1648
+5C
79
Y0000109 Thiomersal
30 mg
1625
+5C
79
T1200000 Thiopental
500 mg
0212
+5C
79
Y0001478 Thiopental for system suitability
10 mg
0212
+5C
79
Y0000704 Thioridazine
10 mg
2005
+5C
79
+5C
79
+5C
79
99.8% CHOS
1648
Yes
Yes
T1300000 Thioridazine hydrochloride
100 mg
0586
Y0000541 Thioridazine for system suitability
0.21 mg
0586, 2005
T1305100 Thioxanthene
20 mg
1347
+5C
79
T1305000 Thioxanthone
10 mg
1347
+5C
79
T1340000 Threonine
50 mg
0785,1049
+5C
79
T1350000 Thymol
50 mg
0791
+5C
79
50 mg
T1410000 Tiabendazole
77
Yes
79
0866
+5C
g

Order
Reference Standard
Code
Y0000414 Tiamulin for peak identification
Y0000333 Tiamulin hydrogen fumarate

Information
per vial Unit
2
10 mg
1 Batch 1 is valid until 30 November 2013
2
500 mg
1 98.6% CHNOS
Y0000379 Tiamulin - reference spectrum
Y0000151 Tianeptine sodium - reference spectrum

Y0000152 Tianeptine for system suitability
Monograph Leaflet
Storage
1659
Yes
+5C
1659,1660
Yes
+5C
Extra
Price
charges
79
g
g
79
79
79
79
n/a
1660
n/a
2022
30 mg
2022
+5C
Y0000153 Tianeptine impurity A
20 mg
2022
+5C
79
T1405000 Tiapride hydrochloride
60 mg
1575
+5C
79
T1405050 Tiapride N-oxide
20 mg
1575
+5C
79
T1410900 Tiaprofenic acid
50 mg
1157
+5C
79
1157
+5C
79
79
ethyl 7-bromoheptanoate
T1410910 Tiaprofenic acid impurity C
20 mg
Y0000748 Tibolone - reference spectrum
n/a
Y0000668 Tibolone for system suitability
10 mg
1739
Yes
+5C
79
Y0000465 Ticarcillin monosodium
250 mg
93.2% CHNNaOS
Correction factor 1.054
0956
Yes
+5C
79
T1420010 Ticarcillin impurity A
50 mg
89.8% CHNOS; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)

acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)
0956
+5C
79
T1423000 Ticlopidine hydrochloride
50 mg
1050
+5C
79
T1423025 Ticlopidine impurity F
10 mg
1050
+5C
79
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum
n/a
1767
79
T1450000 Timolol maleate
100 mg
0572
+5C
79
Y0000644 (R)-timolol
20 mg
+5C
79
Y0001270 Timolol for system suitability
5.045 mg
+5C
79
(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid
1739
6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
0572
0572
Yes
T1470000 Tinidazole
100 mg
1051
+5C
79
Y0000899 Tinidazole impurity A
15 mg
2-methyl-5-nitro-1H-imidazole
1051
+5C
79
T1471000 Tinidazole impurity B
20 mg
1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole
1051
+5C
79
T1490000 Tinzaparin sodium
250 mg
0828
+5C
79
Y0000292 Tioconazole - reference spectrum
n/a
2074
79
Y0000282 Tioconazole for system suitability
50 mg
2074
+5C
79
Y0001188 Tiotropium bromide monohydrate
10 mg
2420
+5C
79
Y0001189 Tiotropium for system suitability
10 mg
2420
+5C
79
Y0001179 Tiotropium impurity mixture
0.08 mg
2420
+5C
79
Y0001216 Tiotropium impurity F
10 mg
dithiophen-2-ylmethanone
2420
+5C
79
Yes
Yes
T1500000 Tobramycin
49 mg
49 mg per vial of CHNO; Suitable for LC assay only
0645
Yes
+5C
79
Y0000383 All-rac-alpha-tocopherol for peak identification
50 mg
0692
Yes
+5C
79
Y0000384 All-rac-alpha-tocopheryl acetate for peak identification
30 mg
0439
Yes
+5C
79
78

Order
Reference Standard
Code
T1550000 alpha-Tocopherol
New T1600000 alpha-Tocopheryl acetate

Information
per vial Unit
7
500 mg
1 97,7% CHO ; Vitamin E ; Batch 6 is valid until 31 December 2013
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0692,1256,2
0432
Yes
+5C
0439,0691,1
257
Yes
+5C
79
+5C
79
500 mg
Y0001210 Tobramycin for identification
250 mg
Suitable for identification tests only
T1610000 RRR-alpha-Tocopheryl hydrogen succinate
150 mg
98.6% CHO
+5C
79
T1700000 Tolbutamide
100 mg
0304
+5C
79
Y0000154 Tolfenamic acid
100 mg
2039
+5C
79
T1707000 Tolnaftate
60 mg
1158
+5C
79
Y0001123 Tolnaftate for system suitability
10 mg
1158
+5C
79
Y0000461 Torasemide anhydrous
10 mg
2132
+5C
79
Y0001366 Torasemide impurity E
0.0006 mg
+5C
79
Y0000462 Torasemide for system suitability
5 mg
+5C
79
Y0000155 Tramadol hydrochloride
75 mg
1681
+5C
79
Y0000156 Tramadol impurity A
25 mg
(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol ;
1681
+5C
79
Y0000157 Tramadol impurity E
15 mg
(2RS)-2-[(dimethylamino)methyl]cyclohexanone
1681
+5C
79
Y0000072 Tramazoline hydrochloride monohydrate
20 mg
+5C
79
Y0000065 Tramazoline impurity A
15 mg
N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine ; Batch 1 is valid until

31 August 2013
1597
+5C
79
Y0000066 Tramazoline impurity B
10 mg
75% CHNO; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one
1597
+5C
79
Y0000501 Trandolapril
10 mg
2245
+5C
79
Y0000495 Trandolapril impurity C
10 mg
(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
2245
+5C
79
Y0000496 Trandolapril impurity D
10 mg
ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)
2245
+5C
79
T1810000 Tranexamic acid
50 mg
0875
+5C
79
T1820000 Trapidil
50 mg
1576
+5C
79
T1820002 Trapidil impurity A
20 mg
5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
1576
+5C
79
T1820004 Trapidil impurity B
20 mg
1,2,4-triazol-3-amine
1576
+5C
79
Y0001172 Trehalose dihydrate
250 mg
89.8% CHO,2HO
+5C
79
T1850000 Tretinoin
50 mg
0693,1019,1
385
+5C
g(b)
79
T1899000 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum
n/a
1325
79
G0400010 Triacetin - reference spectrum
n/a
1106
79
T1899990 Triamcinolone
150 mg
1376
79
0645
1258,1259
ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
Yes
2132
2132
Yes
1597
79
2297
Yes
Yes
Yes
+5C

Order
Reference Standard
Code
T1900000 Triamcinolone acetonide

per vial Unit
5
150 mg
1 98.6% CHFO
Y0001459 Triamcinolone acetonide for system suitability
10 mg
T1950000 Triamcinolone hexacetonide
100 mg
Y0000050 Triamcinolone impurity C
10 mg
Y0000837 Triamterene
10 mg
Y0000870 Triamterene impurity B
0.5 mg
Information
Monograph Leaflet
9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
Extra
Price
charges
79
a
0533,0867,1
075
Yes
+5C
0533
Yes
+5C
79
0533,0867
+5C
79
1376
+5C
79
+5C
79
+5C
79
0058
0058
2,7-diamino-6-phenylpteridin-4-ol
Storage
Yes
T1975000 Triazolam - * psy
10 mg
+5C
79
Y0000165 Tribenoside
150 mg
1065
1740
Yes
+5C
79
Y0000166 Tribenoside impurity A
70 mg
90.3% CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose ; Batch 3 is valid until 1 May 2013
1740
Yes
-20C
g(c)
79
New Y0001628 Tribenoside impurity D
Benzyl ether
35 mg
1740
+5C
79
Y0001055 Tributyl acetylcitrate
1 mL
1770
+5C
79
Y0000279 Tri-n-butyl phosphate
300 l
1682
+5C
79
Y0000799 Tributyl acetylcitrate for peak identification
25 mg
1770
+5C
79
T1977990 Tricaprin
150 mg
1410
-20C
79
T1977995 Tricaproin
40 mg
1410
-20C
79
-20C
79
79
79
79
Yes
T1978000 Tricaprylin
225 mg
1410
Y0000111 Trichloroacetic acid - reference spectrum
n/a
1967
T1985000 Trichlorotrifluoroethane
2.5 ml
0393
T1986000 Triethyl citrate - reference spectrum
n/a
1479
T2000000 Trifluoperazine hydrochloride
100 mg
0059,20303
+5C
79
T2005000 Triflusal
50 mg
1377
+5C
79
1377
+5C
79
2032
+5C
79
1626
+5C
79
1626
+5C
79
T2005010 Triflusal impurity B
25 mg
Y0000720 Triglycerol diisostearate
200 mg
Y0000108 Trihexyphenidyl hydrochloride
100 mg
Y0000068 Trihexyphenidyl impurity A
20 mg
2-hydroxy-4-(trifluoromethyl)benzoic acid
1-phenyl-3-(piperidin-1-yl)propan-1-one
Yes
+5C
T2009000 Trilaurin
1250 mg
1410
-20C
79
Y0001319 Trimebutine maleate
10 mg
2182
+5C
79
Y0001260 Trimebutine for system suitability
1.017 mg
2181,2182
+5C
79
Y0000092 Trimetazidine dihydrochloride - reference spectrum
n/a
1741
79
Y0000093 Trimetazidine for system suitability
50 mg
T2100000 Trimethadione
250 mg
100% CHNO
Y0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt
120 mg
91.8 % CHOSSi,Na
T2200000 Trimethoprim
50 mg
Y0000684 Trimethoprim for system suitability
T2200010 Trimethoprim impurity B
0.00075 mg 1
15 mg
Yes
1741
+5C
79
0440
+5C
79
+5C
79
0060
+5C
79
0060
+5C
79
(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone
0060
+5C
79
80
2645, 2165
Yes

Order
Reference Standard
Code
T2450000 Trimethyltetradecylammonium bromide

per vial Unit
2
200 mg
1
Information
Monograph Leaflet
0378
T2500000 Trimipramine maleate
100 mg
0534
Y0000759 Trimipramine for peak identification
0.51 mg
0534
T2500100 Trimyristin
500 mg
T2501200 Tristearin
100 mg
Storage
+5C
Extra
Price
charges
79
g
+5C
79
+5C
79
1410
-20C
79
1410
-20C
79
Yes
T2545000 Trolamine
2250 mg
1577
+5C
79
Y0001184 Trolamine impurity A
250 mg
Ethanolamine
1577
+5C
79
Y0001183 Trolamine impurity B
1 ml
Diethanolamine
1577
+5C
79
T2550000 Trometamol
100 mg
1053
+5C
79
New T2580000 Tropicamide
50 mg
1159,1197
+5C
79
Y0001247 Tropicamide impurity C
10 mg
(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)
1159
+5C
79
Y0001248 Tropicamide impurity D
10 mg
Phenylacetic acid
1159
+5C
79
Y0001316 Tropicamide for peak identification
10 mg
1159
+5C
79
Y0000616 Tropisetron hydrochloride
40 mg
2102
+5C
79
Y0000618 Tropisetron impurity B
10 mg
2102
+5C
79
1H-indole-3-carboxylic acid
T2580300 Tropine
50 mg
1308
+5C
79
Y0000429 Trospium chloride
10 mg
1798
+5C
79
Y0000432 Trospium impurity A
20 mg
hydroxydiphenylacetic acid (benzilic acid)
1798
+5C
79
Y0000431 Trospium impurity B
20 mg
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate
1798
+5C
79
Y0000430 Trospium impurity C
5 mg
(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
1798
+5C
79
Y0000497 Troxerutin
30 mg
2133
+5C
79
T2600000 Trypsin BRP
100 mg
+5C
79
T2610000 Tryptophan
100 mg
+5C
79
T2880000 Tylosin
150 mg
+5C
79
T2880100 Tylosin D
5 mg
1273,1274,1
661
+5C
79
Y0000498 Tylosin phosphate for peak identification
10 mg
1273,1274,1
661
+5C
79
T2880200 Tylosin tartrate - reference spectrum
n/a
1274
79
T2900000 Tyrosine
50 mg
+5C
79
T3000000 Tyrothricin
20 mg
+5C
79
U0020000 Ubidecarenone
50 mg
1578
+5C
79
U0020001 Ubidecarenone for system suitability
1 mg
1578
+5C
79
0.707 microkatal per mg
0476,0579,0
580, 0694
1025 IU per mg ; Batch 1 is valid until 31 August 2013
1273,1274,1
661, 20702
Yes
1272
81
Yes
0782,0895,1
161,
1272,1384
0907,1662
Yes
Yes

Order
Reference Standard
Code
U0020008 Ubidecarenone impurity D

Information
per vial Unit
2
5 mg
1 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione
Monograph Leaflet
Storage
1578
+5C
Extra
Price
charges
79
a
U0100000 Uracil arabinoside
60 mg
0760
+5C
79
U0600000 Urea
100 mg
0743
+5C
79
U0800000 Ursodeoxycholic acid
100 mg
+5C
79
Y0001163 Ursodeoxycholic acid for system suitability
1.26 mg
1275
Yes
+5C
79
Y0000834 Valaciclovir hydrochloride (anhydrous)
100 mg
96.5% CHNOCl
1768
Yes
+5C
79
Y0001225 Valaciclovir for system suitability
10 mg
1768
Yes
+5C
79
Y0001096 Valaciclovir impurity D
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate
1768
+5C
79
Y0001097 Valaciclovir impurity E
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate
1768
+5C
79
Y0001098 Valaciclovir impurity F para-toluenesulfonate
12 mg
2-hydroxyethyl L-valinate
1768
+5C
79
Y0001099 Valaciclovir impurity G
10 mg
N,N-dimethylpyridin-4-amine
Y0000583 Valerian standardised dry extract
400 mg
0.43 % of CHO
V0030000 Valine
50 mg
0453,1898,1
899,2400,25
26
0770,0771,0
Y0000584 Valnemulin hydrochloride
10 mg
2137
Y0000533 Valnemulin hydrogen tartrate
120 mg
Y0000585 Valnemulin for peak identification
10.25 mg
Y0000586 Valnemulin impurity E
10 mg
V0033000 Valproic acid
100 mg
Y0001422 Valproic acid for system suitability
Y0001132 Valsartan
Y0001131 Valsartan for peak identification

Y0001145 Valsartan for system suitability
1189,1275
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
2137
+5C
79
1378
+5C
79
10 mg
0678,1378
+5C
79
10 mg
2423
+5C
79
10 mg
0.202 mg
V0045000 Vancomycin hydrochloride
100 mg
102000 IU per vial
V0050000 Vanillin
100 mg
0747
Y0001198 Varicella vaccine ( live)
420 mg
0648
Y0000561 Vecuronium bromide
10 mg
1769
Y0000625 Vecuronium for peak identification
10 mg
1769
Y0001093 Vedaprofen
5 mg
2248
Y0001118 Vedaprofen impurity mixture
0.006 mg
2248
Y0000587 Venlafaxine hydrochloride
50 mg
2119
Y0000588 Venlafaxine for system suitability
1.002 mg
2119
1768
Yes
796
2137
98.7% CHNOS
2137
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)

82
Yes
Yes
2423
Yes
+5C
79
2423
Yes
+5C
79
1058,20702
Yes
-20C
79
+5C
79
-80C
90
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
Yes
Yes

Order
Reference Standard
Code
V0100000 Verapamil hydrochloride

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0573
+5C
Extra
Price
charges
79
g
V0100018 Verapamil impurity I
5 mg
(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride
0573
+5C
79
V0100026 Verapamil impurity M
10 mg
5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]
0573
+5C
79
Y0000661 Verbenalin
11 mg
0.97 mg per vial of CHO
V0180000 VERO cells
1 ml
Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of

live measles, mumps and rubella vaccines
Y0001400 Vigabatrin
10 mg
Y0001401 Vigabatrin impurity A
25 mg
94.7% CHNO; (5RS)-5-ethenylpyrrolidin-2-one
2305
Y0001402 Vigabatrin impurity B
20 mg
(2E)-2-(2-aminoethyl)but-2-enoic acid
2305
Y0001404 Vigabatrin impurity D
50 mg
4-aminobutanoic acid
Y0001403 Vigabatrin impurity E
10 mg
2-[(2RS)-2-aminobut-3-enyl]propanedioic acid
V0300000 Vinblastine sulfate
5.01 mg
V0305000 Vinblastine sulfate - reference spectrum
n/a
V0400000 Vincristine sulfate
4.96 mg
V0405000 Vincristine sulfate - reference spectrum
n/a
V0500000 Vindesine sulfate
5 mg
V0500010 Vindesine sulfate - reference spectrum
n/a
Y0000463 Vinorelbine tartrate
50 mg
Y0000464 Vinorelbine impurity B
7 mg
Y0000589 Vinpocetine
10 mg
Y0000590 Vinpocetine impurity A
10 mg
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
Y0000591 Vinpocetine impurity B
10 mg
Y0000790 Vinpocetine impurity C
10 mg
Y0000760 Vinpocetine impurity D
Y0000793 Vinyl acetate

Y0001395 Voriconazole
1854
Yes
+5C
79
0213,0538,1
057
Yes
Liquid nitrogen
100
+5C
79
-20C
79
+5C
79
2305
+5C
79
2305
+5C
79
-80C
g(d)
79
79
79
79
g(d)
79
79
2305
0748,0749
Yes
Yes
0748
0748,0749
Yes
-80C
0749
5.19 mg per vial of CHNOS ; Batch 2 is valid until 24 April 2013
1276
Yes
-80C
1276
2107
-80C
g(d)
79
2107
-80C
g(d)
79
2139
+5C
79
2139
+5C
79
(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
2139
+5C
79
ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)
2139
+5C
79
10 mg
(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
2139
+5C
79
200 mg
+5C
79
120 mg
100% CHFNO
2576
+5C
79
Y0001396 Voriconazole impurity B
10 mg
(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol
2576
+5C
79
Y0001398 Voriconazole impurity D
10 mg
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)
2576
+5C
79
4-O-deacetylvinorelbine
Yes
2152,2523
83
Yes

Order
Reference Standard
Code
Y0001397 Voriconazole impurity E

Information
per vial Unit
1
50 mg
1 [(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)
W0100000 Warfarin sodium
Y0000778 Warfarin sodium clathrate

X0075000 Xylazine hydrochloride
Monograph Leaflet
Storage
2576
+5C
Extra
Price
charges
79
g
10 mg
0698,0699
+5C
79
10 mg
0699
+5C
79
125 mg
1481
+5C
79
Y0000158 Xylazine impurity C
50 mg
2,6-dimethylphenyl isothiocyanate
1481
+5C
79
Y0000159 Xylazine impurity E
15 mg
87.5% CHNS ; methyl (2,6-dimethylphenyl)carbamodithioate
1481
Yes
+5C
79
Y0001224 Xylazine impurity mixture
0.02 mg
1481
Yes
+5C
79
500 mg
1381
Yes
+5C
79
X0100000 Xylometazoline hydrochloride
100 mg
0972,1162
+5C
79
X0101000 Xylometazoline impurity A
10 mg
1162
+5C
79
X0200000 Xylose
100 mg
+5C
79
Y0000656 Yohimbine hydrochloride
20 mg
99.1% CHClNO
2172
+5C
79
Z1900000 Zidovudine
60 mg
99.5% CHNO
1059
+5C
79
Z1902000 Zidovudine impurity A
10 mg
1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl pyrimidine-2,4
(1,3)-dione
1059
+5C
79
Z1904000 Zidovudine impurity B
15 mg
1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione
1059
+5C
79
Z2000000 Zinc acexamate
50 mg
1279
+5C
79
Z2000010 Zinc acexamate impurity A
50 mg
6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid
1279
+5C
79
Y0001286 Ziprasidone hydrochloride monohydrate
100 mg
95.6% CHClNOS
2421
Yes
+5C
79
Y0001272 Ziprasidone for system suitability 1
10 mg
2421
Yes
+5C
79
Y0001241 Ziprasidone for system suitability 2
0.465 mg
2421
Yes
+5C
79
Z2500000 Zolpidem tartrate - * psy
200 mg
1280
+5C
79
Z2500010 Zolpidem impurity A
10 mg
N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide
1280
+5C
79
Z3000000 Zopiclone -* psy
40 mg
1060
+5C
79
Z3001000 Zopiclone oxide
20 mg
1060
+5C
79
Y0000062 Zuclopenthixol decanoate - reference spectrum
n/a
79
Y0000534 Zuclopenthixol for system suitability
0.26 mg
+5C
79
Y0000083 Zuclopenthixol impurity B
10 mg
+5C
79
New X0080000 Xylitol

N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide
1278
Yes
1707
1707
2-chloro-9H-thioxanthen-9-one
84
1707
Yes

Web Catalog CRS

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Web Catalog CRS

Uploaded by

Copyright:

Available Formats

List of European Pharmacopoeia Reference Standards

Effective from 2013/11/12

Y0001484 Medroxyprogesterone acetate for peak identification

Y0001523 Ursolic acid

Y0001532 Norethisterone acetate for system suitability

Y0001562 Doxylamine hydrogen succinate

Y0001565 Recombinant Major Allergen rBet v 1

10.25 micrograms of rBet v 1

Y0001566 Recombinant Major Allergen rPhl p 5a

8.56 micrograms of rPhl p 5a

Y0001567 Docusate sodium

Y0001570 Nitrofural impurity B

Y0001571 Naloxone impurity D

Y0001573 Atovaquone for system suitability

New Y0001574 Mesalazine for system suitability

Batch 1 is valid until 30 April 2014

Y0001575 Bupivacaine impurity F

Y0001577 Isoprenaline impurity A

Y0001580 Rocuronium bromide

Y0001585 Cellulose acetate butyrate

Y0001591 Flutamide for system suitability

Y0001592 Ivy leaf dry extract HRS

Y0001594 Megestrol acetate impurity K

New Y0001595 Diacerein

Y0001596 Diacerein impurity B

Y0001597 Diacerein impurity mixture

Y0001603 Dutasteride for system suitability

Y0001604 Finasteride for peak identification

Y0001605 Eucommia bark HRS

Y0001609 Norflurane - reference spectrum

New Y0001617 Ketotifen for peak identification

New Y0001619 Ketotifen hydrogen fumarate

New Y0001620 2,4-dichlorobenzyl alcohol

New Y0001621 2,4-Dichlorobenzyl alcohol impurity A

Council of Europe, all rights reserved 2013

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2013/11/12

New Y0001642 Capecitabine

New Y0001643 Capecitabine impurity A

New Y0001644 Capecitabine impurity B

New Y0001645 Capecitabine impurity D

Y0001561 Abacavir sulfate

Y0001551 Abacavir for system suitability

Y0001552 Abacavir for peak identification

Y0000055 Acamprosate calcium - reference spectrum

Y0000116 Acamprosate impurity A

Y0000354 Acarbose for identification

Y0000427 Acarbose for peak identification

A0040000 Acebutolol hydrochloride

Y0000359 Acebutolol impurity B

Y0000127 Acebutolol impurity C

Y0000128 Acebutolol impurity I

Y0000056 Aceclofenac - reference spectrum

Y0001094 Aceclofenac for peak identification

Y0000085 Aceclofenac impurity F

Y0000086 Aceclofenac impurity H

Y0000811 Acemetacin impurity A

Y0000842 Acemetacine impurity mixture

A0070000 Acesulfame potassium

A0070020 Acesulfame potassium impurity B

Y0001084 Acetazolamide for system suitability

Y0000002 Acetylcholine chloride